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0.3 Abstract
The regulation of gene expression is essential for the correct function of virtually all
cellular processes and misregulation has a range of pathological consequences,
including Alzheimer’s disease and cancer. The NuA4 coactivator complex is an
essential eukaryotic histone acetyltransferase, that promotes transcriptional activation
and DNA repair. The complex targets the N-terminal tail of H4 and H2A, recruited to
specific loci by DNA-binding transcriptional activators. NuA4 is highly modular, with
several subcomplexes that can exist independently, or shared with other coactivator
complexes such as SAGA, allowing for targeted acetylation of specific gene loci.
An investigation of the structure and function of the NuA4 subcomplex TINTIN, is
presented herein, a trimeric module comprised of the subunits Eaf3, Eaf5 and Eaf7.
TINTIN has been implicated in promoting transcription elongation, via a proposed
interaction with RNA polymerase II and regulating nucleosome stability. TINTIN has
been recombinantly expressed, purified and subjected to crystallography trials, which
failed, despite multiple truncated TINTIN constructs that produced complexes of
higher stability and purity. Nevertheless, these constructs provided insights into
TINTIN architecture and identified key determinants for complex stability and major
differences with the orthologous complex found in humans. A combination of
SEC-MALS, native mass spectrometry and small-angle X-ray scattering analysis,
provide low-resolution information, regarding the overall topology and oligomeric
state of the complex.
TINTIN exists predominantly in its heterotrimeric state, though the interaction
between Eaf5 and the rest of the complex is relatively labile. The complex adopts an
extended conformation, with some indications of partial flexibility/disorder.
Additional factors may be required to stabilise TINTIN, such as subunits of the parent
NuA4 complex and/or the RNA Pol II CTD, which pull-down experiments presented
herein, suggest directly interacts with the complex.
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0.3.1 Brief Aims and Objectives
The TINTIN subcomplex was originally identified by immunoprecipitation from yeast
(Rossetto et al. 2014), which showed that a complex of NuA4 subunits Eaf3, Eaf5 and
Eaf7, could be purified from cellular extracts without its NuA4 parent complex.
Furthermore, TINTIN localised to gene bodies and correlated highly with the presence
of H3K36me3 and Pol II CTD phosphorylation at Ser2. However, the molecular
features of TINTIN structure and its putative association with modified histones and
Pol II were unknown. The aim of this thesis was to explore these aspects of yeast
TINTIN function, by structural and biochemical analysis, with the following
objectives:
1. To express, purify and structurally characterise the TINTIN complex, using a
combination of X-ray crystallography, native ion mobility-mass spectrometry
and SAXS.
2. To generate a series of truncated TINTIN constructs, followed by
expressions/purifications, to identify essential components for complex
assembly and function.
3. To explore the relationship of TINTIN to the orthologous complex
MRG15/MRGBP, which lacks an ortholog of Eaf5.
4. To verify an interaction between TINTIN and Pol II CTD, using pull-down
assays with purified TINTIN and phosphorylated peptides, that mimic the CTD
at different stages of transcription.
5. To determine whether TINTIN could interact directly with methylated histone
H3 and to compare this affinity, to that of the isolated chromodomain of Eaf3.
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0.4 Abbreviations
International system of units (SI) abbreviations and standard notation for chemical
elements/formulae are used in this thesis. Additional abbreviations include:
1. Act1: Actin-1.
2. AI media: Autoinduction media.
3. Å: Angstroms.
4. Arp4: Actin-related protein 4.
5. ATP: Adenosine triphosphate.
6. bp: base-pairs.
7. BSA: Bovine serum albumin.
8. CCS: Collision cross sections.
9. ChiP: Chromatin immunoprecipitation.
10. CID: Collision induced dissociation.
11. Cryo-EM: Cryo-electron microscopy.
12. CSD: Charge state distribution.
13. CTD: C-terminal domain.
14. Ctk1: Carboxy-terminal kinase.
15. CV: Column volumes.
16. Dmax: Maximum dimension within a molecule.
17. DFL: Dual-function loop.
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18. DMSO: Dimethyl sulfoxide.
19. DNA: Deoxyribonucleic acid.
20. DTT: Dithiothreitol.
21. Eaf1-7: Esa1 associated factors 1-7.
22. EDTA: Ethylenediaminetetraacetic acid.
23. Epl1: Enhancer of polycomb-like protein 1.
24. Esa1: histone acetyltransferase protein.
25. ESI: electrospray ionisation.
26. FACT: Facilitates chromatin transcription remodelling complex.
27. FATC: FAT(FRAP, ATM, TRRAP) C-terminal domain.
28. FL: full-length protein.
29. GST: Glutathione S-transferase.
30. H2A: Histone 2A.
31. H2B: Histone 2B.
32. H3: Histone 3.
33. H4: Histone 4.
34. HAT: Histone acetyltransferase.
35. HBL: Histone binding loop.
36. HDAC: Histone deacetylase.
37. HEAT: Huntingtin, elongation factor 3 (EF3), protein phosphatase 2A (PP2A),
and the yeast kinase TOR1 domain.
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38. HFD: Histone fold domain.
39. HPLC: High performance liquid chromatography.
40. HSA: Helicase /SANT-associated domain.
41. I(0): SAXS forward scattering intensity.
42. IEX: Ion-exchange chromatography.
43. IM-MS: Ion mobility-mass spectrometry.
44. ING1: Inhibitor of growth protein-1.
45. IPTG: Isopropyl β - d-1-thiogalactopyranoside.
46. kDa: kilo Daltons.
47. LB: Luria broth.
48. LS: Light-scattering signal
49. M/Z: Mass/Charge ratio.
50. MALDI: Matrix assisted laser desorption/ionisation.
51. MES: 2-(N-morpholino)ethanesulfonic acid buffer.
52. MMS: Methyl methanesulfonate.
53. MPA: Methiopropamine.
54. MRG15: MORF related gene 15 protein.
55. MRGBP: MRG15 binding protein.
56. mRNA: Messenger RNA.
57. MSMS: Tandem mass spectrometry.
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58. MW: Molecular weight.
59. Native MS: Native mass spectrometry.
60. NCP: Nucleosome core particle.
61. NMR: Nuclear magnetic resonance.
62. NSD: Normalized spatial discrepancy.
63. NuA4: Nucleosome acetyltransferase of H4.
64. OD: Optical density.
65. Dmax: Maximum dimension of a species (SAXS).
66. PCR: Polymerase chain reaction.
67. PDB: Protein data bank.
68. PEG: Polyethylene glycol.
69. PIC: Pre-initiation complex.
70. PIKK: Phosphatidylinositol 3-kinase-related kinase family.
71. Pol II: RNA polymerase II.
72. PTM: Post-translational modifications.
73. R f ree: Crystallographic R-factor (from 5% of data).
74. Rg: Radius of gyration.
75. Rwork: Measure of agreement between crystallography model and experimental
data
76. rcf: Relative centrifugal source.
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77. RI: Refractive index.
78. RNA: Ribonucleic acid.
79. Rpd3S: Rpd3 small complex.
80. rpm: Revolutions per minute.
81. SAGA: Spt-Ada-Gcn5-acetyltransferase complex.
82. SAXS: Small-angle X-ray scattering.
83. SDS-PAGE: Sodium dodecyl sulfate polyacrylamide gel electrophoresis.
84. SEC-MALS: Size-exclusion chromatography, multi-angle light scattering.
85. SPB: Spindle pole body.
86. Strep: Streptavidin.
87. SWI/SNF: SWItch/Sucrose Non-Fermentable.
88. SWR1: Chromatin remodelling complex.
89. T7: Bacteriophage T7 polymerase.
90. TAP: Tandem-affinity purification.
91. TB: Terrific broth.
92. TBP: TATA box binding protein.
93. TEEAA: Tra1, Eaf1, Eaf5, actin and Arp4.
94. TINTIN: Trimer independent of NuA4 involved in transcription interactions
with nucleosomes.
95. Tip60: Human histone acetyltransferase of H4.
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96. Tm: Temperature at which ~50% of protein has denatured in thermofluor assays.
97. TOR: Target of rapamycin.
98. Tra1: Transcription-associated protein.
99. TRRAP:Transformation/Transcription domain associated protein.
100. TS: Temperature sensitive.
101. UAS: Upstream activator sequence.




106. Yaf9: Yeast homolog of the human leukemogenic protein AF9.
107. Yng2: Yeast ING1 homolog.
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1.1 What is Chromatin?
Eukaryotes, unlike their prokaryotic counterparts, have evolved to package their
genetic material into large complexes of DNA and histone proteins, termed chromatin.
The structure of chromatin has long been associated with the regulation of cellular
processes and this includes, but is not limited to; transcription, DNA replication and
cell cycle progression.
We have been aware of chromatin since the early 20th century, by staining eukaryotic
nuclei, which revealed condensed structures of DNA and protein, at various stages of
mitosis (Huisinga et al. 2006). Chromatin arranges itself into regions of varying
density, with the denser regions (heterochromatin) associated with reduced levels of
gene expression, compared to the less compact euchromatin (Lorentz et al. 1992).
Chromatin is dynamic and can transition between these two states, depending on the
stage of the cell cycle, or to allow for the activation of specific gene loci (Grewal and
Moazed 2003, Lai and Pugh, 2017).
The basic repeating unit of chromatin is the nucleosome core particle (NCP), which
has been structurally characterised to a high-resolution (Luger et al. 1997) (Figure
1.1). These NCPs assemble into a "beads on a string" arrangement, which consists of
long fibres of DNA, punctuated by nucleosomes, made visible by Olins and Olins
(1974) with negative staining.
Figure 1.2 presents a schematic of the repeating beads on a string array, which is
generic for eukaryotes. NCPs are the target of large chromatin modifying machinery,
that can result in subtle changes, such as the post-translational modification of specific
histone residues, to the complete exchange/movement of histone subunits.
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Figure 1.1: 2.8 Å resolution crystal structure of the human nucleosome core particle
(Luger et al. 1997). 147 DNA base pairs (grey) wrap around a protein octamer, con-
sisting of two copies of the four following proteins: H2A, H2B, H3 and H4 (which
have been colour coded). Histones form histone fold domains (HFD), helical regions
connected by unstructured loops, that arrange in a head to tail manner. The HFDs are
essential for forming contacts between individual histones within the nucleosome, as
well as contact with the surrounding DNA.
These varying modifications can have profound consequences on the fate of the cell
and understanding the mechanisms by which chromatin is modified, has given birth to
an entire field of molecular biology. Insights into the structural/chemical modification
of chromatin, has helped better understand certain disease pathologies.
For example, gain of function mutations in the "guardian of the genome" p53, have
been shown to lead to increased methylation and acetylation of chromatin, which in
turn leads to a pathogenic increase in the expression of tumour promoting genes (Zhu
et al. 2015).
The pathological mechanisms of other diseases, such as Alzheimer’s, have also been
implicated in the structure/state of chromatin (Frost et al. 2014). Furthermore,
chromatin modification has also been shown to play a critical role in DNA damage
repair pathways (Bird et al. 2002).
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Figure 1.2: A generic schematic of the "beads on a string" arrangement of chromatin,
typically found in eukaryotic systems. Histone octamers form a platform for DNA to
wrap around. The nucleosome core particle is the basic repeating unit of chromatin,
comprised of 147 bp of DNA wrapped around a histone octamer. Post-translational
modification of the N-terminal tails of these histones, which protrude from the NCP, is
completed by large, multisubunit protein complexes. These modifications can alter the
packaging of chromatin (heterochromatin vs euchromatin), or act as molecular markers
that allow for the association of more modifying complexes to specific loci.
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1.1.1 Transcription
In eukaryotes, RNA Polymerase II (or Pol II) is responsible for transcribing gene loci
into mRNA, which is then exported from the nucleus and translated by the ribosome
into protein (the process of splicing; removing introns, or non-coding RNA, from the
mRNA sequence must also occur prior to translation) (Lee and Young 2000).
Pol II is a large, multisubunit protein complex that has been thoroughly studied in
terms of its regulation and structure (Bernecky et al. 2016, Ehara et al. 2017). The
complex initiates transcription at specific sites, upstream of coding DNA, termed
promoters. Recruitment of Pol II to promoters is facilitated by general transcription
factors (and other factors for recruitment to specific loci) to form a pre-initiation
complex. The complex consists of; TFIIA, TFIIB, TFIID, TFIIE, TFIIF, TFIIH (which
contains the TATA box binding protein, TBP) and the mediator complex (Kelleher et
al. 1990, Louder et al. 2016, Harper and Taatjes, 2018.)(Figure 1.3).
Figure 1.3: Schematic of the pre-initiation complex over a eukaryotic promoter se-
quence. RNA Pol II forms a large complex with general transcriptions factors TFIIA-
H. The TFIID complex associates with a TATA box sequence, approximately 30 bp
upstream of the transcription start site (TSS) via the TBP subunit. Other subunits help
recruit the polymerase and prime the promoter DNA for transcription initiation.
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Pol II is recruited to specific gene loci via the mediator complex, a multisubunit
complex that bridges the PIC to transcription factors, that associate with regions
upstream of the promoter (enhancers). This provides an additional layer of spatial and
temporal regulation of gene activation and is further controlled via the modification of
histones, that promotes/represses the assembly of the PIC.
Upon initiation, the polymerase escapes the initiation complex, and the following
processes of transcription elongation and termination, are tightly regulated. Much of
this regulation is implemented by the phosphorylation of the Pol II C-terminal domain
(CTD), as well as the association of various factors at specific intervals.
1.1.2 Readers, Writers and Erasers
Advances in the fields of structural, molecular and cell biology, have revealed that
post-translational modifications (PTM) of histones, play a significant role in chromatin
structure and by extension, the regulation of cellular processes such as transcription.
Post-translational modifications are carried out by coactivator complexes, which are
also tightly regulated both spatially and temporally, ensuring the targeted
activation/inhibition of target gene loci (Kouzarides, 2007).
The majority of PTMs occur on the N-terminal tails of histones, which are often
protruding out from the NCP and are therefore the most accessible region of the
protein assembly (Figure 1.2).
There are several types of PTM, including; phosphorylation, methylation and
acetylation, to name a few (Sterner & Berger 2000, Zhang & Reinberg 2001, Zhang et
al. 2014). Many of these modifications are reversible and a set of antagonistic
complexes are in place, to remove said modifications at the appropriate time and
position.
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Post-translational modification of histones can directly influence the structure of
chromatin, or act as markers for binding and additional interactions with other
chromatin modifying complexes. This allows for dynamic regulation of gene
expression, in what has been termed: the histone code (Jenuwein et al. 2001).
Coactivator complexes can also be recruited to upstream activator sequences/enhancer
regions by transcription factors and promote/repress the assembly of basal
transcriptional machinery (Figure 1.4).
Chromatin must also be modified after transcription/replication/repair events have
been initiated. For example, remodelling complexes such as FACT modify the histone
composition of nucleosomes, thereby destabilising the NCP in preparation for
incoming Pol II, maintaining transcription elongation rates (Belotserkovskaya et al.
2003). The FACT complex removes the H2A-H2B dimer, acting as a histone
chaperone.
Figure 1.4: Schematic summary of coactivator recruitment. Transcription activators
bind upstream of transcription initiation sites. Coactivators are subsequently recruited
and carry out post-translational modification of histones and/or directly interact with
the forming pre-initiation complex, promoting transcription activation.
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1.1.3 The Role of Acetylation
Histone acetylation results in the incorporation of an acetyl functional group onto
lysine residues, from an acetyl-CoA substrate, resulting in loss of the overall positive
charge of the NH+3 group.
Acetylation occurs at lysine residues located on the N-terminal tail of histones and was
initially proposed to reduce the overall positive charge on the surface of nucleosomes,
resulting in reduced electrostatic interactions with the phosphate backbone of DNA.
The net result is the loosening chromatin and exposing promoters to transcriptional
machinery, for increased levels of expression (Loidl 1994).
Advances in our understanding of the histone code, have shown that these acetylation
markers, also act as recruiting interfaces for transcription factors and DNA repair
machinery (Natsume-Kitatani et al. 2011, Tscherner et al. 2012). It is likely that both
changes to the physico-chemical properties (as suggested by Loidl et al.) in
combination with the recruitment of transcription factors, drive increased levels of
transcription.
Histone acetylation occurs at specific amino acid residues on N-terminal tails, which
protrude out from the complex and are more accessible to coactivator complexes.
Histone acetyltransferase complexes, such as SAGA and NuA4, are responsible for
this form of modification. These acetylation events have a wide range of biological
consequences, some of which are catastrophic in the event of misregulation.
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1.2 NuA4
The first indication that histones were acetylated in a targeted fashion was established
by Kuo et al. (1996), who showed that the histone acetyltransferase (HAT) Gcn5,
acetylated lysine residues on the N-terminal tails of H3 and H4.
In search of more HAT complexes, Grant et al. (1997) began to isolate fractions
produced from yeast cell extract, which contained HAT activity (these fractions were
produced using a combination of ion exchange and gel filtration). HAT activity was
measured by incubating fractions with purified nucleosome (or free histones) and
tritium labelled acetyl-CoA. After incubation, samples were separated by SDS-PAGE
and acetylated histones could be visualised by fluorography and identified by their
molecular mass on the polyacrylamide gel.
The final size-exclusion chromatography step, produced four distinct peaks
representing protein complexes with HAT activity. Only two of these peaks contained
the Gcn5 enzyme, though Grant et al. primarily focussed on the Gcn5 containing
protein complex (called SAGA).
Allard et al. (1999) would make the first attempt to characterise these newly
discovered HAT complexes, noticing that one could tetra-acetylate H4 and H2A, a
profile that matched the already characterised HAT enzymes Tip60 and yeast homolog
Esa1 (Yamamoto & Horikoshi 1997). By raising antibodies against Esa1 and
incubating their purified HAT fraction with a resin cross-linked to the antibody, they
were able to capture the complex and confirm that Esa1 was a component of this novel
multi-protein fraction.
Tip60 and Esa1 are members of the MYST family (MOZ, Ybf2/ Sas3, Sas2 and Tip60)
of HATs. This is the largest of the HAT families and has been implicated in cancer
pathology, cell cycle progression and even chromosomal translocation, when
investigating certain forms of Leukemia (Avvakumov & Côté 2007).
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Esa1 is the only HAT enzyme found to be essential in yeast, though mutations that
abolish in vitro activity are not lethal (Smith et al. 1998). It was suggested that
additional interacting proteins aided in stabilising the enzyme, as with Gcn5 and the
other SAGA subunits (e.g. Ada2), which could compensate for the reduced activity of
the catalytic subunit in vivo. Temperature sensitive(ts) mutants of Esa1 results in loss
of H4 and H2A acetylation and prevented the purification of the novel "NuA4"
complex (nucleosome acetyltransferase of H4).
NuA4 and SAGA acetyltransferase complexes preferentially associate with promoters,
this association is followed by increased levels of acetylation in these regions and
transcriptional activation of downstream sequences (Utley et al. 1998, Ginsburg et al.
2009). The association to these regions by either complex, is driven by the interaction
between the shared subunit; Tra1 and transcription factors, such as HAP4 (Brown et al.
2001).
The last two decades of research has revealed that the S. cereviseae NuA4 is a thirteen
subunit complex, with multiple subcomplexes of varying function. This includes:
global levels of acetylation, recruitment to transcription factors, promotion of
transcription elongation rates, splicing and DNA repair. Figure 1.5 shows a schematic,
summarising our current understanding of NuA4 subunit composition, with
subcomplexes colour coded according to their in vivo role.
At present, there are no high-resolution structures of the complete complex. Chittuluru
et al. (2011) were able to provide a low-resolution structure of the complete complex
using electron microscopy, to a final resolution of 20 Å. This has since been shown to
actually correspond to a low-resolution structure of the single Tra1 subunit
(Diaz-Santin et al, 2017), as evidenced by recent incomplete EM structures of the
NuA4 complex, that will be discussed at the end of this chapter.
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Figure 1.5: A schematic representation of the yeast NuA4 complex. Subunits are ar-
ranged according to their interactions and colour-coded according to their proposed
biological function. Epl1, Yng2, Eaf6 and Esa1 are coded dark blue and represent the
Piccolo NuA4 subcomplex, which houses the catalytic Esa1. The central scaffold pro-
tein Eaf1 is coded purple and is the only NuA4 specific protein found in yeast. Tra1 is
the largest component of the 1.3 MDa complex, constituting approximately 40% of the
molecular mass of NuA4 and shown to physically link the complex to transcriptional
activators such as c-Myc. Eaf3/5/7 are coloured light blue and represent the TINTIN
(trimer independent of NuA4 for transcription interactions with nucleosomes) subcom-
plex. Subunits that are shared with the SWR1 chromatin remodelling complex and
implicated in DNA damage repair mechanisms, have been labelled orange.
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1.2.1 The Tip60 Complex
Doyon et al. (2004) is a good summary of all that was known about NuA4 at the time.
They note that NuA4 shares 12 of its 13 subunits with the human Tip60 HAT complex
(with the exception of Eaf5, which is unique to S. cerevisiae) (Figure 1.6). The human
Tip60 complex is a fusion of the yeast NuA4 acetyltransferase and the SWR1
remodelling complex (which also shares four subunits with NuA4) and possesses the
functionality of both yeast complexes.
Figure 1.6: A schematic representation of yeast NuA4, SWR1 and human Tip60 com-
plexes. Yeast NuA4 shares 12 of its 13 subunits with the human Tip60, which does not
possess an Eaf5 ortholog. NuA4 and SWR1 are known to possess a shared subcomplex,
which has been highlighted in orange. The Tip60 complex appears to be a fusion of the
yeast HAT NuA4 and the SWR1 remodelling complex and has been reported to show
both activities in vivo. Tip60 functions as an acetyltransferase and remodelling com-
plex. The Tip60 complex has been implicated in Alzheimer’s and cancer pathologies.
Figure 1.6 highlights the benefits of using yeast NuA4 as a proxy for understanding the
Tip60 complex function. While Tip60 shows additional chromatin remodelling activity
(due to SWR1 subunit orthologs), later reports would show that yeast NuA4 and
SWR1 work in concert, to acetylate and then remodel chromatin, similar to the activity
of the Tip60 complex (Zhang et al. 2004).
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This coordination is achieved in yeast, in part, by the two complexes sharing subunits.
The role of the Yaf9 subunit is a good example of the two complexes working together,
as it enables the incorporation of non-canonical histone H2A.Z in the promoter region
of the PHO5 gene. This alteration is usually associated with regions of chromatin
being prepared for transcriptional activation and is often enriched near hyperacetylated
H4 (likely a reflection of SWR1 and NuA4 joint modification of chromatin)
(Santisteban et al. 2000, Kurdistani & Grunstein. 2003).
Tip60 has been shown to be essential for DNA damage response pathways, which is
likely due to its role in acetylation (via the NuA4-like subunits) and remodelling (Ikura
et al. 2000). These activities possibly prepare regions of the genome in close
proximity to sites of DNA damage, for repair machinery binding, in a similar manner
to how chromatin is primed for the formation of the pre-initiation complex, for
transcriptional activation. However, the exact function of Tip60/NuA4 in DNA
damage repair mechanisms remains largely uncharacterised, while its role as a
coactivator complex has slowly been delineated.
1.2.2 The Piccolo Subcomplex
In 2003, Boudreault et al. showed that Esa1, Epl1 and Yng2 could form a stable trimer
in vivo which was catalytically active and likely responsible for global, non-targeted
acetylation of H4. Transient inhibition of the expression of any of these proteins (when
under the influence of a GAL1 promoter), led to the accumulation of cells in G2/M
stage of the cell cycle (measured by fluorescence-activated cell sorting).
This subcomplex was named Piccolo and all three components are essential for cell
cycle progression. The transient repression experiments suggested that global H4
acetylation is carried out by the Piccolo subcomplex, as opposed to the targeted
acetylation carried out by complete NuA4. This global activity is independent of the
rest of the NuA4 complex.
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Mutations in Piccolo subunits result in sensitivity to rapamycin and MMS, implying
the complex plays a role in ribosome biogenesis, TOR signalling and DNA damage
repair.
Piccolo acetylates residues K5, K8, K12 and K16 of H4 with approximately 20X
higher rate in the complete NCP, compared to the free histone (Berndsen et al. 2007).
Comparing free Esa1 acetylation activity to its activity in the Piccolo trimer, reveals
that the complex acetylates nucleosomes preferentially, whereas the free enzyme is
incapable of acetylating the NCP and will acetylate H4 with equal activity and
efficiency, as it does peptides mimicking the N-terminal tail of H4. This data supports
the roles of Yng2 and Epl1 in both facilitating NCP binding and increased catalytic
activity from Esa1.
Yan et al. (2000) would provide the first crystal structure of the active site of Esa1 in
complex with acetyl-CoA. They identified the region critical for HAT activity in vitro
by generating a series of truncated Esa1 constructs, narrowing their search down to
residues 160 - 435.
While these constructs retained catalytic activity in vitro, their in vivo activity
appeared to be disrupted, resulting in growth defects during complementation studies.
They speculated that the deleted regions contained interfaces for interactions with
other components of NuA4, which were required for fully functioning activity.
Superimposing Esa1 with the structure of Gcn5 (PCAF) and Hat1 bound to substrate,
revealed that acetyl-CoA binds to a similarly structured position in each case and was
in close proximity to a conserved glutamate residue, a proton acceptor during the
catalytic mechanism. They also noted that there was sufficient space for the side chain
of a lysine residue being modified, to dock between the glutamate and the acetyl-CoA
binding positions.
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While useful, this structure was of the incomplete enzyme and NuA4 at this point was
still a relatively obscure complex in terms of our understanding of subunit
composition; with only Tra1 and Esa1 having been identified. More information was
required to deduce the apparent specific transcriptional activation associated with
NuA4’s in vivo activity.
Esa1 contains an essential non-canonical chromodomain (located between its
N-terminal and catalytic domain) which is unable to bind methylated lysines (Selleck
et al. 2005, Jacobs et al. 2001). The chromodomain identified would later be shown to
actually form an anti-parallel 5-stranded β -barrel structure, more akin to a tudor
domain than canonical chromodomains (Shimojo et al. 2008, Maurer-Stroh et al.
2003).
The tudor domain shows structural similarity to the archael DNA binding protein,
SSo7D and was shown to promote nucleosome binding, potentially via direct contact
with DNA (Huang & Tan, 2013) (Figure 1.7).
A) B)
Figure 1.7: A) 2.1 Å structure of Archaeal Sso7D protein (red) in complex with double
stranded DNA (PDB entry: 1BNZ). B) NMR solution structure of of the Esa1 tudor
domain (cyan). The domain forms an anti-parallel β -barrel with a distinct loop (red)
conserved between Esa1 and MOF, which has been implicated in the catalytic activity
of the enzyme, despite being distinct from the active site. (PDB entry: 2RO0).
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Yng2, a plant homeodomain (PHD) containing protein, is a component of NuA4
(Nourani et al. 2001, Eisen et al. 2001). The PHD domain is a cys-his-cys motif;
found in many proteins involved in chromatin modification and implicated in cancer
pathology (Aasland et al. 1995, Gunduz et al. 2000). Yng2 mutants are also growth
sensitive to MMS, a DNA damaging agent (Garkavtsev et al. 1996). This is to be
expected, when we consider it shares sequence similarity with the tumour suppressor
ING1.
Interestingly, this PHD domain is not essential for restoring the wild-type (WT) levels
of sensitivity to DNA damaging agents, which leaves questions regarding the domain’s
overall role. Like its ortholog ING1, Yng2 directly interacts with human "guardian of
the genome" p53 and this interaction results in the hyperacetylation of nucleosomes in
close proximity to p53.
The Epl1 subunit interacts directly with the other two components of Esa1 and Yng2,
but these two proteins do not co-purify in the absence of Epl1, strongly supporting its
role as the scaffold subunit within the trimer. Strains expressing Epl1 truncated at the
non-essential C-terminal domain, prevent co-purification of NuA4 via Esa1, but cells
are otherwise viable, suggesting that this smaller subcomplex is the essential
component of NuA4 for cell viability.
A 20-residue N-terminal region, in the conserved EPcA (Enhancer of poylcomb A)
domain of Epl1, is essential for HAT activity (Boudreault et al. 2003). Like the Esa1
tudor domain, mutations in this region reduce catalytic activity, as opposed to the
binding of nucleosomes (Huang & Tan. 2013).
Rossetto et al. (2014) were able to to show that Eaf1 deletion followed by TAP-tagged
purification via Eaf6, yields the three subunits of Piccolo. C-terminal truncation of
Epl1, which results in separation between Piccolo and the rest of NuA4, followed by
Eaf6 TAP-tag purification yields identical results, indicating that Eaf6 is a member of
the Piccolo subcomplex.
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This is a reasonable suggestion, when we consider that the human ortholog of Eaf6
forms a tetrameric complex in vivo, which is responsible for global acetylation of
nucleosomes in humans (though not with the Tip60 HAT) (Doyon et al. 2006). Piccolo
has since been structurally characterised to a high resolution, in the form of individual
structures of Esa1 (in complex with its acetyl-CoA substrate) and the complete
complex (Yuan et al. 2012, Xu et al. 2016).
The major leap in Piccolo structure/function understanding was recently made by Xu
et al. (2016), who produced high-resolution structures of Piccolo (including Eaf6) in
complex with acetyl-CoA and a peptide mimicking the N-terminal tail of Ht1z. The
peptide bound structure was produced at a resolution of 3.23Å(R f ree/Rwork =
25.0/27.3) and includes all essential domains. (Figure 1.8)
Figure 1.8: Subunits of the Piccolo complex, from a 3.23 Å resolution crystal struc-
ture (R f ree/Rwork = 25.0/27.3). PDB entry: 5J9Q. Includes most critical domains for
integrity and HAT activity, with the exception of tudor domain of Esa1. Subunits have
been colour-coded and are arranged broadly into two distinct regions; a catalytic core
consisting of Esa1 and the EPcA-I domain of Epl1, and a helical bundle of Eaf6, Yng2
and the EPcA-II domain of Epl1.
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The structure can be broadly split into two regions; the catalytic core and a four-helix
bundle. The catalytic core consists of Esa1 and an N-terminal end of the EPcA domain
of Epl1, while the C-terminal region of the EPcA domain forms a four-helix bundle
with the remaining Piccolo subunits and likely fulfils a structural stabilising role in the
complex.
The two distinct regions within the EPcA domain show weak interactions and are
connected by a loop described as the dual-function loop (DFL). The N-terminal region
of the EPcA domain, which had been characterised by Huang & Tan (2013) for its role
in catalytic activity, extends out from the complex to then loop around Esa1 and an
Epl1 globular domain, that interacts with Esa1, at a site neighbouring the catalytic
domain.
The cleft between a conserved glutamate and CoA binding site, forms the docking
position for histones (specifically the amine side chain of lysine) and resides within a
α2-β7 loop, termed the histone binding loop (HBL).
They show that, unlike Yan et al.’s structure of free Esa1, the α2-helix of Esa1 in
Piccolo interacts with the DFL via a FRR motif, which rearranges the loop to extend
outwards. Additional points of contact with Epl1 and Esa1 ensures that the Esa1 HBL
loop stays in this extended conformation. They confirm an auto-acetylation event as
proposed by Yuan et al. (2012), which is further stabilised by interaction with Ser291
and Tyr289.
The lysine binding pocket is shallow and substitution of amino acids downstream from
the lysine on the peptide, to larger residues (such as histidine) produces a dramatic
reduction in catalytic activity. H4 N-terminal lysines are usually flanked by relatively
short residues such as alanine, which show minimal steric clashing with the residues of
the Esa1 binding pocket, this is the basis for preferential H4 acetylation by NuA4.
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Finally, Xu et al. produced a 7.9 Å resolution structure of Piccolo in complex with the
NCP, by docking their newly produced structure, the tudor domain solution structure
produced by Shimojo et al. and a high-resolution NCP structure onto their electron
density.
The helical bundle of the Piccolo structure, appears to protrude at a peripheral position
to the NCP and the conserved glutamate of Esa1, rests 24 Å from the N-terminal tail of
H4, which is sufficient for access to the four lysine residues. The H2A N-terminal tail
on the other hand, is nearly 3X the distance from this glutamate as the H4 tail is, likely
exacerbating the preferential acetylation of H4.
H2B and H3 N-terminal tails by contrast, are on another face of the nucleosome
structure, preventing direct interaction with the active site. This is direct evidence of
what had been inferred by many years of biochemistry research; that the structures of
the Piccolo complex and NCP, positions Esa1 in such a way that is optimal for H4
acetylation, as opposed to other histone proteins.
1.2.3 Tra1 and NuA4 Recruitment
SDS-PAGE analysis of the NuA4 fractions consistently produce a high-molecular
weight band (400 kDa). Tra1 was quickly identified as a candidate protein; being one
of the few yeast proteins to match this MW and is also a component of the HAT
complex, SAGA (Saleh et al. 1998).
Tra1, like its human ortholog TRRAP, had been shown by Saleh et. al to associate with
transcription factors such as c-Myc, suggesting a direct connection between chromatin
acetylation and transcription activation.
Other groups had shown that Tra1 was essential for c-Myc and E1A driven
transcription activation, as Tra1 mutants blocked oncogenic transformation of the
transcription factors (McMahon et al. 1998).
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Tra1 likely plays additional roles in the mechanism of SAGA and NuA4 activity, when
we consider mutations that do not alter the targeting or integrity of either coactivator
complex, but nonetheless show reduced rates of transcription (Knutson and Hahn,
2011).
The subunit is part of the Phosphoinositide 3-Kinase-related kinase (PIKK) family of
proteins, which play a role in growth regulation, mTOR signalling and cancer
pathology when misregulated (Yang et al. 2013, Baretic and Williams, 2014).
Tra1(and human TRRAP) lacks catalytic activity and its structure has been solved to
3.7 Å resolution by cryo-EM (Diaz-Santin et al. 2017)(Figure 1.9).
Figure 1.9: 3.7 Åresolution cryo-EM structure, of the PIKK family protein, Tra1 (PDB
= 5OJS). The protein is structured as a "diamond ring", with the inactive kinase, FRB
and FAT domains forming the head of the structure. The majority of the structure
however is alpha-helical, arranged into HEAT repeat solenoids, found in the "finger"
and "ring" regions.
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The protein contains all domains associated with the PIKK family (Baretic and
Williams 2014, Aylett et al. 2016), including an FRB domain, the inactive catalytic
site and a FATC domain at the C-terminal. Over 80% of the structure is comprised of
α-helical HEAT repeat domains, these solenoid structures form a large "ring" and
"finger" region, which rests beneath the "head" and "clasp" regions. HEAT repeats are
found throughout the structure, but the head and clasp domains contain the FAT, FRB
and inactive kinase domains.
Comparisons to other PIKK family members reveals that Tra1 shows mutations in
ATP/Mg binding sites and contains an 18 residue insertion in a known activation loop,
which may explain its inactivity (Yang et al. 2013, Sibanda et al. 2017).
The ring and finger regions contains high-surface area, solvent accessible channels,
though activator binding sites which were previously identified by mutation studies,
were found scattered across the entire complex (Brown et al. 2001, Knutson and Hahn,
2011). The wide distribution of these sites ensures that mutations that would disrupt
binding between Tra1 and one activator, will not interfere with binding to other
activators.
1.2.4 Eaf1: The NuA4 Scaffold
Eaf1 is the essential NuA4 scaffold, around which other subunits in the complex
assemble (Auger et al. 2008)(Figure 1.5). Eaf1 shows strong identity with the Tip60
component p400/Domino, though lacks a SWI/SNF family ATPase domain, essential
for the incorporation of the non-canonical histone H2A.Z into the NCP (Cöté et al.
1994, Narlikar et al. 2013).
TAP purification of natively expressed Eaf1, followed by mass spectrometry and
western blot analysis, identified Eaf1 as the only subunit specific to the complete
NuA4 complex.
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TS mutants show sensitivity to MMS and ionising radiation, further implicating
NuA4’s role in DNA repair mechanisms. Like the subunits of Piccolo-NuA4, Eaf1
mutants also show rapamycin sensitivity and reduced PHO5 expression levels (Bennett
et al. 2001, Auger et al. 2008).
Eaf1 makes direct contact with Epl1, tethering the Piccolo subcomplex, as well as Tra1
via a C-terminal SANT domain. SANT domains are usually found in proteins that play
a role in chromatin modification and often possess histone or DNA binding properties
(Boyer et al. 2004). Eaf1 also makes contact with NuA4 subunits shared with the
SWR1 remodelling complex (Eaf2, Arp4, Act1 and Yaf9) via Eaf2 and Rossetto et al.
(2014) would show that the Eaf5/7/3 subcomplex would also tether to Eaf1 via Eaf5.
These contacts were inferred by several studies and finally verified with by the
cryo-EM structure of the core NuA4 complex Wang et al. 2018) (Figure 1.10).
While a functioning Piccolo subcomplex is the minimal requirement for viable HAT
activity in vivo, Eaf1 couples this non-specific HAT activity to other NuA4 components
that act to guide the coactivator complex to specific loci (Tra1 and Arp4 for example).
The loss of Eaf1, while not immediately catastrophic for the cell, is required for the
specific activation of transcription for certain genes. The subsequent acetylation of
promoters that follows, results in recruitment of basal transcription machinery, such as
TFIID (Uprety, Sen and Bhaumik, 2015).
1.2.5 Chromatin Remodelling Module
Eaf2, Arp4, Act1 and Yaf9 are all components of the SWR1 chromatin remodelling
complex and NuA4, (Galarneau et al. 2000, Le Masson et al. 2003, Auger et al. 2008).
The role of these subunits in NuA4 is the least understood, though some efforts have
been made to delineate their function.
Eaf2 tethers this module to Eaf1 and makes direct contact with Yaf9. As with Eaf1,
Eaf2 contains a SANT domain and is essential for WT levels of cell growth.
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Mutations in Eaf2 also result in MMS sensitivity, but unlike other NuA4 components,
these do not show sensitivity to rapamycin.
Yaf9 mutants produce growth defects and reduced H4 acetylation levels, and is also
implicated in spindle pole body (SPB) formation (Loewith et al. 2001, Gavin et al.
2002, Le Masson et al. 2003). While mutations in Yaf9 show sensitivity to benomyl (a
microtubule disrupting compound), it is difficult to determine whether these mutations
(and their consequences) are a result of disruption to NuA4 activity or SWR1.
Act1 had already been shown to be a component of the mammalian chromatin
modifying complex SWI/SNF; responsible for altering the histone composition of
canonical NCP (Zhao et al. 1998).
Arp4 is an interesting component, having been shown to play a role in activation of
specific loci, such as LYS2 (Jiang & Stillman 1996) and directly interacts with histones
(Galarneau et al. 2000). TS mutations of Arp4 have similar results to mutations in
Yaf9 and Esa1, leading to reduced growth and even reduced levels of acetylation in the
same gene loci.
The above mentioned data implicates this module in DNA repair functionality, though
it is difficult to distinguish this from consequences for the SWR1 complex, which is
also important for DNA repair processes (Rosa et al. 2013).
1.2.6 Core NuA4 and SAGA
Throughout the course of this project, advances have been made in our understanding
of the structure and function of the complex (discussed in the next section), which has
been aided largely due to advances in electron microscopy techniques and the so called
"resolution revolution."
Figure 1.10 shows a 4.7 Å resolution cryo-EM structure of the NuA4
TEEAA-complex (Tra1, Eaf1, Eaf5, Actin, and Arp4) by Wang et al. (2018).
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This represents the most complete (and highest resolution) image of the NuA4
complex available. While they are able to purify the complete 13 subunit complex, the
predominant complex observed in their microscopy experiments was deficient of Eaf7,
Eaf3, Swc4(Eaf2), Yaf9 and Piccolo (though they also produce a 7.8 Å structure of this
"core" complex, with a docked Piccolo crystal structure).
Their structures suggest that Tra1 also plays a scaffolding role in parallel with Eaf1,
making contacts with Eaf5, as well as the two Piccolo subunits; Epl1 and Yng2.
Wang et al. observe direct contact between the Eaf1 HSA domain and the actin, and
Arp4 subunits (as had previously been inferred by Auger et al. 2008) via a series of
hydrophobic interactions. The Eaf1 SANT domain was also shown to be in direct
contact with Tra1’s LBE and FACT domains, by hydrogen bonding and ionic
interactions, partially explaining Tra1 mutations associated with reduced growth rates
in yeast (Hoke et al. 2010). Wang et al. (2018) produced a lower resolution structure
of TEEAA-Piccolo, suggesting that the catalytic subcomplex makes contact with Tra1
via Yng2 and with the Eaf1 HSA domains, via the C-terminal of Epl1.
Eaf1 in the TEEAA structure has relatively large regions that are
unresolved/disordered, but upon binding of the Piccolo complex, the scaffolding
complex becomes more compact/ordered.
This TEEAA subcomplex gives some definitive insights into subunit arrangement, and
is generally in agreement with what had been inferred indirectly in the previously
discussed literature. The structure of the Tra1 subunit is largely in agreement with the
structure our group had previously produced (Figure 1.10).
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Figure 1.10: 4.7 Å resolution cryo-EM structure of the TEEAA (Tra1, Eaf1, Eaf5,
Act1, Arp4) NuA4 subcomplex produced by Wang et al. (2018). An additional structure
of lower resolution was also produced (data not included), docking the position of the
Piccolo subcomplex, its docking position in the TEEAA complex has been circled.
Significant portions of the Eaf1 subunit remain disordered/unresolved, however both
SANT and HSA domains, which are responsible for direct contacts with Tra1 and Arp4/
actin, respectively, are represented.
A complete, high-resolution picture of the NuA4 complex remains elusive, in part due
to the flexibility of key modules, and also due to the transient nature of interactions
between specific interfaces. Moreover, recent data has emerged that conflicts with the
structure of the TEEAA (Setiaputra et al. 2018, Cheung and Diaz-Santin,
2019)(Figure 1.11). Negative stain EM and cross-linking mass spectrometry data from
Setiaputra et al. (2018), are in general agreement with the structure of the TEAA
complex, though they suggest a different position for the Piccolo subcomplex within
the greater NuA4 complex.
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Figure 1.11: Negative stain data, proposed to depict the structure of NuA4 (Accession:
EMD-7131) with a higher resolution, cryo-EM structure of Tra1 (PDB = 5OJS) super-
imposed. The centre of the complex is believed to house Tra1, Eaf1 and the Piccolo
subcomplex. Two lobes, one suspected to correspond to Eaf5/7/3 and the other corre-
sponding to Ac1/Arp4/Swc4/Eaf2, can be seen extending away from the core of Eaf1
and the head region of Tra1.
While NuA4 is slowly resolved, other coactivators, such as SAGA are more clearly
defined (Liu et al. 2019). Also a HAT complex, implicated in global transcription
activation and recruited to promoters via Tra1, SAGA is a larger complex (1.8 MDa)
with additional deubiquitylation activity.
However, recent studies suggest that the SAGA complex should be considered a
general transcription factor in S. cerevisiae, after it was found to bind to upstream
activator sequences (UAS) of almost all Pol II transcribed genes, occupying the same
region as the essential Mediator complex (Baptista et al. 2017). As our understanding
of NuA4’s function and recruitment improves, it would be interesting to compare to
SAGA, considering the complexes share such a large and versatile recruitment
interface in Tra1.
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1.3 The TINTIN Subcomplex
1.3.1 Discovery and Basic Properties
TINTIN (trimer independent of NuA4 for transcription interactions with
nucleosomes) is the most recently discovered subcomplex of NuA4, comprising of
Eaf3, Eaf5 and Eaf7 (Rossetto et al. 2014, Bhat et al. 2015). The complex can be
natively purified upon affinity tagging any of the three subunits and when followed by
gel filtration, produces fractions of complete NuA4 and a distinct peak, containing the
three subunits.
1.3.2 Composition and Structure
Eaf5 is unique to yeast and is believed to serve as a bridge between Eaf3/Eaf7 and
NuA4, though has no recognised conserved domain within its sequence (Rossetto et al.
2014). Eaf5’s structure has been partially characterised when in complex with the
TEEAA "core" NuA4 complex, via extensive contacts with Tra1 (Figure 1.12). Much
of Eaf5 remains unresolved, including its points of contact with Eaf1, that was
identified by cross-linking MS. An interaction interface with the two other TINTIN
subunit has also yet to be identified (Xie et al, 2015).
Eaf3 is a chromodomain containing protein, that is shared with the histone deacetylase
(HDAC) Rpd3S, which is antagonistic to NuA4. Deletion of the subunit results in no
growth phenotype and the NuA4 complex appears otherwise stable, but reduced levels
of transcription are reported, originally proposed to be a consequence of a shift in
acetylation patterns (Eisen et al. 2001, Reid et al. 2004).
The chromodomain preferentially associates with trimethylated lysine 36 (K36) of H3,
a post-translational modification carried out by the Set2 complex, during transcription
elongation (Sun et al. 2008).
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The domain has been structurally characterised, revealing a distinct "chromo barrel"
structure, similar to the human ortholog of Eaf3, MRG15 (Figure 1.13)(Zhang et al.
2006 , Sun et al. 2008).
Figure 1.12: Part of the 4.7 Å structure of the TEEAA complex (PDB: 5Y81), in
order to display Eaf5 interactions within the complex. The subunit forms a series of
α-helices, extended over the large Tra1 subunit. Several regions within the structure
remain unresolved, including contact between Eaf1 and Eaf5.
Figure 1.13: Ribbon representation of crystal structures of Eaf3 and the MRG15
chromo barrel domain. A) Crystal structure of Eaf3 chromo barrel domain (residues
1-124), at 2.5 Å resolution (PDB: 3E9G). B) Crystal structure of the MRG15 chromo
barrel domain (residues 13-102) at 2.2 Å resolution (PDB: 2F5K).
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Eaf3 also shares an MRG domain with human MRG15, towards its C-terminal. The
domain acts as a binding interface with proteins, such as the rest of the Rpd3S
complex and likely Eaf7 (Xie et al. 2015).
Eaf7 is negatively charged at physiological pH (isoelectric point ~5). Besides its
negative charge and variable migration rates during SDS-PAGE analysis, little is
known about the subunit’s role in the trimer. Deletion studies by Rossetto et al. (2014),
hint that the subunit acts as a scaffold for the other subunits to assemble around. Eaf7
shares ~30% sequence identity with human MRGBP, primarily in their N-termini. The
C-terminal half of both proteins, have no apparent conserved domain and several
disorder prediction algorithms suggest this region is highly disordered (Appendix A).
Human proteins, MRGBP and MRG15 form a dimer in vivo, that has been shown to
directly interact with TIP60 and has been proposed to play a role in alternative splicing
mechanisms (Gowher et al. 2012, Kirkwood et al. 2013). An NMR solution structure
of the binding interface in the dimeric human complex, has been produced (Figure
1.14).
The Eaf3 ortholog (MRG15) had been shown to bind the MRGBP subunit (Eaf7
ortholog), using the same MRG domain that facilitates association with Rpd3S (Xie et
al. 2015). This may enable the HAT and HDAC complexes to compete for the Eaf3
subunit, though Rossetto et al. (2014) purifications of Eaf3, find the subunit
preferentially associates with the Rpd3S. The study also revealed that MRGBP
associates with the MRG domain of MRG15, via a "minimal MRG-binding domain"
(MBD), in its N-terminal. This interaction is maintained primarily by a series of
hydrophobic interactions and a highly conserved FxLP motif (where x is any amino
acid) within the MBD.
Eaf7 and MRGBP show highest levels of conservation around the MBD, though Eaf7
possesses a 31-residue insertion (residues 88-118) which is highly polar, as identified
by Xie et al. (2015) (Figure 1.15).
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Comparison of the hydropathicity of the two MBDs, using a grand average of
hydropathicity index (GRAVY) score from ExPASy ProtParam, reveals that the Eaf7
MBD is significantly less hydrophobic than MRGBP MBD (-0.984 and 0.580,
respectively, where positive values indicate hydrophobic sequences).
Eaf7 conserves 10 of the 28 key residues within the MRGBP MBD, that were shown
to form hydrophobic interactions with the MRG domain. Whether this variation
diminishes the strength of interaction between Eaf7 and Eaf3, relative to their human
orthologs, has yet to be tested.
Figure 1.14: Ribbon representation of human MRG15 MRG domain (residue 155-
323) associating with MRGBP MBD (residue 69-119), from an NMR study. The MRG
domain is an essential binding interface and facilitates interactions between MRG15
and binding partners, such as MRGBP.
Eaf3 in comparison, has no major insertions in its MRG domain, with respect to the
MRG15 protein. The two orthologs share ~33% sequence identity, though Eaf3
conserves 18 of the 33 residues in the MRG15 MRG domain, that were shown to form
hydrophobic interactions with the MRGBP MBD. Several conserved residues in Eaf7
MBD and Eaf3 MRG domains, were shown to make contact in the human orthologous
complex (Figure 1.15).
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Whether these residues can interact, despite the relatively large insertion in Eaf7’s
MBD, has yet to be evaluated. A high-resolution structure of TINTIN would be of use,
for a comparison of the yeast and human complexes. A summary of the conserved
residues between the human and yeast subunits, that form points of contact in human
MRG15/MRGBP, is listed in figure 1.15B.
A noticeable difference in the Eaf3 MRG domain, is the substitution of 5 of the 12
residues that make contact with the FxLP motif in the MBD. It is possible that
differences in these positions, may also weaken interactions between the two domains.
However, we cannot exclude the possibility that these substituted residues, make
similar interactions to complete TINTIN assembly.
GRAVY scores for both Eaf3 and MRG15, suggest similar levels of hydrophobicity in
both MRG domains (-0.18 and -0.32, respectively). It would be interesting to see
whether Eaf3/Eaf7 interact via the MRG domain in the Eaf7 N-terminal, in the same
way that the MRG15/MRGBP dimer is formed.
The interaction between Eaf5 and the rest of the complex is the least understood,
though cross-linking mass spectrometry data, suggests the C-terminal of Eaf5 makes
contact with Eaf7 N-terminal (Setiaputra et al. 2018). A summarising figure shows
schematic representations of the TINTIN subunits, annotated to display conserved
domains and highlights any regions that have been structurally characterised (Figure
1.16).
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Figure 1.15: A) Sequence comparison of the "minimal binding domain" (MBD) of the
yeast Eaf7 subunit and the MBD of human ortholog MRGBP, identified by Xie et al.
(2015). Residues that were shown to be essential for MRG15/MRGBP interactions,
have been highlighted with an asterisk, these have been colour-coded, according to the
type of interaction that occurs at that position. Any residue that is conserved, is marked
with a red box. The 31-residue insertion in Eaf7, is displayed in the red dashed box be-
neath the sequence. B) Table listing conserved residues in the MRGBP and Eaf7 MBD,
with the corresponding residues in the MRG15 MRG domain, that make direct points
of contact based on NMR data (Xie et al. 2015). Residues are numbered according to
their position in the human subunits. Residues that are listed in red, are conserved in
the MRG domains of Eaf3 and MRG15.
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Figure 1.16: Schematic representation of the three TINTIN subunits, depicting con-
served domains and their residue boundaries. Human orthologs MRGBP and MRG15
have also been displayed, for comparison with Eaf7 and Eaf3 respectively. Regions that
have been structurally characterised have been marked with an asterisk. A) Eaf7 and
the human ortholog, MRGBP. With the exception of an N-terminal region, that shares
~ 30% sequence identity with the MBD of MRGBP, Eaf7 shows no conserved domains
within its sequence. B) Eaf3 and human ortholog, MRG15. The protein contains two
distinct conserved regions, a chromo barrel domain (N-terminal) that has been resolved
by X-ray crystallography and an MRG domain (C-terminal). C) Schematic of Eaf5.
The protein is unique to yeast and has no known conserved domain within its sequence.
Eaf5 has been partially characterised as part of a TEEAA "core" NuA4 structure. Un-
resolved regions are displayed as black bands and may correspond to flexible linkers
between the short α-helices observed in the structure.
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1.3.3 Biological Role
Eaf3, Eaf5 and Eaf7 mutants are sensitive to rapamycin, but not MMS, suggesting that
the trimer is involved in NuA4’s ribosome biogenesis activity, as opposed to its DNA
damage repair functions. Furthermore, double mutants of these subunits and the Set2
methyltransferase, showed reduced growth when exposed to caffeine, mycophenolic
acid (MPA) and 6-azauracil (6-AU); reagents implicated in nucleotide depletion and
reduced transcription elongation rates (Reines et al. 2003, Rossetto et al. 2014).
The Set2 complex follows RNA Polymerase II during transcription elongation,
associating with the phosphorylated CTD and methylating H3 in the wake of the
transcribing complex (Schaft et al. 2003). This methylation (and phosphorylation of
the Pol II CTD) leads to the stabilisation of the nucleosome, by recruiting histone
deacetylases (HDAC) such as Rpd3S and remodelling complexes (Biswas et al. 2008,
Govind et al. 2010, Heidemann et al. 2013, Corden. 2016). The function of this
nucleosome stabilisation is to repress cryptic, spurious transcription within the body of
the gene, after the DNA has been exposed by transcribing Pol II.
Set2 methylation is not essential for Rpd3S recruitment, as the Pol II CTD directly
interacts with Rpd3S during transcription, but mutations in Set2 are often implicated in
the transcription of intragenic material (Govind et al. 2010, Smolle et al. 2013).
Interestingly, compensating mutations of TINTIN, can suppress intragenic
transcription observed in Set2 mutants, suggesting that the trimer plays a role in
nucleosome destabilisation (Rosetto et al. 2014).
Ginsburg et al. (2009) had already shown that NuA4 and SAGA appear to overlap in
their positions along chromatin (UAS regions, upstream of transcription start sites) and
were required for transcription activation and elongation by RNA polymerase II.
However, while chromatin immunoprecipitation studies suggest that TINTIN
associates with NuA4 over promoters, the subcomplex also associates with Rpd3S and
Pol II over coding regions downstream (Schulze et al. 2011, Rossetto et al. 2014).
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Moreover, pull-down of Pol II via tagged NuA4 subunits, is only possible when
TINTIN is present and able to interact with the rest of NuA4. This may imply that the
trimer is directly interacting with Pol II.
Pol II C-terminal domain (CTD) contains heptapeptide repeats with multiple
phosphorylation sites. These sites are modified at different stages of the transcription
process, allowing for the recruitment of specific factors to Pol II, at the correct time
and position (Mitchell et al. 2008, Heidemann et al. 2013, Rossetto et al. 2014).
Ctk1 is responsible for the phosphorylation of the Pol II CTD, at Ser2 in the
heptapeptide repeat. Deletion of the Ctk1 protein, disrupts the localisation of Eaf7
over coding regions (Rossetto et al. 2014). Eaf7 also preferentially pulls down Pol II
phosphorylated at Ser2, a prevalent PTM in the late transcription elongation stage.
Eaf5 appears to preferentially purify the Ser5 phosphorylated CTD, which is
associated with earlier stages of transcription and this interaction is not dependent on
the presence of Eaf7.
Taken into consideration, this data suggests that NuA4 components, particularly
TINTIN subunits, are directly interacting with Pol II via its CTD, though no direct
interaction has been observed. Given that these experiments were immunoprecipitation
assays from cellular extracts, we cannot exclude the potential presence of additional
factors, that may mediate interactions between TINTIN and Pol II.
Interestingly, ChIP analysis reveals that Eaf7 can be found over the coding regions of
actively transcribed genes, when either Eaf5 or Eaf3 is deleted, albeit at a reduced
signal. However, when Eaf3/Ctk1 double mutants are generated, this association is
almost completely abolished. This suggests that TINTIN relies on the two interactions
for correct recruitment; one with H3K36me3 (via Eaf3) and the other with the Pol II
CTD (via Eaf5 and/or Eaf7).
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Eaf7 is also shown to interact with the Spt16 subunit of the FACT complex, which is
responsible for rearranging histones in preparation for transcribing RNA Pol II
(Avvakumov et al. 2011). Rossetto et al. (2014) also showed that Eaf3/5/7 mutations
(and mutations in Esa1), allowed for the expression of reporter genes, under the
control of a cryptic transcription initiation site, provided chromatin remodelling
complexes were available.
These same studies reveal synthetic lethality when Eaf5 and Eaf7 deletions are
combined with SWR1 mutations, a remodelling complex responsible for incorporating
the non-canonical H2A.Z into nucleosomes. SWR1 has been implicated in
transcription elongation and splicing mechanisms (Neves et al. 2017), which further
implicates TINTIN in the process of transcription elongation and potentially
co-transcriptional splicing. The fact that the majority of genes that possess introns in
yeast, are of ribosomal proteins, could explain why TINTIN mutants are sensitive to
compounds that disrupt ribosome biogenesis, if the complex does indeed play a role in
splicing.
Current research suggests that NuA4 is localised to transcription initiation sites, in
order to carry out its HAT activity. The TINTIN trimer may then associate with
elongating Pol II as it progresses downstream, recruiting remodelling complexes such
as FACT and then the HDAC Rpd3S, to regulate NCP stability during transcription
(Figure 1.17).
However, the exact mechanism of TINTIN recruitment remains unclear, as does the
process by which it is released from the rest of the NuA4 complex, upon transcription
initiation. Rossetto et al. (2014) also proposed that the trimer somehow promotes the
processivity of RNA Pol II, though how exactly this might be achieved, remains
unclear.
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Figure 1.17: Schematic representation of the potential role of TINTIN, during tran-
scription elongation. A) The NuA4 complex acetylates histones prior to the approach
of transcribing RNA polymerase II. This acetylation and the Eaf7 subunit, recruits re-
modelling complexes such as FACT, which destabilises nucleosomes, facilitating the
continued movement of the incoming Pol II. B) Pol II CTD is phosphorylated during
transcription, recruiting the Set2 methyltransferase, which in turn methylates H3K36.
C) H3K36me3 acts as a target for the Eaf3 chromodomain, which has been released
(with Eaf7 and Eaf5) from NuA4. D) Recruitment of the Rpd3S complex by Eaf3 and
Pol II CTD, which deacetylates histones in the wake of Pol II and helps stabilise the
NCP.
56
1.3.4 Aims and Objectives
It is clear that TINTIN subunits play some important role in NCP stability and
transcription elongation rates, though their exact mechanistic function remains
obscure. If the trimer does indeed eject from the rest of NuA4, what triggers this
transition?
The fact that NuA4 and Rpd3S act antagonistically in vivo, while sharing the Eaf3
subunit, raises the question if and how the subunit is passed from one complex to the
other. TINTIN has no known catalytic activity and this relatively small complex may
act as an intermediary, between the larger chromatin modifying complexes and Pol II.
Additionally, the Eaf3 chromodomain has been shown to have a weak affinity for
H3K36me3, but whether this affinity directs both TINTIN and Rpd3S recruitment to
specific loci, is not clear. Importantly, the presentation of the Eaf3 chromodomain in
TINTIN vs. Rpd3S might also alter its binding properties. We suspected that
incorporation of Eaf3 into TINTIN might stabilise the chromodomain, modulating its
affinity for H3K63me3 and providing additional binding to other features of the
nucleosome.
One of the major objectives of this investigation, was to address these aspects of
TINTIN function using structural, biophysical and biochemical techniques. Structural
studies would be highly informative in elucidating the molecular mechanisms of the
TINTIN complex and provide testable hypotheses for further study. The interactions of
the TINTIN complex with Pol II and chromatin were to be verified biochemically,
which would also evaluate the specificity of these interactions, ultimately aiming to
confirm that the complexes preferentially associate during transcription elongation.
This would be tested using in vitro pull-down assays, with purified sample and
peptides mimicking chromatin or the CTD, at different stages of transcription.
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Additionally, Eaf5 is unique to yeast, whereas the human orthologous complex to
TINTIN, is composed of a dimer of MRG15 (Eaf3 ortholog) and MRGBP (Eaf7
ortholog), hence the function of Eaf5 is ultimately unclear. Some significant sequence
differences in the minimum MRG binding domain of Eaf7 (compared to the MBD of
MRGBP), were proposed to weaken interactions with the MRG domain of Eaf3. It
was also speculated that the additional Eaf5 subunit, plays a role in stabilising the
structure, as well as bridging the complex to the rest of NuA4.
The structure of the TEEAA complex, suggests that the interaction between Eaf5 and
the rest of TINTIN is weak. We therefore aimed to evaluate the strength of this
interaction, by purification and native mass spectrometry, followed by collision
induced dissociation.
Finally, over 50% of the Eaf7 subunit is predicted to be disordered from its C-terminal,
despite the subunit apparently playing a scaffolding role between Eaf5 and Eaf3
(Rossetto et al. 2014) (Appendix A). Another objective of this experiment was to
identify the essential regions within Eaf7 (and other TINTIN subunits), for complex
assembly and stability. We theorised that the C-terminal of Eaf7 was dispensable for
complex assembly.
To confirm this theory and to identify the boundaries of interaction interfaces between
subunits, a series of truncated TINTIN constructs would be generated. These
truncations would also be used in Pol II CTD pull-down studies, to help identify
features responsible for this interaction. This would be carried out in parallel to
structural analysis, with techniques such as X-ray crystallography and SAXS. The aim
being to visualise the architecture of the complex and ideally, identify binding regions





2.1 Construct Design and Cloning
Throughout the project, several TINTIN constructs, including the full-length complex
and constructs with truncated subunits were designed. A pRSFDuet-1 plasmid
containing subunits Eaf1, Eaf5, Eaf3 and Eaf7 with a C-terminal 3C protease site,
followed by a Twin-Strep tag, had already been generated by Dr Alan Cheung. The
Eaf5/7/3 sequences (and cleavage site + tag) were cloned into a pET-28a plasmid
(Figure 2.1).
All plasmids were designed using the open source software ApE (A Plasmid Editor),
with primers designed using the same software. Primers were designed to contain 3’
overhangs of at least 20 nt for Gibson assembly reactions (Gibson et al. 2009), these
overhangs would contain complementary sequences between PCR products we wished
to ligate. Annealing temperatures of primers were calculated with NEB Tm calculator.
50µL PCR reactions were carried out using the New England Biolabs Q5 hot start
high-fidelity DNA polymerase. The reaction scheme followed the volumes and
concentrations recommended by NEB, with the addition of 5% DMSO as listed in
Table 2.1.
Components Stock Concentration Volume (µL) Final Concentration
Q5 Reaction Buffer 5X 10 1X
dNTPs 10 mM 1 200 µM
F/R Primer 10 µM 2.5 0.5 µM
DNA Template 1 ng/µL 1 20 ng/µL
Q5 Polymerase 2 units/µL 0.5 0.02 U/µL
DMSO 100% 2.5 5%
H2O - 30µL -
Table 2.1: Summary of components used for 50 µL PCR reactions using the NEB
hot start Q5 high-fidelity DNA polymerase. Mili-Q ultrapure water was used for all
reactions.
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The PCR reaction followed the same general scheme. Beginning with denaturation at
98 °C (35 seconds) followed by 25 cycles of: 98 °C (10 seconds), annealing
(primer-dependent temperature) (30 seconds), elongation at 72 °C (30 seconds/kb).
This was completed with a final extension step at 72 °C for 2 minutes.
The success of PCR reactions was determined by gel electrophoresis. Samples were
first mixed with 10 µL of 6X DNA loading dye, 50 µL of the resulting mixture was
then loaded onto the gel (1X TAE, 1% agarose, 1X Invitrogen SYBR safe dye) and run
for 60 minutes at 100 V.
If bands were revealed by UV detector, they were excised and processed by a
QIAquick gel extraction kit (Qiagen) and eluted with 30 µL elution buffer. The
concentration of these PCR products was determined by NanoDrop spectrophotometer.
Fragments to be annealed would be mixed at a ratio of 0.04:0.04 pmols, and incubated
at 50 °C for 45 minutes in equal volume with a 2X NEBuilder HiFi DNA assembly
master mix, a commercially available Gibson reaction kit.
The resulting Gibson assembly reactions were then added directly to 50 µL aliquots
XL10-Gold competent cells. These were then incubated on ice for 30 minutes before
heat shock (42 °C for 45 seconds), followed by the addition of 500 µL of SOC rich
media and further incubation at 37 °C for 1 hour.
Cells were then pelleted (5 krpm for 2 minutes) and then streaked onto LB agar plates
containing 50 µg/mL kanamycin. Plates were then incubated at 37 °C for 16 hours. If
colonies were observed after this incubation, they were picked and incubated in 5 mL
of LB (including µg/mL kanamycin) for an additional 16 hours.
Assuming growth was observed, plasmids were purified from these overnight
incubations, using the QIAprep Miniprep kit (Qiagen). Samples of these purified




The majority of constructs cloned used the pET-28a vector, which confers kanamycin
resistance (Figure 2.1). The backbone contains a T7 promoter under the control of the
lac operon (Dubendorfft et al. 1991).
Figure 2.1: Schematic of the pET-28a vector and representative of the full-length
TINTIN construct that acted as the foundation for this project. The low-copy number
plasmid confers kanamycin resistance to transformed cells, and contains a T7 promoter
under the influence of a lac operon.
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2.1.2 Constructs Generated
A series of truncated constructs were derived from the full-length TINTIN complex,
subjected to test expressions and purified for the purpose of this project (Figure 2.2).
All constructs included a C-terminal 3C protease site, followed by a Twin-Strep tag.
Truncation boundaries were informed by limited proteolysis and native mass
spectrometry results, later discussed in this chapter and results.
Figure 2.2: List of TINTIN associated constructs cloned and subjected to test expres-
sions throughout this project. Schematics of each subunit are included and the bound-
aries of any truncation are listed within the schematic of the subunit in question. The




Rosetta 2 competent cells were used to express the TINTIN-pET-28a construct and
had been transformed identically to the XL10-Gold competent cells in the cloning
process. Preliminary (small-scale) expressions tested the efficacy of 2 types of media
across 4 different expression protocols in Rosetta 2 cells (Table 2.2). The media
included were LB and the autoinduction (AI) media described by Studier (2005);
ZYM-5052 (referred to as AI media for this report).
AI media based expression, relies on growth of cells in a mixture of glucose, α-lactose
and glycerol as sources of carbon. Cells grow in this media readily, while the T7 lac
promoter is repressed in the presence of glucose. Upon depletion of glucose (which is
preferentially metabolised before other carbon sources), cells have grown to higher OD
(than they would in media such as LB), before the α-lactose driven induction begins.
The aim of this method is to increase overall levels of protein expression by way of
higher cell count, with the added advantage of allowing for cells to grow before
potentially toxic recombinant proteins are expressed. Formulation of this media is
summarised in Table 2.3.
Transformed cells were used to inoculate 5 mL LB pre-cultures, including 50 µg/mL
kanamycin and 34 µg/mL chloramphenicol (resistance conferred by the Rosetta 2
strain). The resulting overnight culture was used to inoculate AI, TB or LB containing
flasks (at a ratio of 1 mL pre-culture to 500 mL of expression media).
For upscaled AI media expressions, 12 L of AI media was used. This was increased up
to 24 L for LB/TB expressions, depending on the construct being expressed. Cells
were harvested at 4000 rcf, with the supernatant removed and cell pellets flash frozen
in liquid nitrogen for storage.
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Condition Pre-Induction Induction OD [IPTG] (mM) Post-Induction
AI1 37 °C 0.5 - 18 °C(24 hours)
AI2 37 °C 0.5 - 37 °C(16 hours)
LB1 37 °C 0.5 0.2 37 °C(4 hours)
LB2 37 °C 0.5 0.2 18 °C(18 hours)
Table 2.2: Summary of test expression schemes used in the production of TINTIN. All
cells were shaking at 200 rpm throughout their expressions. Protocols in the table are
displayed as: pre-induction temperature, OD cells reach before induction, IPTG induc-
tion concentration and the post-induction conditions cells are incubated in. Conditions
























Table 2.3: Summary of stock buffer compositions used for formulation of ZYM-5052
media designed by Studier (2005). Stocks were stored separately and diluted with ZY
media (1% tryptone (w/v) and 0.5% yeast extract (w/v)) to prepare 12 X 1 L media in 2
L conical flasks. M and 5052 media are diluted to 1X, while trace metals are diluted to
0.2X and MgSO4 is diluted to 2 mM.
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2.3 TINTIN Properties and Purification Design
Prior to purifications attempts, the ExPASy ProtParam tool was used to approximate
some of the properties of Eaf5, Eaf7 and Eaf3.
Eaf7 (including a 3C protease site followed by the Twin-Strep tag at the C-terminal
position), has a theoretical molecular weight of ~53 kDa and an isoelectric point of
5.19. Eaf3 has a theoretical MW of ~45 kDa and isoelectric point of 8.5. Eaf5 has a
theoretical MW of 31 kDa and isoelectric point of 8.03.
The combined theoretical molecular weight of the complex is ~130 kDa with an
averaged isoelectric point of 5.95. It was noted that the literature suggested that Eaf7
may not migrate across an SDS-PAGE gel at a rate expected of a protein of equivalent
molecular weight, this would be verified by our own SDS-PAGE gels and mass
spectrometry.
2.4 Purification Summary
All purifications followed the same general scheme:
1. Lysis via sonication.
2. Clarification of cell-lysate by centrifugation.
3. Strep-Tactin purification.
4. Ion-exchange chromatography (IEX).
5. Size-exclusion chromatography (SEC).
6. Final spin concentration of sample.
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2.4.1 Purification Buffer
All purifications used the same stock buffer A (100 mM Tris/HCl (pH 8.0), 1 mM
EDTA, 10 µM ZnCl2, 150 mM NaCl), which is recommended for Strep-Tactin based
purifications. Modifications to this formula are listed where appropriate. Thermofluor
data (Appendix B) suggests that TINTIN is stabilised in lower salt concentrations and
NaCl concentration was reduced to 50 mM in the final, optimised purifications.
2.4.2 Lysis and Clarification
Cells pellets were resuspended in buffer A ( with additional 0.1% NP40 + 2X
Sigma-Aldritch protease inhibitor cocktail tablets). After resuspension, cells were
lysed by sonication at 75% amplitude at 3 x 10 minute intervals. The resulting lysate
was subjected to centrifugation at 17 krpm for 1 hour in a Sorval SLA-1500, the
supernatant from this was then applied to Strep-Tactin resin.
2.4.3 Twin-Strep Tag System
The recombinant tag employed in purification of the TINTIN trimer, was a Twin-Strep
tag designed to bind to the engineered Streptavidin: Strep-Tactin. Twin-Strep tags
contain two copies of the conventional Strep-tag (WSHPQFE), which are separated by
a short spacer region (serine, alanine). This allows for increased levels of binding and
specificity of binding between the tagged protein and Strep-Tactin resin.
Elution from Strep-Tactin resin and Strep-TactinXT (which is designed to bind
Twin-Strep tagged proteins as opposed to a single Strep-tag) is facilitated by the
application of 50 mM desthiobiotin and biotin respectively, the required volume of
elution buffer (Buffer A + 0.1% NP40 + 50 mM biotin/desthiobiotin + 2X
Sigma-Aldritch protease inhibitor cocktail tablets) was subject to optimisation and is
discussed in the results chapter 3.
67
2.4.4 Chromatography System
An ÄKTA Pure chromatography system was used for ion-exchange and size-exclusion
chromatography steps. Method creation, data collection and analysis was carried out
using the UNICORN 7 software. Prior to use, all columns were washed with 1.5
column volumes (CV) of degassed H2O and equilibrated in 1.5 CV of buffer.
2.4.5 Ion-Exchange Chromatography
Prior to any use of the ÄKTA Pure system and its high-resolution columns, samples
were filtered with Sartorius Minisart NML syringe filters, to remove precipitate which
could potentially damage the columns. The two columns used in this step include a
Mono Q 5/50 (GL) and Mono S 5/50 (GL) for anion and cation exchange respectively.
Due to the large volume of Strep-purified protein, columns were loaded with TINTIN
using the systems’ sample pump. The system was eventually programmed so that the
flow-through of the Mono Q column was immediately loaded onto the Mono S,
followed by collection. After sample application, columns were washed with 10 CV
buffer A before an increasing percentage buffer B (buffer A + 2 M NaCl) over 20 CV.
A final high-salt wash of 100% buffer B was applied to remove any proteins still
bound to the columns. Samples were eluted into 0.5 mL fractions.
2.4.6 Size-Exclusion Chromatography
SEC steps also use buffer A. Protein samples to be loaded onto these columns, were
spun down (13 krpm for 10 minutes at 4 °C) before being injected onto the ÄKTA
Pure loop. The volume of the loop used, ranged from 0.5 mL to 5 mL, depending on
the column used and volume of TINTIN sample being loaded. All loops were washed
with 2X their volume of buffer A to apply to the SEC columns.
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Either the Superdex 200 increase 10/300 GL or the HiLoad 16/600 Superdex 200 pg
were used in purifications, both are able to resolve proteins within the MW range of
10,000 to 600,000. Either column was washed with 1.5 CV of buffer A to elute the
protein. Samples were eluted into 2 mL fractions.
Calibration curves were made for these columns (Appendix C) by Dr Alan Cheung,
which allowed for MW approximations of experimental proteins, based on their
elution profiles.
2.4.7 Protein Concentration
TINTIN constructs were concentrated for the purpose of crystallisation. This proved to
be a major bottleneck in the final yield of the protein and as a result, multiple spin
concentrators (varying in MW cut-off and membrane type) were tested for their
efficacy (Table 2.4).
Concentrator Membrane Type Mw Cut-Off (kDa)
Amicon Centrifugal Filter Regenerated Cellulose 10
Amicon Centrifugal Filter Regenerated Cellulose 30
Amicon Centrifugal Filter PES 10
Amicon Centrifugal Filter PES 30
Centriprep Centrifugal Filters Regenerated Cellulose 10
Table 2.4: Summary of concentrating equipment used to prepare the purified TINTIN
complex for crystallisation trials.
After multiple optimisations of this concentration process (data not included), it was
found that the devices that resulted in minimal loss of protein were the Centriprep
centrifugal filter (10 kDa cut-off) and the amicon centrifugal filter (10 kDa cut-off,
regenerated cellulose). 5-10% glycerol was also included in the final purification




Concentration of the sample was generally determined using a NanoDrop
spectrophotometer, though for post-Strep purified protein (which contained the
detergent NP40), concentration was quantified by Bradford assay using a
commercially available quick-start Bradford assay kit and protocol (Bio-Rad).
2.4.9 SDS-PAGE
Purified samples were diluted with a 6X SDS-PAGE loading buffer (360 mM Tris pH
6.8, 10% SDS, 50% glycerol, 0.03% bromophenol blue, 600 mM DTT). Diluted
samples were boiled for 2 minutes before loading onto a commercially available Bolt
Bis-Tris gel, immersed in MES buffer. Gels were run at 200 V for 45 minutes and
stained using InstantBlue Coomassie stain.
2.4.10 Mass Spectrometry
After SDS-PAGE analysis of the final purified product, bands that were proposed to
correspond to TINTIN subunits, were excised and placed into 1.5 mL Eppendorf tubes
and sent to St. Andrews Mass Spectrometry service, for protein identification by
MALDI MS & MSMS (Egelhofer et al. 2002). This was also employed when
suspected degradation products were observed in gels.
2.5 Crystallisation Trials
The crystallisation of protein samples is an essential step in the production of
high-resolution structures by X-ray crystallography (McPherson and Gavira 2014).
The process of crystallisation is complex, depending on several factors including (but
not limited too): sample concentration, salt concentration, pH, temperature, sample
homogeneity and structural flexibility (Figure 2.3).
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We aimed to crystallise the full-length TINTIN complex for X-ray crystallography
purposes, using a range of commercial screens, sample concentrations, temperatures
and adjustments to buffer. Additionally, truncations were generated in the TINTIN
complex (primarily of the Eaf7 subunit) in order to generate a more stable core
complex, potentially removing flexible regions that were inhibiting the crystallisation
process.
Figure 2.3: Summary of optimal crystallisation conditions, which are dependent on salt
and protein concentration, but also pH, temperature, homogeneity and protein flexibil-
ity. Crystallisation is a state of supersaturation, sample and solvent concentration must
be balanced to ensure this supersaturation is reached without precipitating the protein.
Crystals (which can form in metastable and labile regions) must nucleate and grow to
significant dimensions for X-ray analysis, this can only occur in the theoretical labile
region.
2.5.1 Commercial Screens
Crystallisation screens were carried out in parallel with the TINTIN purification
optimisation (Table 2.5 and 2.6). The concentration of TINTIN for each round of
crystallisation attempts, reflects the maximum yield of the trimer achievable at that
point in time. As a result, increasing concentrations of TINTIN were used with each
attempt.
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Sparse Matrix Screen Concentration of TINTIN (mg/mL)
4.2 7.0 12.4 10.0 (4 °C)
JCSG-plus X X X X
Pact X X - X
SaltRX HT X - X X
Index X X X X
Structure Screen 1 X X X X
Midas X - - -
ProPlex X X X -
Morpheus HT-96 - X X X
Table 2.5: Summary of crystallisation attempts of full-length construct. Each commer-
cially available sparse matrix screen is given an ‘X’ if it was used for a corresponding
TINTIN preparation. Protein sample and buffers from each screen were mixed 1:1 (v/v)
by Mosquito crystal for accuracy and reproducibility. The resulting plates were stored
at 16 °C in a Rigaku Minstrel DT imager and gallery DT plate hotel. Screens that were
stored at 4 °C, were periodically checked for crystal formation by light microscope.
Screens EA88A EA88B
Concentration (mg/mL)
8* 11 5 6
Index X X X X
JCSG X X X X
Pact X X X X
Morpheus X X X X
Structure X X X X
Table 2.6: Summary of crystallisation trials of truncated TINTIN constructs. Screens
were incubated at 16 °C in the Rigaku Minstrel DT imager and gallery DT plate hotel
and periodically imaged for the presence of crystals. The concentration marked with an
asterisk was tested at both 16 °C and 4 °C.
TINTIN truncations (EA88A and EA88B) were also purified and subjected to
crystallization trials using the Index, JCSG, Pact, Morpheus and Structure commercial
screens. Commercially available, sparse matrix screens were used to cover a wide
range of crystallisation conditions. TINTIN samples were mixed with each condition
(150 nL sample + 150 nL buffer) by Mosquito crystal into MRC 2-well vapour
diffusion plates.
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These were stored at 16 °C in a Rigaku Minstrel DT imager and gallery DT plate
hotel. Each plate was immediately imaged upon loading onto the hotel platform,
allowing for detection of any immediate crystal formation. Samples were then
periodically examined by the device and saved on a database for review.
2.5.2 Custom Hanging Drop Screens
If suspected TINTIN crystals were identified in any of the commercial screens, the
buffer that corresponded to the well in question, was scrutinised and used to design
multiple hanging-drop screens, in an effort to improve or replicate the crystallization
process.
Qiagen hanging-drop plates were used, containing varying concentrations of purified
protein +/- 10% and varying concentrations of precipitants. Wells contained 500 µL of
a precipitant mix, with hanging-drops containing 1 µL purified protein and 1 µL
precipitant mix. This maintained the ratio of 1:1 (volume/volume) used in the test
commercial screens.
2.6 Differential Scanning Fluorimetry Assays
Differential scanning fluorimetry (Thermofluor) assays were conducted on purified
full-length TINTIN (2.48 mg/mL), across a range of buffer conditions obtained from
the RUBIC buffer screen (Molecular Dimensions). The aim was to identify stabilising
buffer conditions. (Appendix B).
25 µL reactions were carried out in a MyIQ real-time PCR instrument using the Sypro
Orange dye. The raw fluorescence signal vs temperature data was converted to
-dRFU/dT vs T, a derivative plot, which displays changes in fluorescence vs
temperature, allowing for easier determination of Tm (melting temperature).
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Buffer conditions were from the commercially available RUBIC buffer screen. A
positive control of 12 µL 2 mg/mL lysozyme + 12 µL buffer was used. A negative
control of 24 µL buffer was also included. Sypro Orange absorbs light of wavelength
470 nm and emits at 569 nm.
Reactions were carried out in PCR-microplates, with each well containing 21 µL of
RUBIC buffer, followed by the addition of 2 µL protein and finally 2 µL Sypro
Orange at a final concentration of 5X from the original stock (5000X).
Plates were sealed with ClearVue seals, before being placed in the RT-PCR device,
pre-equilibrated to 5 °C. The device was programmed to gradually increase the
temperature from 5 °C to 95 °C (at a rate of 1 °C/minute). Filters used were
compatible with the maximum excitation/emission wavelengths of Sypro Orange.
Experiments were carried out in duplicate and averaged, with melting temperatures of
the TINTIN complex in each of the RUBIC buffers compared to determine conditions
of higher stability.
2.7 Limited Proteolysis
The JBS Floppy-Choppy limited proteolysis kit was used for limited proteolysis
experiments, with the objective of removing regions with high levels of flexibility from
the TINTIN complex.
The proteases included in these experiments included: α-chymotrypsin, trypsin,
subtilisin and papain. Initial attempts at proteolysis followed a manual recommended
ratio of TINTIN:protease (1 µg:1 ng) in a reaction volume of 40 µL (containing
TINTIN purification buffer). Samples were incubated for 30 minutes at 22 °C and
quenched with 8 µL of 6X SDS loading dye. The extent of proteolysis was then
determined by SDS-PAGE by loading 20 µL of this reaction mixture.
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Optimised reactions contained 2.8 µg of TINTIN for better visualisation on the
SDS-PAGE gel. Protease quantities were optimised for progressive levels of
proteolysis (Table 2.7). Temperature was maintained at 22 °C and reactions were
carried out in triplicate, quenching at 10 minute intervals (Table 2.7).
If bands observed on the SDS-PAGE gel were intense, discreet from other bands (not
part of a smear) and reproducible, these were excised and stored in 1.5 mL Eppendorf
tubes. Stored samples were sent to St. Andrews mass spectrometry and proteomics
facility for sample identification. This data was used to determine boundaries for
cloning of truncated TINTIN constructs.

















Table 2.7: Summary of optimised limited proteolysis experiments on the full-length
TINTIN complex with the JBS Floppy-Choppy kit. 2.8 µg of TINTIN was mixed with
varying quantities of protease (in a 40 µL reaction) and quenched at varying time points
with 8 µL of 6X SDS loading dye. All reactions were carried out at 22 °C, with tem-
peratures maintained using a heat block.
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2.8 Disorder Prediction
TINTIN subunits were submitted to the MobiDB database (Piovesan et al. 2018), to
identify regions of flexibility and disorder within each of the subunits. This would also
be used to identify targets for truncation.
The database provides multiple outputs from various software packages, then overlays
and averages these results, so that users can have more confidence in disorder
prediction (Appendix A).
2.9 TINTIN Interaction/Pull-down Assays
As proposed by Rossetto et al. (2014), the TINTIN trimer has been predicted to bind
to the phosphorylated CTD of RNA Polymerase II, though this interaction had yet to
be directly tested.
As a result, purified TINTIN constructs EA88A, EA88B and the Eaf3 chromodomain
(the long form described in Sun et al. 2008), were subjected to pull-down assays
(Wysocka, 2006), using peptides that mimicked the Pol II CTD. These peptides
contained phosphorylation patterns representative of the CTD at different stages of
transcription elongation, as well as various methylated histone peptides (mimicking
the H3 N-terminal tail), that potentially interact with the chromodomain of Eaf3.
2.9.1 Peptides
Biotinylated peptides were designed to bind Strep-Tactin dynabeads. Once fixed to the
resin, the peptide would be exposed to the protein sample, followed by multiple wash
steps. If interaction between peptide and protein occurred, then SDS-PAGE analysis of
the resin, would reveal the presence of the applied protein.
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Histone and CTD peptides were chemically synthesised (Sigma-Aldrich and Alta
Bioscience respectively) and provided in a lyophilized form. All peptides were
dissolved to 0.5 mg/mL in commercially available PBS buffer (Sigma-Aldrich), with
CTD-peptides being dissolved in PBS + 20% DMSO (Table 2.8.). CTD peptides were
designed to replicate 2 consecutive heptad repeats, with post-translational
modifications present on both of the repeats.














Table 2.8: Summary of biotinylated peptides used for TINTIN pull-down assays. All
peptides were diluted to 0.5 mg/mL in PBS buffer, though Pol II CTD peptides were di-
luted with additional 20% DMSO (v/v). Post-translational modifications are listed with
the corresponding histone peptide, for example H3K36me1 = lysine 36 of H3, with a
single methyl group. CTD peptides are listed with as the post translational modification
pattern they correspond to, for example; Y1p = phosphorylated tyrosine 1.
2.9.2 Strep-tag cleavage
The C-terminal Twin-Strep tag used in all constructs was removed with a GST-tagged
3C protease, to prevent binding to the Strep-Tactin resin used in the pull-down assay.
98 µL of purified protein (~4 mg/mL) was cleaved with 10 µL 3C protease (1.5
mg/mL) and 2.2 µL DTT (50 mM), incubating for 1 hour at room temperature.
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After incubation, protease was removed with GST resin (2 µL samples per 1 µL of
resin), incubating the sample and resin for 15 minutes, before pelleting with a tabletop
centrifuge at maximum speed for 2 minutes.
The supernatant was then applied to Dynabead (Strep-Tactin) resin and the process was
repeated to remove the cleaved tag. The final protein sample, cleared of the C-terminal
Twin-Strep tag and protease, was diluted with purification buffer to 1 mg/mL.
2.9.3 Pull-down Assay
The pull-down assay is summarised in Table 2.9. 40 µL Strep-Tactin Dynabeads were
used to fix the biotinylated peptides. Controls (resin + protein) were also included to
evaluate the extent of non-specific binding between TINTIN and resin.
Component [Stock](µg/mL) Volume (µL) Incubation (seconds) Wash Buffer
Dynabeads - - - PBS-T
Peptide 0.5 15 120 PBS-T
Protein 1 15 120 Buffer A-T
Table 2.9: Summary of pull-down reaction scheme. Reaction components are listed
sequentially, with wash buffer (applied in 3 x 500 µL batches) applied after the addi-
tion of each component. All buffers included 0.1% (v/v) triton X-100 (denoted "-T").
Reactions were incubated at 25 °C while shaking (1200 rpm).
Assays were carried out at 25 textcelsius while shaking (1200 rpm) which was
maintained by heat block. The addition of each component was followed by a wash
step of 3 x 500 µL wash buffer (either PBS or purification buffer A with 0.1% (v/v)
triton X-100). Triton X-100 was included to reduce non-specific binding.
The success of each assay was determined by SDS-PAGE analysis. After the final
wash step, 20 µL 3X SDS-PAGE loading buffer was applied to the resin. The
magnetic resin allows for separation of solution and resin with a magnetic rack and 15
µL of the supernatant was loaded onto the gel.
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2.10 SEC-MALS
SEC-MALS (size-exclusion chromatography - multi-angle light scattering) is a static
light scattering technique for determining the absolute molecular mass of a protein
(Tarazona and Saiz 2003, Folta-Stogniew, 2006). The technique was employed when
the oligomeric state of TINTIN (theoretical MW = 130 kDa) and truncated EA88B
(Eaf7 residues 1-260, theoretical MW = 111 kDa) was brought into question and also
to assess the polydispersity of the sample. Protein samples were purified as described
above and diluted to 0.7-0.8 mg/mL prior to analysis.
2.10.1 Data Collection and Analysis
A DAWN 8+ MALS detector and an Optilab T-rEX refractive-index detector were
used to collect data, recording UV280, light scattering (DAWN) and refractive index
(T-rEX) signals. These instruments were connected to a HPLC system (Agilent HP
1100), using a Superdex 200 increase 10/300 gel filtration column.
The column was washed with MiliQ water –> 0.5 M acetic acid –> MiliQ –> 0.5 M
NaOH –> MiliQ (2 column volumes at each step), before being equilibrated with
purification buffer until RI (refractive index) and LS (light scattering) detectors
reached a stable baseline. All liquids were degassed within the HPLC system prior to
equilibrating the column and detectors.
100 µL of protein sample was injected into the system to initiate the run. The flow rate
of the system was set to 0.5 mL/min, with a pressure limit of 30 bar. RI signal and
UV280 signal was used to verify protein concentration. LS signals were used to
determine the absolute molecular weight of species within UV peaks. This data was
interpreted using the proprietary ASTRA 6.1 software (Wyatt technology).
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2.11 Native Ion Mobility-Mass Spectrometry
The EA88B truncated TINTIN construct (Eaf7 residues 1-260, theoretical MW = 111
kDa) was subject to native mass spectrometry (Native-MS) and ion mobility-mass
spectrometry (IM-MS), to gain a better understanding of TINTIN’s structure and
subunit composition.
This was carried out in collaboration with Charles Eldrid of the Thalassinos lab, who
was essential for operation of the Synapt G1 (Waters, UK) and carried out analysis of
the raw data that has been interpreted and presented here.
2.11.1 General Theory
Native ion mobility-mass spectrometry (native-MS) is a powerful complimentary
technique to high-resolution structural determination techniques (X-ray
crystallography, cryo-EM etc.), when investigating the architecture of macromolecular
assemblies. Combining conventional mass analysers with ion mobility apparatus,
provides information regarding oligomeric state, physical dimensions and
flexibility/disorder of protein complexes (Wojnowska et al. 2013, Beveridge et al.
2014, Marklund et al. 2015).
Electrospray ionization (ESI) allows for the "gentle" ionization of proteins injected
into mass spectrometry machinery, by releasing protein molecules in a spray of buffer
droplets from a highly charged Taylor cone. This is followed by gradual desolvation
and accumulation of charge on the gas-phase protein ion. This technique can ensure
the overall structure of a protein complex is preserved and is termed ESI-MS or native
MS (Fenn et al. 1989, Hall et al. 2012, Beveridge et al. 2014). Native MS is
advantageous for projects involving low-yield protein samples, requiring a fraction of
the material required for conventional structural analysis techniques (Heck, 2008).
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The desolvation process gives rise to a distribution of charges states, whereby protons
accumulate on solvent accessible, protonation sites (proton accepting residues).
Folded/globular proteins generally have fewer protonation sites exposed to the surface
and therefore tend to accumulate fewer protons, compared to extended/disordered
proteins, resulting in lower charge states and narrower charge state distributions
(CSDs) (Dobo and Kaltashov, 2001).
Figure 2.4: Schematic representation on the influence of order/disorder on Native/IM-
MS spectra. Solute proteins are ionised via electrospray ionization (ESI), prior to ejec-
tion from highly charged ESI tip. Prior to entry into the mass analyser, proteins experi-
ence desolvation, retaining some of the charge from the ESI step. Highly ordered pro-
teins have fewer exposed protonation sites compared to disordered proteins, resulting
in fewer representative ionized species and a narrower range of collision cross sections.
Ion mobility (IM) adds an additional layer of analysis to mass spectrometry
instruments, by providing information on the physical dimensions of the analysed
species, in the form of collision cross sections (CCS) (Uetrecht et al. 2010). The
relationship between CCS can be approximated as the square of the radius of gyration
(Rg), a value typically cited in other biophysical techniques such as SAXS, though this
relationship is weakly correlated (Chirot et al. 2010, Beveridge et al. 2014).
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The technique works by pulsing ionized proteins (by electric field) through a cell
containing inert gas, with larger proteins (with a greater collision cross section)
impeded to a greater extent, compared to smaller/more compact proteins. Proteins can
produce a distribution of arrival times through the IM-cell, as a consequence of
conformational flexibility and variation in charge states (and therefore produce a range
of CCS values).
2.11.2 Sample Preparation
TINTIN and protein standards were buffer exchanged into 100 mM and 200 mM
ammonium acetate (pH 7.4) solution, respectively. The exchange was carried out using
Amicon Ultra centrifugal filtration units (Merck Millipore). Ammonium acetate is a
volatile solution, suitable for desolvation during the ESI process, and tends to produce
more compact CSDs as a consequence of salt-crowding.
Proteins were diluted to 5-10 µM (TINTIN = 0.7 mg/mL ~6 µM) prior to injection








Table 2.10: List of proteins used in calibration for IM-MS experiments. The Amphirite
software was used to generate a calibration curve (CCS vs arrival time) from these
samples, with an R2 value of 0.98. Arrival times of TINTIN ions were compared to this
standard curve to determine CCS values.
82
2.11.3 Instrument and Operation
A Synapt G1 (Waters, UK) IM-MS device was used throughout the experiments. The
IM-cell is positioned between a quadrupole and time-of-flight(TOF) mass analyser.
This allows for the selection of ions with specific m/z values for ion mobility
experiments, as well as tandem mass spectrometry and collision induced dissociation
experiments.
Experimental settings are summarised in table 2.11. Initial native spectra was first
inspected to identify the presence of TINTIN species and any TINTIN-associated
subunits (individual subunits or dimers).
MS
Capillary (kV) 1.4
Sampling cone (V) 40
Extraction cone (V) 1.0
Backing pressure (mbar) 6.00
Trap CE (eV) 6
Transfer CE (eV) 4
Bias 16
Mass range (m/z) 1000 - 16,000
Ion Mobility
Source wave velocity (ms−1) 300
Source wave height (V) 0.2
Trap wave velocity (ms−1) 300
Trap wave height (V) 0.2
IMS velocity (ms−1) 260
IMS wave height (V) 8.0
Transfer wave velocity(ms−1) 260
Transfer wave height (V) 8.0
Table 2.11: Summary of general settings during native ion mobility mass spectrometry
experiments, using a Synapt G1 (Waters, UK). These were set in collaboration with
Charles Eldrid of the Thalassinos lab.
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2.11.4 Collision Induced dissociation
Upon identification of a suspected TINTIN ion (+22 charge state), the quadrupole was
adjusted to select for this specific m/z species. The selected species was then subjected
to collision induced dissociation, by increasing the voltage of trap and transfer
components, in order to break the suspected TINTIN complex into its component
subunits. Collision voltages increased in increments of 10 V, until the single peak in
the spectra split into two or more peaks, indicative of subunit dissociation.
2.11.5 Data Analysis
Mass calculation and peak identification was carried out using MassLynx (v4.1). CCS
calculation was determined with Amphirite (Sivalingam et al. 2013) by Charles Eldrid.
The relationship between the CCS values and the corresponding MW of proteins, can
be described with a linear function (Beveridge et al. 2014).
The linear relationship between CCS and MW for folded proteins is distinct from the
linear relationship for disordered proteins. The two functions can be plot and act as
standards, to compare experimental data against.
After the median CCS and CSD values of each TINTIN associated species was
determined with MassLynx and Amphirite, these values were plot against the linear
functions established by Beveridge et al.. Comparison of these values against both
functions, informs whether or not the species in question has CCS:MW or Charge
state:MW ratios closer to that of ordered or disordered proteins.
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2.12 Small-Angle X-ray Scattering
2.12.1 General Theory
For protein samples that cannot be crystallised, or are unsuitable for for structural
characterisation by electron microscopy and NMR, SAXS offers a low-resolution
alternative that is rapidly produced and can provide insights into protein stoichiometry,
general architecture, and physical dimensions (Jacques and Trewhella, 2010).
When a collimated beam of X-rays interacts with molecules in solution, the incident
beam may be absorbed, pass through without perturbation, or scattered (Mertens and
Svergun, 2010). If there is minimal energy transfer between incident and resultant
beams, the X-rays are said to have elastically scattered.
Elastically scattered waves may interact constructively or destructively, producing
unique diffraction patterns in the case of protein crystals (Ameh, 2019).
Unlike molecules in a crystal lattice, proteins in solution have no fixed orientation and
the resulting scattering signal produced from such experiments, is radially averaged.
This contains information regarding the protein’s MW and physical dimensions, but
loses high-resolution information obtained in X-ray crystallography. These datasets
are initially represented as one dimensional curves of scattering intensity I vs. s (the
magnitude of the scattering vector/momentum transfer).




Where Θ is half the angle between scattered and incident beam, and λ is defined as the
wavelength of the incident beam.
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For proteins in solution, the radially averaged scattering vector will be the sum
contribution from both the solvent and solute. The mean difference in scattering
density between solute and solvent is referred to as the "contrast" and is usually low
between proteins and their solvent.
Therefore, the contribution to the scattering signal from the sample of interest may be
determined, by subtracting a scattering signal from the solvent in the absence of
protein.
2.12.2 Sample Preparation and Data Acquisition
Two TINTIN constructs truncated in the Eaf7 C-terminal were analysed by SAXS;
EA88A (Eaf7 residues 1-221) and EA88B (Eaf7 residues 1-260).
Data acquisition was carried out with the BM29 BioSAXS facility at ESRF Grenoble,
with the aid of Dr Nikos Pinotsis. 60 µL samples were kept at 4 °C in a quartz glass
capillary (diameter 1 mm).
All beamlines have a fixed range of s from which data can be collected. The lower
limit is particularly important, as it defines the lower limits at which the Guinier
analysis (discussed below) is valid. For BM29, the s-range = 0.025 - 5 nm−1.
10 frames were collected for each concentration and each of the buffer blanks (at 1
frame/second). The 10 frames were averaged with the PRIMUS software package
(Konarev et al. 2003). The Edna in-house software package compared scattering
profiles of each frame and confirmed there were negligible levels of radiation damage.
Constructs were analysed in a concentration series (Table 2.12), to determine whether
or not the resulting signal was concentration dependent (diluted with purification
buffer A). A BSA control (4.5 mg/mL) was also used in the experiment, for MW
determination of the species in solution.
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Concentration of Samples (mg/mL)




Table 2.12: Summary of concentration series used throughout SAXS experiments in-
vestigating the structure of two truncated TINTIN constructs (EA88A and EA88B).
The relationship between scattering intensity and sample concentration, can be defined
as:
I(0) = N(∆ρV )2 =
C∆ρ2v2MW
NA
Where, I(0) = Forward scattering intensity, N = number of scattering particles per unit
volume, ∆ρ = contrast, C = mass concentration, v = partial specific volume, MW =
molecular weight and NA = Avagadro’s number.
This equation shows that low concentrations of high-MW contaminants can
disproportionally influence the experimental scattering signal, necessitating
high-purity samples for analysis that we evaluated with SEC-MALS.
2.12.3 Analysis of Raw Data
All data analysis was carried out with ATSAS software package v2.8 (Franke et al.
2017). The PRIMUS software suite was used to carry out the following analysis:
The scattering profile (log(I) vs. s) can be used to derive the forward scattered
intensity, I(0) and the radius of gyration, Rg. I(0) represents forward scattered
intensity, where 2θ = 0◦. I(0) is dependent on the number of particles per unit volume
and can be used to calculate the molecular weight of the specimen in question.
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Rg, is the radius of gyration, the root-mean-squared distance from an objects centre of
mass and gives insights into dimensions of the object. Guinier identified a relationship




Plotting ln(I) vs s2 therefore produces a line from which both aforementioned
parameters can be determined.This relationship is only pertinent between Smin (limited
by equipment used) and sRg < 1.3 (Figure 2.5).
Figure 2.5: Example of background subtracted SAXS data and corresponding Guinier
analysis in the PRIMUS software package. Plotting the natural log of intensity from
this raw data against the reciprocal of the scattering vector squared, should produce a
straight line within the limit of smin and sRg < 1.3. The Rg and I(0) can be extrapo-
lated from this. Upward curvature in this plot suggests protein aggregation, while a
downward curve might suggest repulsive interactions.
I(0) can be used to determine the molecular weight, provided a protein standard of
known molecular weight is included in experiments.
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The I(0) of the BSA was determined and the MW of TINTIN species was calculated






Where x is the protein of interest.
Indirect Fourier transform of the scattering profile, with the GNOM software suite
(Svergun 1992), produces a P(r) (pair-distance distribution) function. This describes
the frequency of interatomic distances, within the molecule of interest (Svergun and
Koch, 2003)(Figure 2.6A and B).
The shape/symmetry of a protein can significantly influence the resulting P(r) function
and the plot can provide additional information, not immediately derived from the
scattering profile.
For example, the theoretical determination of Dmax (the maximum dimension of the
protein molecule), can be derived from the P(r) function. This is achieved by
identifying the r coordinate where P(r) approaches 0 .
P(r) functions can also be used to determine both the Rg and I(0) using the entire
dataset. The variance of a P(r) function provides the Rg, while integrating under the





Unlike Guinier approximations, the P(r) function uses the entire dataset and is
considered a more accurate means of determining the physical dimensions of the
protein under investigation. However, both methods were used to determine values of
Rg, Dmax and I(0) (and by extension; MW).
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Figure 2.6: A and B) Example P(r) function in the PRIMUS softawre package. The
function uses the entire raw dataset (unlike Guinier analysis) and provides values for Rg,
Dmax and I(0). Globular proteins produce normal P(r) distributions, whereas extended
conformations produce tailed traces as seen in the figure. C and D) Kratky plots of
same SAXS data set (Is2 vs s), which are used to measure the flexibility of protein
samples.
The shape of P(r) functions from the data was also considered, as globular proteins are
expected to produce normal distributions, whereas extended conformations generally
produced asymmetric distributions. Is2 vs s plots (Kratky plots), were also used to
determine whether or not the proteins under investigation showed signs of flexibility.
Normal distributions are associated with stable, globular proteins, while asymmetric
distributions indicate disordered or partially flexible proteins (Putnam et al. 2007)
(Figure 2.7).
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The Porod volume can then be derived, provided the I(0) has been determined, either




For globular proteins, the Porod volume can be approximated as 1.6X the MW of the
species in question. Determination of the Porod quotient is sensitive to noise in the
high s range, which was observed in the collected data, and P(r) function indicated an
elongated structure (see Results). As a result, Porod calculated volume is cited in the
results chapter, but was not used to determine the MW of the TINTIN complex in
solution.
Figure 2.7: Example of Kratky analysis of three proteins, representative of unfolded,
partially folded/flexible and folded structures. Integration of the Kratky plot between s
= 0 and s = ∞ yields the Porod quotient Q, which can be used to determine the volume




.out files produced by GNOM were used to generate ab initio models with the dammin
software package (Svergun, 1999). dammin works by first creating a search space
filled with dummy atoms. The software assigns each dummy atom within the space as
either "protein" or "solvent". Dammin then generates theoretical scattering profiles for
these models and attempts to match the theoretical curve, with the experimental curve.
The dimensions of the search space were determined by analysis of the P(r), therefore
a cylindrical model (due to skewed P(r) function) of length 280 Å (determined to be
above the predicted Dmax of ~260 Å) and diameter 60 Å.
Dammin reiterates this process between 10-20 times and generates a log file with χ2
values that should approach 1. The process was repeated, altering the dimensions of
the search space until the statistically best model constraints were applied.
Ab initio models from dammin, are then averaged and filtered with the DAMAVER
software suite (Volkov and Svergun, 2003), as follows:
1. DAMSEL: Compares all ab initio models with an additional program that
superimposes structures (SUPCOMB) and statistically assesses the quality of
this superposition, by comparing normalized spatial discrepancy (NSD) values*.
Outliers are are identified if their NSD score is greater than the mean NSD value
+ 2 standard deviations.
2. DAMSUP: Chooses a reference model based on the best NSD scores
(discarding outliers identified by damsel) and generates a list of reference "r"
models from these alignments with SUPCOMB.
3. DAMAVER: takes all "r" .pdb files and generates a probability map based on
the position of atoms within these structures, in the form of a damaver.pdb file.
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4. DAMFILT: removes low-occupancy atoms from the damaver-generated
probability map, to generate a most probable damfilt.pdb model, that satisfies the
volume restraints of the damaver.pdb file.
*NSD is a quantitative measure of similarity between 2 .pdb files. Higher similarities
result in NSD values that approach 0, whereas NSD > 1 indicates some fundamental







The full-length TINTIN trimer has been bacterially expressed and purified via a
Twin-Strep tag on the C-terminal of Eaf7. The final sample appears to be relatively
pure when assessed by SDS-PAGE and mass spectrometry analysis validated the
presence of the three subunits.
Full-length TINTIN was subjected to crystallisation trials, with the aim to produce a
high-resolution structure. The majority of crystal screens show no sign of
supersaturation, despite protein concentrations higher than 12 mg/mL. Expression of
the full-length complex was inconsistent and limited crystallisation trials at higher
concentrations.
The presence of degradation products during purification steps and the inability to
crystallize the complex, led to the design of truncated TINTIN constructs. While
truncations in the Eaf7 C-terminal improved yield and quality of the sample, additional
Eaf5 truncations appear to compromise the integrity of the trimer. Nevertheless, test
expression/purification of these constructs, provides insights into the architecture of
the complex. The most successful of these constructs were subjected to up-scaled
expression and purification and while some promising leads were observed, the
complex was still unable to crystallise, despite efforts to further refine expression,
purification and buffer conditions.
Finally, pull-down assays were carried out between truncated TINTIN constructs and
known (and predicted) TINTIN binding partners. This included peptides mimicking
RNA Pol II CTD at various stages of transcription, as well as peptides mimicking H3
N-terminal tail of various methylation patterns. The results of these assays are
inconclusive, while low levels of binding are observed (by SDS-PAGE analysis), bands
appear faint. However, there may be indications of direct interaction with Pol II CTD.
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3.2 Initial Purifications of Full-length TINTIN
After generating the TINTIN-pET28a constructs, Rosetta 2 cells were transformed and
incubated in the following expression conditions, to survey for optimal TINTIN
expression (Table 3.1)
Condition Pre-Induction Induction OD [IPTG] (mM) Post-Induction
AI1 37 °C 0.5 - 18 °C(24 hours)
AI2 37 °C 0.5 - 37 °C(16 hours)
LB1 37 °C 0.5 0.2 37 °C(4 hours)
LB2 37 °C 0.5 0.2 18 °C(18 hours)
Table 3.1: Summary of test expression schemes used in the production of TINTIN.
All cells were shaking at 200 rpm throughout their expressions. Schemes in the table
are displayed as: pre-induction temperature, OD cells reach before induction, IPTG
induction concentration, post-induction conditions cells are kept at. Conditions listed
as AI1 and AI2 used auto-induction media and therefore did not require IPTG driven
induction.
Small-scale (50 mL) expressions were harvested, flash frozen with liquid nitrogen for
storage, then subjected to Strep-Tactin purification. SDS-PAGE analysis of these
purifications show that all three TINTIN subunits are expressed, irrespective of the
conditions cells are incubated in, with each lane producing a similar pattern of bands
(Figure 3.1).
It was also noted that despite the Strep-tag’s high-affinity and specificity, the elution
lanes produce many contaminant bands. Condition AI2 yields the best result in terms
of intensity of suspected TINTIN subunits, though it also appears to have the highest
concentration of contaminant proteins. The Eaf7 subunit runs ~20 kDa higher in
SDS-PAGE analysis (just above 70 kDa), with respect to other proteins of equivalent
MW. Eaf3 (45 kDa) shows a more conventional migration pattern, running between 40
kDa and 55k DA, and Eaf5 runs close to 35 kDa.
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Figure 3.1: SDS-PAGE analysis of small-scale (50 mL) expressions/purifications of
TINTIN-pET-28a in Rosetta 2 cells, comparing LB and auto-induction(AI) media based
expressions. Lanes are grouped according to the expression scheme they represent (see
Methods) and correspond to the conditions listed in Table 3.1. Lanes contain 50 µL
loads, from a mixture of 10µL 6X SDS-buffer + 50 µL Strep-TactinXT beads. Con-
dition AI2 appears to produce the highest concentrations of TINTIN subunits (based
on band intensity). All lanes show high levels of contamination, despite the high-
specificity of the purification system employed.
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3.3 Strep-Tactin Purification Optimization
Test expression results show that the optimal conditions for TINTIN expression, was
to incubate cells in AI media at 37 °C (200 rpm) for 24 hours. This was up-scaled to
12 L expressions, producing cell pellets with mass in the range of 150 g.
Early purifications from these pellets were limited by inefficient lysis by sonication
(60% amplitude, 2 s/2 s (on/off) for 10 minutes), and a sub-optimal Strep-purification
step, using 1.5 mL of resin and eluting with 5 x 2 mL aliquots of elution buffer (Figure
3.2A). Samples taken from elutions of the Strep-Tactin purification step, produced
faint bands corresponding to suspected TINTIN subunits. Furthermore, elutions from
this step were highly contaminated by the products of TINTIN degradation, which
were verified by mass spectrometry.
Later purification attempts (Figure 3.2B) involved a series of adjustments to improve
yield and sample quality. These adjustments included; doubling the concentration of
protease inhibitor cocktail (to reduced degradation), using 3 mL Strep-TactinXT resin
which is designed specifically to bind twin-Strep tags with higher affinity and capacity.
These adjustments dramatically increased the concentration of TINTIN subunits
purified after Strep-TactinXT purifications (Figure 3.2B). Eaf5, Eaf7 and Eaf3 bands
were equally intense, and the final quantity of purified TINTIN (after IEX and SEC
purification steps) was ~1.8 mg of protein.
Despite these improvements, two outstanding issues became apparent. Firstly, the
Strep-TactinXT purification step produced relatively impure sample, as seen in Figure
3.2B. Secondly, while the intensity of TINTIN bands increased, we found that even
after the addition of up to 14 mL of elution buffer (containing 50 mM biotin), elution
was incomplete. This indicated that a large percentage of the expressed complex was
still bound to the resin and that the elution step required further optimisation.
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This was supported by the fact that regenerated resins (washing the resin with a low
concentration sodium hydroxide solution), showed reduced binding of TINTIN in
future purification attempts.
Further optimisation of the Strep-purification step addressed the suspected degradation
of the purified sample and maximised the elution of TINTIN from the Srep-TactinXT
resin (Figure 3.2C). To reduce the degradation issue, we included protease inhibitor in
all buffers (including the elution buffer) at 2X the manual recommended concentration
(1 tablet per 100 mL of buffer).
To ensure that all of the TINTIN sample was cleared from the resin, we resuspended
the resin in 20 mL of elution buffer, and left it rotating at 4 °C for 1 hour, before
eluting all 20 mL in one step. An additional 20 mL of buffer was added and the
resuspension/incubation was repeated. The pooled 40 mL of buffer was found to
contain up to 27 mg of protein (measured by Bradford assay), a tenfold increase in
yield from initial Strep-Tactin purification attempts (Figure 3.2C).
We verified that the resin had been stripped of TINTIN, by adding an additional 5 x 2
mL aliquots of elution buffer, finally observing a tapering of band intensity with
consecutive applications (Figure 3.2C). To confirm complete elution, the resin was
incubated overnight in elution buffer and no protein was detected in SDS-PAGE
analysis (data not included).
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Figure 3.2: SDS-PAGE analysis showing the iterative optimization of Strep-Tactin pu-
rification stage. Lanes correspond to consecutive elution fractions (30 µL loads, from a
mixture of 30 µL of eluted protein and 6 µL loading dye). A) Representative of early
elution attempts while all TINTIN subunits. The faint bands reflect low-yields as a re-
sult of suspected degradation of the trimer. B) Representative of purifications after use
of Strep-TactinXT resin. There is a large abundance of contaminating bands in every
lane, but TINTIN subunits are clearly distinguishable. Despite the addition of 7 x 2
mL of elution buffer, the intensity of these bands does not appear to taper, suggesting
that a large proportion of TINTIN remained bound to the resin. C) Representative of
optimised elution scheme, using XT resin. Lanes E1 to E5 represent addition of 2 mL
fractions of elution buffer added consecutively, after incubating the resin with 2 x 20
mL of elution buffer for 2 hours (Data not included).
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3.4 Further Purification
The theoretical pI of TINTIN did not reflect the proteins behaviour during ion
exchange chromatography. With the pI of sample predicted to be ~5 and the buffer of
our purification remaining at pH 8 throughout all steps, it was expected that the sample
would be anionic and bind the Mono Q (5/50 GL) 1 mL column.
However, TINTIN purified from the Strep-purification step, does not appear to bind
the resin and a strong UV280 signal is detected in the flow-through after sample
application. No protein eluted after application of a high-salt buffer B. It appears that
other contaminants that are present in the initial sample, elute upon application of the
high-salt buffer gradient (data not included). Due to this result, the flow-through from
the Mono Q 5/50 GL (which should have contained TINTIN) was loaded onto a Mono
S 5/50 GL (Figure 3.3A and B), a cation-exchange column.
Unlike the Mono Q column, the flow-through of the Mono S appears to be completely
clear of protein, while we detect a strong UV280 signal during the high-salt elution
gradient (~16% high-salt buffer B). This peak overlaps with 2 smaller peaks, which are
always present, despite optimisation of earlier stages of the purification (Figure 3.3A).
The major peak was confirmed by SDS-PAGE analysis to contain TINTIN subunits,
albeit with less contaminating bands (Figure 3.3B). Many of the contaminating
proteins seen in the Strep-purification step, are separated into the smaller peaks and the
height of these peaks correlated with the extent of TINTIN degradation.
As seen in Figure 3.3, while the major peak does contain TINTIN, there is certainly
overlap with the subsequent peaks. Eaf7 bands appear to reduce in intensity with each
fraction, while contaminating bands increase, supporting the notion that TINTIN
subunits (more specifically Eaf7) were being degraded.
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While there is certainly full-length TINTIN subunit found in these peaks, a
compromise between sample yield and purity had to be made for the sake of
crystallography trials and biophysical characterisation. As a result, the first five 0.5 mL
fractions in the major 280 nm peak were pooled and further purified by SEC.
Initially, due to the low-yield of protein after IEX, the Superdex 200 Increase 10/300
GL (1CV = 24 mL) was used, but was increased to a Hi Load Superdex 200 16/600 (1
CV = 120 mL). TINTIN elutes in the first major 280 nm peak from these runs (Figure
3.3C and D), followed usually by two additional peaks which contain contaminating
proteins.
Again, the height of these contaminating peaks was usually a reflection of the quality
and yield of the final product. The higher the contaminant peaks, the greater levels of
degradation that were observed to have occurred by SDS-PAGE analysis.
The first peak is sufficiently pure for pooling and concentrating for crystallisation
trials. However, concentration of the sample usually resulted in loss of 30-50% during
spin-concentration steps. This issue was never resolved, despite several attempts at
optimising the membrane of the spin-concentrators, MW cut-off and even the addition
of stabilising agents such as glycerol.
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Figure 3.3: Chromatograms of the IEX and SEC steps of TINTIN purification and
their corresponding SDS-PAGE gels. Each curve has been colour coded and bars on the
bottom of each trace match the lanes labelled in the adjacent gels. A) Chromatogram
of the TINTIN sample loaded onto a Mono S 5/50 GL, after being cleaned by a Mono
Q 5/ 50 GL. The first major peak elutes during the application of the high-salt (2 M
NaCl) gradient (16% buffer B). Fractions that correspond to this peak were sampled
for SDS-PAGE analysis (highlighted by a red bar). B) SDS-PAGE analysis of the IEX
chromatography step, using a Mono S 5/50 GL. Lanes above the red bar correspond
to peak 1 in A and were pooled for further purification. C) Chromatogram of the final
SEC step of the purification, using a Hi Load 16/600 Superdex 200 pg. Bars beneath
the trace correspond to the bars in D. D) SDS-PAGE analysis of SEC purification step.
The TINTIN trimer is clearly visible in the first peak with some minor contaminants.
The first peak is consistently produced during these purifications and was pooled for
concentration and crystallisation trials.
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3.5 Validation of TINTIN Purification
To confirm that the bands being observed were TINTIN subunits, test purifications
were carried out at a smaller scale. Suspected TINTIN bands in the final SDS-PAGE
analysis were excised, along with two intense bands that were consistently appearing
in this final stage of purifications (Figure 3.4).
The bands were sent to the St. Andrews mass spectrometry unit for protein
identification, verifying the presence of TINTIN subunits. It was also found that the
two intense bands that elute after the complex, are degradation products of the Eaf7
subunit.
Figure 3.4: SDS- PAGE analysis of SEC purification from TINTIN purification,
marked bands were sent to St. Andrews mass spectrometry service for protein iden-
tification. The band between 100 kDa and 70 kDa is identified as Eaf7, the two bands
close to 55 kDa were identified as Eaf3, the band above 30 kDa was identified as Eaf5.




Despite the relatively high-yields of the TINTIN complex that were being expressed in
AI media, it was noted that there was an abundance of degradation products observed
in the initial stages of the purifications, particularly of the Eaf7 complex. At this stage,
crystallisation trials were yielding no successful leads and it was proposed that the
complex was too dilute, or that the contaminants seen after the final gel filtration step,
were somehow impeding the crystallisation process.
Moreover, expression of the full-length complex was extremely inconsistent, with
discrepancies in protein yield between identical expressions/purifications, despite no
obvious change in growth rate in Rosetta 2 cells. The integrity of the expression
system and construct were assessed by test expression of other constructs and
sequencing (data not included), but the source of this inconsistency was never
identified with certainty.
With the aim to improve the consistency of yield and purity, LB and Terrific broth
media were tested for their efficacy, in expressing the TINTIN complex. In both
instances, 6 x 1 L LB/TB (in 2 L flasks) was inoculated with 2 mL of pre-culture
grown overnight (flasks also contained kanamycin and chloramphenicol as described
in the Methods). Flasks were incubated until OD = 0.6-0.7 before induction with 0.2
mM IPTG, and were further incubated at 18 °C for 18 hours.
Pellets produced from either type of expression, were subjected to the same optimised
purification protocol, used for AI media expressed TINTIN. The complex behaves
identically throughout the purification and the final result observed suggests no
observable improvement over AI media expression (Figure 3.5). Moreover, we find
that the yield of purified TINTIN, is dramatically lower than the original expression
and purification scheme, for equivalent volumes of media used.
105
Figure 3.5: SDS-PAGE analysis of TINTIN purifications, where the complex has been
expressed in LB or TB. In both instances, TINTIN subunits are clearly expressed and
purified, however contaminant bands are still observed. The yield of these purifications
was also significantly lower than those produced by AI media expressions. A) LB
expressed/purified TINTIN. 50 µL loads from SEC fractions (from a mixture of 50 µL
sample + 10 µL 6X dye). B) TB expressed/purified TINTIN. 50 µL samples from the
SEC elutions were taken and mixed with 10 µL loading dye. 50 µL of this was loaded
onto the gel.
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3.7 Full-length TINTIN Crystallisation Trials
Crystallisation screens were carried out in parallel with the TINTIN purification
optimisation (Table 3.2.). The concentration of TINTIN for each round of
crystallisation attempts, reflected the maximum yield of the trimer achievable at that
point in time. As a result, increasing concentrations of TINTIN were used with each
attempt.
Commercially available, sparse matrix screens were used to cover a wide range of
crystallisation conditions. TINTIN samples were mixed with each condition (150 nL
sample + 150 nL buffer) by Mosquito crystal into MRC 2-well crystallisation plates.
These were stored at 16 °C in a Rigaku minstrel DT imager and gallery DT plate hotel.
Each plate was immediately imaged upon loading onto the hotel platform, allowing for
detection of any immediate crystal formation. Samples were then periodically imaged
by the device and saved on a database for review. Early purification attempts were
limited in their yield and purity, but gradual improvements to purification protocols
steadily improved this.
Sparse Matrix Screen Concentration (mg/mL)
4.28 7 12.4 10 (4 °C)
JCSG-plus X X X X
Pact X X - X
SaltRX HT X - X X
Index X X X X
Structure Screen 1 X X X X
Midas X - - -
ProPlex X X X -
Morpheus® HT-96 - X X X
Table 3.2: Summary of crystallisation attempts. Each commercially available sparse
matrix screen is given an ‘X’ if it was used for a corresponding TINTIN preparation.
Protein sample and buffers from each screen were mixed 1:1 (v/v) by Mosquito robot
for accuracy and reproducibility, the resulting plates were stored at 16 °C or 4 °C and
regularly imaged to search for the presence of crystal formation.
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3.7.1 Index
The vast majority screens containing 4.28 mg/mL TINTIN appear completely clear,
even after 240 days of incubation, with a minority (~15%) showing signs of
supersaturation (in the form of precipitation, phase separation etc.). We speculated that
this was due to the aforementioned limitations of the TINTIN purification process,
which was further optimised to 7 mg/mL, 10 mg/mL and then 12.4 mg/mL (at a
volume sufficient to prepare > 5 sparse matrix screens).
Even after improvements in yield, crystals were not observed to form after 240 days
incubation, with most wells clear (~80% on average across all screens). Six screens
were incubated at 4 °C, using one of the highest concentrations of TINTIN produced
(10 mg/mL) (these plates required manual analysis, without the aid of a UV detector).
While the majority of wells in the 4 °C plates remained clear, there was a marginal
increase in the number of wells containing some form of precipitation, or phase
separation. Once again, crystal formation was not observed across any of the 6 sparse
matrix screens. After 3072 tested conditions, covering a spectrum of buffer conditions,
temperatures and increasing sample concentrations, no indication of crystal formation
was ever obtained.
Despite this, several distinct wells in the Index screen were scrutinised for their buffer
composition, after certain buffer components were shown to repeatedly coincide with
sample precipitation. Figures 3.6A and B show two wells produced from 12.4 mg/mL
TINTIN, incubated at 16 °C after 17 days of incubation.
The figure shows small, round structures that UV detectors suggest contain protein.
The drop in Figure 3.6B looks particularly interesting, due to the hard-edged
appearance of these aggregates.
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Earlier attempts with this particular screen (using lower concentrations of TINTIN) do
not show any indication of precipitation in these particular wells. It was noted that
both wells contain polyethylene glycol (PEG) 3,350, which immediately led to review
of any other well within the screen, that contained the compound.
Of the 39 wells containing varying percentages of PEG 3,350, only one other well
(containing 0.1 M succinic acid, 15% PEG 3,350 with an average pH of 7.3) shows a
similar level of precipitation and morphology.
Comparison of these three wells, revealed that they each contained buffering
components with similar functional groups. Sodium malonate, sodium citrate tribasic
dihydrate and succinic acid, are derivatives of Krebs cycle compounds. Examining the
screen once again, revealed that wells that contained similar compounds, were more
likely to contain precipitated protein. There were no other trends in pH, salt
concentration or precipitant observed (Table 3.3.).
Interestingly, this trend of citric acid cycle derivatives driving TINTIN precipitation, is
observed in other sparse matrix screens (Figure 3.6C and D). For example, in a well
from the ProPlex crystal screen, containing 0.05 M calcium acetate, 0.1 M sodium
cacodylate, pH 6, 25% (v/v) MPD (Figure 3.6C).
Another well in the Structure screen, containing: 0.1 M sodium citrate, pH 5.6, 20%
(w/v) polyethylene glycol 4000, 20% (v/v) 2-propanol, produced similar results
observed in the Index screen (Figure 3.6D).
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Figure 3.6: Wells containing 150 nL 12.4 mg/mL purified TINTIN and 150 nL of
buffer from the Index sparse matrix screen, after 17 days incubation at 16 °C. A and B
are from the Index screen, while C and D are from the ProPlex and Structure screens,
respectively. Protein aggregates have been circled in red. A) This well contains 0.2 M
sodium malonate pH 7, 20% (w/v) polyethylene glycol 3,350, average pH = 7.4. B)
0.2 M sodium citrate tribasic dihydrate, 20% (w/v) polyethylene glycol 3,350, average
pH = 8.3. The structures produced in this well appear hard edged and were initially
mistaken for protein crystals. C) This well contains 0.05 M calcium acetate, 0.1 M
sodium cacodylate, pH 6, 25% (v/v) MPD. D) Contains: 0.1 M sodium citrate, pH 5.6,
20% (w/v) polyethylene glycol 4000, 20% (v//v) 2-propanol. After 240 days incubation
at 16 °C, no further changes in morphology were observed for either drop.
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Compound Concentration (M) pH Result PEG 3,350
Citric acid (+2M Ammonium Sulfate) 0.1 3.5 High Precipitate -
Citric acid (+3M NaCl) 0.1 3.5 High Precipitate -
Sodium Citrate Tribasic Dihydrate 1.4 7.5 Precipitate -
Sodium Citrate Tribasic Dihydrate 0.2 8.3 Precipitate 20%
Ammonium Citrate Tribasic 1.8 7 Low Precipitate -
Ammonium Citrate Tribasic 0.2 7 Clear 20%
Succinic acid 0.1 7 Precipitate 15%
Succinic acid 0.8 7 Clear -
Succinic acid 1 7 Clear -
Sodium Malonate 2.4 7 High Precipitate -
Sodium Malonate 1.1 7 Clear -
Sodium Malonate 0.2 7 Precipitate 20%
Table 3.3: Summary of analysis of Index sparse matrix screens, containing derivatives
of the citric acid cycle. Concentrations of each compound are described, as well as
the pH and PEG 3,350 content. PEG 3,350 and pH levels do not appear to be the
determining factor in the extent of precipitation. 75% of the conditions described here
show some level of saturation of the TINTIN sample. We verified that the precipitation
observed contained protein by UV detector within the Rigaku storage device.
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3.7.2 Morpheus
One other sparse matrix screen produced a promising trend of results. The Morpheus
HT- 96 screen produced results similar to those seen in Figure 3.6, but did not contain
citric acid cycle derivatives. As with the Index sparse matrix screen, when TINTIN
was applied to this screen at concentrations < 12.4 mg/mL. These wells appear
completely clear, indicating that the phenomenon observed is dependent on protein
concentration.
The well in Figure 3.7A contains 0.12 M ethylene glycol, 0.1 M buffer system 1, pH
6.5 50% (v/v) precipitant mix 1. The well in Figure 3.7B contains 0.12 M
monosaccharides, 0.1 M buffer system 2, pH 7.5, 50% (v/v) precipitant mix 1. The
common compounds in both wells are found in ‘precipitant mix 1’ which consists of:
40% (v/v) PEG 500 MME and 20% (w/v) PEG 20,000. As a result, wells that
contained this precipitant mix were analysed to search for signs of
precipitation/supersaturation.
Of the 24 wells that contained the precipitant mix 1, none show similar results to the
two described in Figures 3.7A and B. However, in 20 drops containing these
precipitant compounds, phase separation is observed (Figure 3.7C). This occurs at T0
without any change over the course of 240 days. No other trend in pH levels,
precipitant mixtures, buffering compounds, or salt concentration was observed in the
Morpheus screen (or any other sparse matrix screens).
Some unique conditions produced similar results to the drops displayed in Figures 3.6
and 3.7. The chemical composition of these drops did not appear to belong to any
identified trend, but nonetheless, show the protein sample reaching supersaturation
(using 12.4 mg/mL TINTIN in the preparation of these drops) (Figure 3.7D).
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Figure 3.7: Drops produced from the Morpheus® HT-96 screen, containing 150 nL
buffer + 150 nL 12.4 mg/mL TINTIN incubated for 17 days at 16 °C. The round struc-
tures (circled red) were confirmed to contain protein by UV detector. A) Buffer in this
well contains: 0.12 M ethylene glycol, 0.1 M imidazole, 0.1 M MES, pH 6.5, 20% (v/v)
PEG 500 MME and 10% (w/v) PEG 20,000. TINTIN appears to form round clusters,
some of which appear to possess hard edges. B) Buffer in this well contains 0.12 M
monosaccharides, 0.1 M HEPES, 0.1M MOPS, pH 7.5, 20% (v/v) PEG 500 MME and
10% (w/v) PEG 20,000. C) This is representative of 20 other drops from the Morpheus
screen, containing the same precipitant mixture. The buffer contains: 0.12 M ethylene
glycol, 0.1 M HEPES, 0.1 M MOPS (pH 7.5), 20% (v/v) PEG 500 MME and 10% (w/v)
PEG 20,000. These drops also form immediately, and show no morphological change
over a 240 day period. D) This drop is from the ProPlex screen and contains: 0.05 M
magnesium chloride, 0.1 M MES, pH 6.5, 10% (v/v) 2-propanol and 5% (w/v) PEG
4000. This is representative of a small subset of results, across all sparse matrix screens
used, with no apparent trend between buffer composition and protein precipitation.
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3.8 Limited Proteolysis and Design of Truncated
The lack of success in crystallising the full-length TINTIN complex necessitated a
change in approach. High levels of degradation were also observed during the
purification process, irrespective of the expression scheme used and optimization
attempts. Limited proteolysis was carried out to identify a truncated, but stable
TINTIN core and also to identify key components for TINTIN assembly.
Purified TINTIN was mixed with 4 proteases at varying ratios and lengths of time at
room temperature. Reactions were quenched with SDS-PAGE loading dye, and the
results analysed by electrophoresis (Figure 3.8A). Both α-chymotrypsin and trypsin
show progressive levels of degradation of the trimer as incubation time increases,
while papain completely destroys the sample and subtilisin consistently produces a
smear of bands.
Distinct bands that were consistently produced throughout optimization attempts, were
excised and sent for analysis to the St. Andrews mass spectrometry service. This
analysis included determination of the boundaries of each peptide detected, allowing
for the design of truncated constructs to be be expressed and purified for
crystallography (Figure 3.8B).
Eaf7 degradation from the C-terminal was observed and degradation from the
N-terminal of Eaf5 was also detected. Eaf3 species showed minor degradation from
both termini, but the subunit remained generally intact. Considering these results, in
combination with disorder prediction methods (Appendix A) that indicated that ~70%
of Eaf7 is disordered from the C-terminal, a series of truncated constructs were
designed (Methods). Each of these constructs contained a C-terminal Twin-Strep tag,
identical to that of the full-length construct. In parallel to this, the chromodomain
domain of Eaf3 was also designed with C-terminal Twin-Strep tags, for the purpose of
TINTIN pull-down assays.
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Figure 3.8: A) SDS-PAGE analysis of optimised limited proteolysis experiments. Val-
ues above each lane correspond to incubation time (minutes), between TINTIN and
protease at room temperature. In the α-chymotrypsin and papain reactions, 140 ng of
protease was present, whereas trypsin and subtilisin reactions contained 2.8 ng of pro-
tease. Reactions were quenched with 8 µL of 6X SDS loading dye, at varying time
points. 20 µL of these mixtures were loaded onto the gel. α-chymotrypsin and trypsin
lanes show the best results, with progressively increasing levels of degradation with
incubation time. Bands marked with red, were excised and sent to St. Andrews for
identification by mass spectrometry. B) The boundaries identified by the mass spec-
trometry analysis, are listed beneath the full-length subunits in a schematic format.
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3.9 Truncated TINTIN Construct Purification
Figures 3.9 and 3.10 display the result of test expressions/purifications of truncated
TINTIN constructs, that had been designed to identify a stable core of the complex and
also to identify boundaries for complex stability. Figure 3.9. displays purifications of
constructs containing Eaf7 truncations. These have been grouped into C-terminal
truncations and N/C-terminal truncations (88A to 88C and 88D to 88F, respectively).
The majority of C-terminal truncations do not appear to compromise the interaction
between Eaf7 and the other TINTIN subunits. In fact with over 50% of the subunit
truncated from the C-terminal end (constructs 88A, 88B and 88C), the complex
appears to express and purify with similar quality to the full-length complex. EA63B
(truncated from residue 143), is the exception to this, as Eaf5 is not obviously present,
though Eaf3 and truncated Eaf7 are distinct.
As with full-length TINTIN, all test purifications show similar levels of contamination,
likely a consequence of the properties of the resin used. In the case of 88C, intense and
smeary bands that do not correlate to TINTIN subunits are also observed, as we might
observe in full-length TINTIN purifications.
In contrast to C-terminal truncations, N-terminal truncations up to residue 86 prove
problematic for complex integrity. Construct 88D, which also includes a C-terminal
truncation from residue 260, is not obviously purified with the Strep-TactinXT resin.
Construct 88E (containing residues 86-354) indeed appears to produce Eaf7
co-purified with Eaf3, but Eaf5 is not observed in this purification.
In the case of construct 88F (86-425), the tagged protein is purified and the
degradation product of Eaf3 may be present, though the band intensity is weak, and
there is no indication of Eaf5.
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Figure 3.9: Test Strep purification of TINTIN constructs with truncated Eaf7. Pro-
posed Eaf7 bands are marked with an asterisk, and Eaf7 boundaries are represented
schematically above the gel. Lanes are grouped between C-terminal and N/C-terminal
truncations. C-terminal truncations do not appear to impede complex integrity, as Eaf5
and Eaf3 co-purify with the tagged protein in each case. 88D fails to clearly yield any of
the TINTIN subunits, whereas 88E yields bands corresponding to truncated Eaf7, Eaf3
and another intense band that does not correspond to Eaf5. 88F yields an ambiguous
result, with a band that potentially corresponds to Eaf7 and potentially a degradation
product of Eaf3. Eaf5 does not appear to be present in N-terminal truncated Eaf7 pu-
rifications.
Figure 3.10 displays the test purifications of Eaf3/Eaf7 dimers, as well as TINTIN
constructs with Eaf5 N-terminal truncations (Eaf7 is C-terminally truncated in each of
these constructs; 1-221 and 1-260). These truncations were found to be sufficient for
complex integrity in the presence of full-length Eaf3 and Eaf5.
Removal of Eaf5 in combination with Eaf7 C-terminal truncations, appears to severely
disrupt complex integrity, as co-purification of full-length Eaf3 via the tagged Eaf7
was not possible (Figure 3.10A).
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Eaf5 N-terminal truncations also seem to disrupt the yield and integrity of purified
TINTIN to a lesser extent (Figure 3.10B.). When combined with the smaller of the
Eaf7 C-terminal truncations (1-221), it is not clear that a stable complex is present,
even at low concentrations. For the construct containing the more complete
Eaf7(1-260), Eaf3 co-purifies, though the Eaf5 subunit appears to be less abundant.
Figure 3.10: Test purifications of Eaf3/Eaf7 dimers (with Eaf7 truncated in each case)
and TINTIN constructs containing truncated Eaf7 and Eaf5. Elution = 20 µL sample
(from 20 µL + 4 µL loading dye), BA = 10 µL XT resin beads after elution. Schematic
representations of each subunit (and residue boundaries) are listed beneath each gel.
A) Test purification of Eaf3/Eaf7 dimers. 98A purification appears to fail to produce
either subunit, while the larger 98B construct yields the truncated Eaf7 band (identical
to the band of construct 88B in figure 3.9) along with several other bands that may
be degradation products of Eaf7 or Eaf3. B) Test purification of the construct EA147
(Eaf7 1-221, Eaf5 141-279), the result of which remains ambiguous, due to several
low-intensity bands. In the test purification of construct EA125 (Eaf7 1-260, Eaf5 141-
279), the tagged Eaf7 truncation and Eaf3 are clearly present. A band that corresponds
with truncated Eaf5 is also observed, this however is less intense than the other TINTIN
subunits.
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3.10 Upscaling Purification Truncated Constructs
Test purifying the multiple truncated constructs and Eaf3/Eaf7 dimers identified two
particularly promising candidates for purification and crystallisation trials. Constructs
EA88A and 88B (containing Eaf7 1-221 and Eaf7 1-260, respectively) were expressed
in 12L LB (using the LB2 expression scheme described in methods) and subjected to
purifications that followed the same general protocol as full-length TINTIN. The result
of both sets of purifications can be seen in Figures 3.11 and 3.12, for constructs 88A
and 88B respectively.
Both constructs appear to express and purify well, with 3 bands corresponding to the
molecular weight of each subunit of the TINTIN complex. Early test purifications of
the complex suggested that the sample was saturating the Strep-TactinXT resin (using
the same volume of resin; 3 mL). As a result, a high-capacity variant of the resin was
used, with over 40 mg of protein (determined by bradford assay) detected in elutions.
In the case of EA88A, the protein content was so abundant, that a single IEX
chromatography step with the Mono S 5/50 GL could not capture all of the protein. As
a result, the run was repeated to capture and further purify the complex.
As with the full-length TINTIN complex, the final size-exclusion step of the
purification of either construct, revealed that the protein eluted early for a species of its
predicted molecular weight (Appendix C).
Generally, both constructs express better in LB than full-length TINTIN expressed in
auto-induction media, in terms of mass of pellet to total protein yield. However, both
constructs share a similar bottleneck to the final yield of the purified protein, that being
the concentration step of the post-SEC sample. As with the full-length construct, when
TINTIN is concentrated to > 4 mg/mL, then we observe rapid loss of sample in the
region ~50%, depending on the final concentration reached.
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Figure 3.11: Summary of the upscale purification of construct EA88A. A) Construct
schematic. B) Strep-TactinXT high-capacity purification stage. BA = resin after elution
of TINTIN with 50 mM biotin (E1–>6). C) Ion-exchange step chromatogram (Mono
S 5/50 GL). Red and yellow bands correspond to lanes in the adjacent SDS-PAGE gel.
D) SDS-PAGE analysis of IEX stage of purification, lanes have been colour coded with
a red and yellow band to correspond to adjacent chromatogram. Fractions within the
red band were pooled for further concentration. E) Chromatogram of final SEC step of
the purification, using a HiLoad 16/600 Superdex 200 pg. The yellow band beneath the
trace corresponds to the yellow band in the adjacent gel. F) SDS-PAGE analysis of the
final size-exclusion step. Lanes within the yellow band correspond to the yellow band in
the adjacent chromatogram and were pooled and concentrated for crystallisation trials.
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Figure 3.12: Summary of the upscale purification of construct EA88B. A) Construct
schematic. B) Strep-TactinXT high-capacity purification stage. SN = clarified lysate.
FT = flow-through after loading the sample on the the Strep resin. BB/ BA = resin
before and after elution of TINTIN with 50 mM biotin, respectively. E1-E5 = 2 mL
elutions after resuspension step. C) Ion-exchange step with a Mono S 5/50 GL. The red
band corresponds to lanes in the adjacent gel. D) SDS-PAGE analysis of IEX stage of
purification. Fractions that correspond to these lanes within the red band were pooled
for further concentration. E) Chromatogram of final SEC step of the purification using
a HiLoad 16/600 Superdex 200 pg. The red band beneath the trace corresponds to the
red band in the adjacent gel. F) SDS-PAGE analysis of the final size-exclusion step.
Lanes within the red band were pooled and concentrated for crystallisation trials.
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It was noted that a 15 kDa contaminant band was present in the final purification of the
full-length TINTIN complex, as well as both of these truncated constructs. This band
was excised and sent for identification to the St. Andrews mass spectrometry service.
This determined that the band was a degradation product of Eaf5, more specifically its
N-terminal (residues 1-145), that seems to follow the complex throughout the
purification, despite multiple rounds of chromatography.
3.11 TINTIN Interaction Studies
The exact biological role of TINTIN is poorly understood and a better understanding
of what proteins the complex interacts with, may provide insights into this role.
Pull-down assays were conducted between purified TINTIN constructs and peptides
that mimic histone N-terminal tails with different methylation patterns, and the RNA
Pol II C-terminal domain with different phosphorylation patterns.
Three constructs of increasing complexity were used throughout these pull-down
assays. The C-terminal chromodomain domain of Eaf3, and two TINTIN constructs
containing a truncated Eaf7 subunit of increasing length; EA88A (Eaf7, 1-221) and
EA88B (Eaf7, 1-260) (Figure 3.13 and 3.14).
Peptides that had been acquired for these experiments contained biotin tags in order to
fix to a Strep-Tactin resin. All proteins used in this project were purified via
C-terminal Strep-tags, these were removed via 3C protease that acted on a 3C cleavage
site upstream the affinity tag. The process of cleaving the Strep-Tactin, followed by
removal of the cleaved tag and protease was a costly process, resulting in loss of over
50% of the sample.
Generally speaking, the affinity between Eaf3 chromodomain and the histone peptides
appears to be very weak (Figure 3.13).
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Comparing the intensity of the cleaved lane (1 mg/mL if protein) with the lanes
corresponding to the protein incubated with peptides, shows that most of the protein
applied to the resin has not bound. Faint chromodomain bands can be seen in the
histone peptide lanes, whereas the CTD peptide lanes appear completely clear. There
does not appear to be any visible difference in intensity between bands observed in the
histone peptide lanes.
Figure 3.14A and 3.14B shows the result of pull-down assays with constructs EA88A
and EA88B (respectively) and the spectrum of peptides tested. Figure 3.14B includes
an additional peptide, mimicking the N-terminal tail of H4 (non-methylated). Similar
to the chromodomain, the two TINTIN constructs containing C-terminally truncated
Eaf7 of varying lengths show weak affinity for histone peptides, irrespective of
methylation state (Figure 3.14).
The shorter EA88A (Eaf7, 1-221) shows no indication of interaction with CTD
peptides, regardless of phosphorylation patterns. The longer EA88B (Eaf7, 1-260)
may appear in low-abundance in Pol II CTD lanes, though this is not conclusive.
Comparing the intensity of TINTIN bands between the cleaved lane (that represents
the protein at its loaded concentration during the assay) and the assay lanes, suggests
that there is weak affinity between TINTIN and the histone peptides. The lack of
TINTIN bands in the negative control lane, suggests that there is minimal non-specific
binding between the protein and the resin.
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Figure 3.13: Pull-down assay between purified Eaf3 chromodomain and commercially
produced peptides, mimicking histone N-terminal tails and Pol II C-terminal domain
with varying post-translational modifications. Full-length (FL) and cleaved lanes com-
pare the purified protein to the protein post cleavage step described in methods. The
cleaved protein was diluted to 1 mg/mL, 2 µL of this mixture was taken and mixed
with 0.4 µL of 6X loading dye, with 2 µL of this loaded onto the gel. Histone peptide
lanes labelled 1-21 and 21-44 represent different regions of the unmodified N-terminal
tails of H3. Bands in line with the 15 kDa mark represent the cleaved chromodomain.
The assay involved the loading of 1 mg/mL of protein onto 20 µL of dynabead Strep-
resin. Comparing the intensity of chromodomain bands in the assay lanes to the cleaved
lane, show that while some binding to the peptide is observed, the majority of the loaded
sample has not bound to the resin. Lanes corresponding to the Pol II CTD with varying
states of phosphorylation, do not appear to contain the chromodomain band.
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Figure 3.14: SDS-PAGE analysis of pull-down assays between two TINTIN constructs
with histone and CTD peptides. "Con" lanes are negative controls, where tag-cleaved
protein was mixed with Strep resin. A) Pull-down assays using the EA88A construct
(Eaf7, 1-221). Faint TINTIN subunits are observed in the histone peptide lanes, though
these are low-intensity bands. The Pol II CTD lanes appear completely clear, sug-
gesting no/low-levels of binding occurred between the complex and these peptides. B)
Pull-down assays using the EA88B construct (Eaf7, 1-260). TINTIN bands appear in
the lanes corresponding to the histone peptides (again at low-levels). There is some
indication of TINTIN peptides present in the Pol II CTD lanes, suggesting there may
be some weak interaction between the complex and Pol II CTD, however these bands
are particularly faint and may be a consequence of some non-specific binding.
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Figure 3.15: Pull-down assays summary, displaying scanned gels above a contrast ad-
justed image for better visualisation of TINTIN bands. A) Eaf3 chromodomain results.







While auto-induction media based expressions of TINTIN produce high levels of the
complex, this expression proved inconsistent despite multiple attempts to make a more
robust expression protocol.
Rosetta 2 cells have been shown to express several of the truncated TINTIN constructs
without issue, and cells grow at a consistent rate, irrespective of vectors they are
transformed with, though some subtle issue with the cells may be present.
TINTIN appears to express consistently in other media (such as TB and LB), though at
significantly lower concentrations. This suggests that both the cells and the TINTIN
pET-28a vector is functioning as intended, and the issue is a consequence of the AI
media driven expression itself.
Removal of the C-terminal half of Eaf7 and expressing these constructs in LB media
circumvented this characteristic inconsistency, which may have been a result of
toxicity. Considering the disordered nature of the Eaf7 C-terminal (Appendix A), the




Despite inconsistent levels of expression, the full-length TINTIN complex has been
concentrated to relatively high levels and subjected to ~3000 crystallisation conditions.
Early attempts at crystallisation of the complex produced a majority of completely
clear wells in the commercial screens, indicating that protein concentration was well
below the threshold for crystal formation.
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The optimisation of TINTIN purifications resulted in a 3X increase in the yield of
purified complex, to a final concentration of 12.4 mg/mL of protein, though limitations
in the final concentration step prevented attainment of higher concentration samples.
With increasing concentrations of protein, indication of protein supersaturation was
observed. Lowering the temperature that the sample was stored in, from 16 °C to 4 °C
also appeared to increase levels of supersaturation.
The majority of wells that showed supersaturation (though still a minority), contained
heavily precipitated protein, indicating that either precipitant or protein (or both)
concentrations were too high. Preliminary thermofluor assays suggested that TINTIN
stabilised in lower salt concentrations and reducing NaCl concentration in the
purification buffer saw marginal increases to yield, but did not improve
crystallography attempts (Appendix B).
While SEC-MALS data (discussed in the next chapter) suggested that the full-length
purified sample was close to homogeneity, there were indications that trace amounts of
a higher order aggregate were present in the mixture and SDS-PAGE analysis
suggested the presence of low MW contaminants (such as a band that consistently runs
close to 15 kDa on the gel, that corresponds the C-terminal of Eaf5).
Moreover, disorder prediction software indicates that over 50% of the Eaf7 subunit
was disordered from the C-terminal end. It is likely that the combination of
low-concentration contaminants, as well as some intrinsic disorder within the
complex, prevent the nucleation of protein crystals and further biophysical analysis
and truncations (of TINTIN subunits) were carried out to circumvent this issue.
These truncations would also serve to identify regions that were essential for complex
assembly and function (in later pull-down assays).
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4.2.2 Truncated Constructs
Removal of C-terminal disordered region from Eaf7, dramatically improves protein
yield per gram of cell pellet used. Both EA88A (Eaf7, 1-221) and the larger EA88B
(Eaf7, 1-260) express at consistently high-yields, when compared to the full-length
complex.
An encouraging indication of improvement in complex stability, was the absence of
high-intensity Eaf7 degradation products in the early stages of the purification, that
were typical of purification of the full-length complex.
Despite further crystallisation trials, neither of these complexes produced crystals,
though showed a higher proportion of supersaturation in the wells of the commercial
screens. This effect was more pronounced when screens were stored at 4 °C.
Higher concentrations of protein were not tested (>8 mg/mL) for two reasons. Firstly,
the majority of supersaturated wells contained precipitated protein and secondly, both
complexes suffered from the same loss of sample during concentration, as the
full-length complex. The latter, limited the number of screens that could be tested with
every purification attempt.
It has been proposed that the interaction between Eaf5 and the rest of the TINTIN
complex is relatively weak. In vitro, this weak interaction could translate to an
equilibrium between the complete trimer and an Eaf5 subunit free of an Eaf3/Eaf7
dimer. This equilibrium would result in polydispresity of the species in solution, which
is not conducive to crystal formation.
Interestingly, low-MW contaminants are present in the final sample and may be
disrupting crystal formation, by increasing polydispersity. This includes the Eaf5
C-terminal, which is essential for interaction with Eaf7 and the rest of NuA4
(Setiaputra et al. 2018).
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4.3 TINTIN Architecture
The pursuit of a more stable TINTIN trimer, has provided insights into the overall
architecture of the complex (via disorder prediction, limited proteolysis and
subsequent generation of truncated constructs).
4.3.1 The Role of Eaf7
Firstly, we can clearly see that predicted disordered C-terminal region of Eaf7 is
dispensable for complex integrity, provided both Eaf5 and Eaf3 are present. 3
C-terminal truncations of Eaf7: EA88A(1-221), EA88B(1-260), EA88C (1-354)
appear to co-purify Eaf5 and Eaf3. However, the greatest C-terminal truncation (Eaf7
1-142) shows weaker affinity for Eaf5, suggesting some significant interaction occurs
between Eaf5 and residues 142-221 in Eaf7.
When C-terminal truncations are combined with truncations in the N-terminal region
(which disorder prediction software suggests is stable), the intensity of TINTIN bands
reaches background levels, or seems to alter the stoichiometry of subunits. EA88D
(Eaf7, 86-260) does not obviously produce any of the TINTIN subunits, highlighting
the importance of the N-terminal for complex assembly. However, the EA88E
complex (Eaf7, 86-354) co-purifies Eaf3, suggesting additional points of contact may
exist between Eaf3 and Eaf7’s C-terminal.
4.3.2 Eaf3/Eaf7 Dimers
The human orthologs of the Eaf3 and Eaf7 subunits form a stable dimer in vivo (Xie et
al. 2015). Whether or not this is reflected in yeast has yet to be verified. Two
constructs of the dimer were generated (EA98A and EA98B) and test
expressed/purified, both containing the MRG and MBD domains found to the basis for
the assembly of MRG15/MRGBP complex.
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Both constructs contained truncations of the Eaf7 subunit (Eaf7, 1-221 and 1-260).
These truncations had not disrupted complex formation, when Eaf5 was also expressed
(EA88A and EA88B respectively).
Interestingly, the absence of Eaf5, in combination with these C-terminal truncations
appears to completely disrupt complex formation. In the case of the smaller Eaf7
construct (1-221), the tagged protein is not purified. From this, it may be inferred that
Eaf5 plays a role in complex integrity and Eaf7 stability is also dependent on
interaction with the other subunits.
A full-length Eaf7 may restore stability and result in co-purification of the Eaf3
subunit, considering that Eaf7 constructs containing residues 86-354 appears to purify
Eaf3. Nevertheless, current in vitro data, indicates that Eaf5 contributes to Eaf3/Eaf7
interactions.
4.3.3 Eaf5 Truncations
Purification of full-length TINTIN and constructs with Eaf7 truncations, consistently
produce a low-MW contaminant band that was found by mass spectrometry analysis to
correspond to the C-terminal of Eaf5. Interestingly, Setiaputra et al. (2018)
cross-linking mass spectrometry data, suggests that this region makes contact with
Eaf7 and the Eaf1 scaffold of NuA4.
Two constructs containing both Eaf7 truncations and an Eaf5 N-terminal truncation
(Eaf5, 141-279) were generated, test expressed and purified. As with the Eaf3/Eaf7
dimer investigation, the Eaf7 truncations included, were not observed to disrupt
complex formation, when both full-length Eaf3 and Eaf5 subunits were present.
N-terminal truncation of the Eaf5 subunit can be sufficient for complex stability,
provided the larger Eaf7 truncated construct is present (1-260). The presence of Eaf5
C-terminal clearly restores complex stability, possibly due to interactions with Eaf7
and Eaf3 in this region.
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The EA125 construct, containing the full-length Eaf3, Eaf7 (1-260) and Eaf5
(141-279), represents the smallest construct of the TINTIN complex thus far. Intensity
of bands in SDS-PAGE gels, indicate that the Eaf5 subunit is less abundant than the
rest of the complex, possibly due to a reduction in strength of interaction. A map of
possible interaction interfaces between TINTIN subunits is included in chapter 7,
including residue boundaries for positions of interaction.
4.4 TINTIN Interaction Studies
TINTIN’s interaction profile is poorly characterised and would likely help explain its
biological role. Eaf3 contains a chromodomain responsible for interacting with
trimethylated H3K36, though the strength of this interaction was found to be relatively
weak (Sun et al. 2008). However, these experiments did not include the complete Eaf3
protein, or Eaf3 in complex with the remaining TINTIN subunits.
Moreover Rossetto et al. (2014) have proposed that the complex directly interacts with
the elongating Pol II via its C-terminal domain, though direct evidence of this has yet
to be produced. To that end, the long-form Eaf3 chromodomain (Sun et al. 2008) and
truncated TINTIN constructs EA88A and EA88B, were subjected to pull-down assays
with peptides that mimic histone N-terminal tails and Pol II CTD at different stages of
transcription.
4.4.1 Histone Peptide Interactions
For all 3 proteins tested, the majority of purified sample does not bind to any of the
peptides. This is evident when we compare the intensity of "cleaved" lanes, which are
representative of the quantity of sample exposed to resin-fixed peptide. Faint bands
suggest that any interaction observed, is weak.
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The presence of the complete Eaf3 (and additional TINTIN subunits) does not
obviously improve affinity between the chromodomain and H3K36me3. Though a
more sensitive and precise experimental technique such as BLI may reveal differences
in affinity. Moreover, no obvious difference in band intensity between histone peptides
is observed, as a result we cannot exclude the possibility that these faint bands are a
consequence of non-specific binding, though controls suggest otherwise.
4.4.2 Pol II CTD Interactions
The chromodomain was not expected to bind to Pol II CTD and pull-down assays
show that while the domain non-specifically binds the histone peptides, CTD lanes
appear completely clear.
For the smaller of the two TINTIN constructs; EA88A (Eaf7 1-221), CTD lanes
appear to be completely clear. Conversely, for the larger TINTIN complex (Eaf7
1-260), faint bands of TINTIN are present in the CTD lanes. While noticeably less
intense than bands in the histone peptide lanes, TINTIN subunits from this construct
appear in all of the CTD lanes.
The additional 22 residues (between EA88B and EA88A) may confer affinity for Pol
II CTD, though it must be noted that this seems to be non-specific, as even the
non-phosphorylated CTD appears to be bound. Whether this interaction is due to some
specific interaction is not obvious from this data. Furthermore, the results are unable to
determine differences in affinity for various phosphorylation patterns, a limitation of
evaluating these interactions by SDS-PAGE.
However, the fact that a more complete TINTIN complex shows signs of interaction
with Pol II CTD is interesting. A more sensitive technique with increasingly complete








The crystallisation trials of the full-length TINTIN complex (and truncated constructs)
failed to produce crystals. The monodispersity of the sample (and the truncated
EA88B) was assessed by SEC-MALS, which also gave an indication of the oligomeric
state of the sample. This data shows that TINTIN existed as a single trimer, though
trace amounts of higher order aggregates may be present.
A truncated TINTIN complex (EA88B) was subjected to native ion mobility mass
spectrometry, to identify contaminant proteins and determine the presence of flexibility
within the complex. From this data, we verified the presence of a monomeric TINTIN
species that, once isolated via quadrupole and subjected to collision induced
dissociation, produced a Eaf3/Eaf7 dimer and Eaf5 monomer.
TINTIN related species identified in the spectra were then further analysed by ion
mobility, suggesting individual subunits are extended. Eaf5 in particular adopts a
highly extended conformation, with a high collision cross section and charge, when
compared to ordered proteins of comparable mass. The TINTIN complex however, is
likely ordered, based on its collision cross section:mass and charge state
distribution:mass ratios.
To better understand the structure of the complex in the absence of high-resolution
data, SAXS was carried out on the two most successful truncated TINTIN constructs
(EA88A and EA88B). Datasets collected, reveal a concentration dependence on the
calculated MW, possibly a consequence of oligomerization events. Higher
concentration samples however, produce a calculated MW which approximates well
with monomeric TINTIN. Both constructs produce similar low-resolution, highly
extended structures of comparable dimensions, as was predicted when considering
chromatograms from SEC-purification steps.
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5.2 Light Scattering Analysis
SEC-MALS
A common feature of TINTIN purifications was the unusually early elution volume for
a complex of its predicted molecular weight, from size-exclusion columns (HiLoad
Superdex 200 16/600 GL)(Chapter 3). According to our own calibrations using MW
protein standards (Appendix C), the sample was eluting at a volume that would
correspond to approximately 3X the theoretical MW of TINTIN (~130 kDa). This
suggested that we were observing a ‘trimer of trimers’ and a similar effect was
observed when purifying the truncated TINTIN constructs (EA88A and EA88B).
We employed size-exclusion chromatography multi-angle light scattering
(SEC-MALS) to determine an absolute mass of the complex and to get an indication of
sample polydispersity for the full-length construct and EA88B (Eaf7, 1-260) (Figure
5.1 and 5.2).
Analysis of the full-length complex, reveals the polydispersity of the major peak in
Figure 1 (MW/Mn) = 1.007 (± 0.987%), indicating that the sample is close to
homogeneity. The light scattering signal, suggests the presence of higher order
aggregates distinct from the primary peak, though these probably account for a small
fraction of the sample, when considering the low-intensity signals for corresponding
refractive index and UV measurements at these positions on the chromatogram.
Molar mass distributions suggest that the full-length TINTIN is 123.7 kDa, which
equates roughly to the predicted MW of monomeric TINTIN (theoretical MW of 130
kDa). However, the molar mass distribution forms a slight downward slope within this
peak, which leads into a plateau with a MW of 122.5 kDa. This also aligns with the
UV/LS tail in the chromatogram.
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Similar to the full-length construct, the EA88B construct (Eaf7, 1-260) is observed in
its monomeric state (approximately 100 kDa). The complex appears to show close to
ideal levels of purity in the primary peak(MW/Mn = 1.003 ± 0.413%), with no obvious
sign of higher order aggregates. Overall, these results show that the constructs had
been purified in their monomeric forms, though the tails in each trace suggest the
presence of a marginally smaller complex.
Figure 5.1: Molar Mass distribution from a SEC-MALS experiment. 0.84 mg/mL of
purified TINTIN was loaded onto a Superdex 200 increase 10/300 GL, connected to a
HPLC system. The sample was loaded and run through the column at a flow-rate of 0.5
mL/min at 25 °C. A Dawn 8+ MALS detector and an Optilab T-rEX refractive-index
detector, were used to collect data. Light scattering is displayed in red, refractive-index
in blue and UV is displayed in green. A strong UV/LS/RI peak is detected at ~12mL,
though there is also a weak LS signal between 7-10 mL. The major peak is followed by
a slight tail, but otherwise appears to account for the majority of protein loaded onto the
column. Molar mass within the major peak appears to slope downward, before reaching
a stable plateau that corresponds to the low-intensity UV/LS/RI tail.
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Figure 5.2: Molar Mass distribution from a SEC-MALS experiment of truncated
TINTIN construct, EA88B (Eaf7, 1-260). 0.71 mg/mL of purified protein was loaded
onto a Superdex 200 increase 10/300 GL, connected to a HPLC system. The sample
was loaded and run through the column at a flow-rate of 0.5 mL/min at 25 °C. A Dawn
8+ MALS detector and an Optilab T-rEX refractive-index detector, were used to collect
data. Light scattering is displayed in red, refractive-index in blue and UV is displayed
in green. As with the full-length complex, a strong UV/LS/RI peak is detected at ~12
mL. This peak is also followed by a slight tail, but otherwise appears to account for the
majority of protein loaded onto the column. The molar mass curve within the major
peak is not as slanted as the full-length complex.
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5.3 Native Mass Spectrometry
5.3.1 Experimental Summary
Native ion mobility mass spectrometry was carried out in the Thalassinos lab with
Charles Eldrid, who also carried out analysis of the raw data generated from the
following experiments. Data was collected using a Synapt G1 (Waters, UK).
Experiments were conducted with the truncated TINTIN construct EA88B, containing
a C-terminally truncated Eaf7 (1-260), which was buffer exchanged into 100 mM
ammonium acetate solution and diluted to 5-10 µM (0.7 mg/mL TINTIN). The
exchange process was costly, with over 50% of the sample being lost as a result. The
mass of each species was determined using MassLynx and Amphirite, which was also
used to calculate collision cross sections (CCS) of TINTIN and associated species.
5.3.2 Identification of TINTIN Species
The full spectrum of the truncated TINTIN construct can be seen in Figure 5.3.
Several species were identified that corresponded to the complete complex, with a
calculated MW close to that of the theoretical value (111 kDa). TINTIN was found to
adopt 3 charge states (+21 to +23).
Interestingly, other TINTIN related species were also detected besides the complete
complex. Most notably, the subunit Eaf5 was detected in 14 different charge states
(+11 to + 25), indicative of a disordered protein. The individual Eaf7 subunit was also
detected, adopting significantly fewer charge states (+12 to +14), while Eaf3 was not
detected as an individual subunit. Futhermore, low-intensity signals were detected for
dimeric Eaf5/Eaf3 (+17 and +18) and possibly a dimeric form of the TINTIN complex
(+31).
A dimeric complex of Eaf3/Eaf7 was not observed, despite the presence of Eaf5
monomer in the spectra.
140
Two additional species were identified in the spectrum, with MW not immediately
correlated to a combination of TINTIN subunits. An 11 kDa species is found,
occupying charge states +6–>+9 and a 91 kDa species, occupying 2 charge states (+20
and +21) are consistently observed in these experiments.
Figure 5.3: Native spectrum of the truncated TINTIN construct (EA88B) from a Synapt
G1, plotting the relative intensity of species observed against their mass/charge ratio.
Significant peaks (corresponding to TINTIN or its component subunits) have been an-
notated and colour coded. Species corresponding to the complex were detected. Species
that correspond to a dimer of Eaf5/Eaf3 are also observed. A low-intensity signal that
may correspond to a dimerization of TINTIN is also detected. Multiple peaks that cor-
respond to Eaf5 and Eaf7 subunits were also detected (the group of peaks have been la-
belled yellow) with Eaf5 adopting 14 different charge states. A dimer of Eaf3/Eaf7 was
predicted to be observed due to the presence of Eaf5 monomer, but was not observed
after multiple iterations of the experiment. A species that correspond to the Eaf5/Eaf3
dimer and corresponding Eaf7 are observed in the spectra. A +22 charge state TINTIN
species was isolated using the quadrupole for further analysis. Unidentified 11 kDa
species (in the monomeric region) and a 91 kDa species are also detected.
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5.3.3 Collision Induced Dissociation
The +22 TINTIN complex was isolated by quadrupole and subjected to collision
induced dissociation (Figure 5.4). The voltage of the collision cell was increased in 10
V steps and upon increasing the trap and transfer to 70 V, a dissociation event appears
to occur, generating multiple highly charged species with low-M/Z values, as well as
larger species with lower charged states. The smaller species were calculated to have a
MW of 31 kDa, whereas the larger species were calculated at 79 kDa, which
correspond to Eaf5 and an Eaf3/Eaf7 dimer respectively.
Figure 5.4: Spectrum displaying the collision induced dissociation of the quadrupole
isolated +22 charge state TINTIN complex. The spectra is produced when the trap and
transfer is increased to 70 V, producing two sets of species in addition to the complete
complex. A set of lower M/Z species with a calculated MW of 31 kDa was detected,
corresponding to the Eaf5 subunit, these species are shown to contain high charge states
for a protein of this MW. Another set of high M/Z species (with low-charge values for
species of this size) were detected in parallel with the Eaf5 species. The MW of this
larger species was calculated to be approximately 79 kDa, which corresponds to a dimer
of Eaf3/Eaf7.
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5.3.4 Collision Cross Section Calculation
Native ion mobility was used to determine the collision cross section (CCS) of
TINTIN (and associated species), to gain a better understanding of physical
dimensions of the complex and to determine regions of flexibility/disorder within the
structure. Collision cross section distributions of each of these species, was calculated
and assessed, providing several structural insights (Figure 5.5).
Eaf5 adopts a broad range of CCS values (2600-5780 Å2) (Figure 5.5A). This
distribution curve reveals a large CCS peak, beside a smaller CCS peak with a
significantly lower intensity. This suggests that the protein is found in two populations,
a smaller CCS (more compact) conformation and a larger CCS (more extended)
conformation, with a higher population.
Figure 5.5B demonstrates the influence of the complex formation on the folding of
individual subunits. The CCS distribution of the Eaf5/Eaf3 dimer, shows a highly
populated peak between 4000 and 5000 Å2, followed by a minor population with CCS
closer to 6000 Å2. This is similar to what was observed for the individual Eaf5
subunit, though the dimer appears to preferentially adopt a more compact
conformation in this instance.
Eaf7 has a comparatively simpler CCS distribution curve (compared to Eaf5 species)
(Figure 5.5C). The CCS distribution of Eaf7 contains a single, significantly narrower
peak. (2840 - 3310 Å2). However, the slight tail in this peak that reaches towards
higher CCS values is also noted and is possibly a reflection of some conformational
flexibility. Figure 5.5D displays the CCS distribution of the complete complex. The
CCS range for TINTIN is a single (relatively narrow) peak, spanning 5680-5740 Å2.
The peak in question has a normal distribution, suggesting the complex formation has
stabilised the otherwise flexible/disordered subunits.
143
The two unexpected species (11 kDa and 91 kDa) were also subjected to this analysis
(Figure 5.6). The 11 kDa species (Figure 5.6A) occupies two CCS populations, a less
populated, compact form and a highly populated, expanded form, similar in behaviour
to Eaf5. The 91 kDa species shows an a preference for a more compact conformation
with a small subset in an extended/disordered conformation, as we observe with the
Eaf5/Eaf3 dimer (Figure 5.6B).
To get a better understanding of the extent of flexibility within the complex and its
component subunits, the median CCS and median charge of each species was plot
against their MW (Figure 5.7). These were compared to mathematical models
generated by Beveridge et al. (2014), that are representative of ordered and disordered
proteins.
Generally speaking, the majority of TINTIN and associated species detected in the
native spectra, appear to possess CCS and charge state distributions, expected of
folded proteins of equivalent molecular mass. One notable exception however, is the
Eaf5 subunit. Eaf5 adopts many charge states for a relatively small protein. Moreover,
as previously mentioned, the CCS values calculated for this monomeric species, are
comparable to that of the Eaf5/Eaf3 dimer, as well as the full-length complex.
The unexpected species are also plot against these models, to assess their
order/disorder. The 11 kDa species has a CCS:mass ratio, similar to that of a
disordered protein. The 91 kDa species however, has a relatively compact
conformation for a protein of its MW.
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Figure 5.5: Collision cross section distribution curves of the monomeric TINTIN and
associated species. Plotting relative intensity (%) against calculated CCS. Charge states
are listed in parentheses. A) CCS distribution curve of Eaf5. The protein is found
in two populations, a more compact (but less abundant) CCS value population ~4000
Å2 and a more extended (and more abundant species) between 5000-6000 Å2. B) CCS
distribution of the Eaf5/3 dimer. As with the monomeric Eaf5, the dimer appears in two
distinct populations, however in this instance, the complex appears to preferentially
adopt a more compact/folded conformation. This is possibly indicative of a stabilising
affect on the Eaf5 subunit, as a result of associating with Eaf3. C) CCS distribution of
the Eaf7 subunit. The CCS distribution is narrower compared to Eaf5, though the curve
clearly contains a slight tail, possibly a reflection of the subunit’s inherent flexibility.
D) CCS distribution of the complete TINTIN complex. The distribution is uniform and
presents a single, narrow population, suggesting that trimer formation stabilises the
component subunits.
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Figure 5.6: Collision cross section distribution curves of species that were not predicted
to be present in the TINTIN sample, plotting relative intensity (%) against calculated
CCS. A) The 11 kDa (+7 species) may adopt two conformations, though the less com-
pact of these conformations is preferentially occupied. B) The 91 kDa (+21) species
also adopts two conformations, though the more compact conformation is preferentially
occupied.
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Figure 5.7: Comparison of physical properties between TINTIN (and associated
species), against mathematical models generated by Beveridge et al. (2014), represent-
ing ordered (black) and disordered (red) proteins. A) Median charge against MW of
experimental species, these have been annotated and colour coded. TINTIN, the Eaf5/
Eaf3 dimer and Eaf7 have charge states indicative of ordered proteins, of equivalent
MW, whereas Eaf5 clearly adopts a higher charge state for a relatively small protein,
indicative of an extended conformation. B) Median CCS vs MW. TINTIN and associ-
ated species have been annotated and colour coded. TINTIN and the dimeric Eaf5/Eaf3
show collision cross sections expected of ordered proteins of equivalent mass, while
both monomers show high CCS values, for relatively low-MW proteins.
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5.3.5 Validation of Eaf5/Eaf3 dimer
The presence of the an Eaf5/Eaf3 dimer in the native ion mobility experiments, was an
unexpected result when we consider the data from Rossetto et al. (2014). When
considered in parallel with truncation studies mentioned in chapter 3, it was speculated
that a direct contact between the two subunits was present within the complex.
As a result, a construct containing full-length Eaf3 and Eaf5 was generated, with a
C-terminal Strep-tag on the Eaf3 subunit (Figure 5.8). This construct was expressed in
Rosetta 2 cells, using LB media at 37 °C until OD reached ~0.6-0.7, before induction
with 0.2 mM IPTG and further incubation (at 18 °C for 20 hours or 37 °C for 3 hours).
Expressions were carried out in small scale (50 mL media). The pellets produced from
these constructs were then subjected to test purifications, to see if Eaf5 would
co-purify with the tagged Eaf3.
The results of these test purifications are inconclusive, Eaf3 may be observed close to
the 50 kDa mark, though it is faint for both constructs, relative to contaminant bands.
Conversely, Eaf5 (MW 31 kDa) is not observed by SDS-PAGE analysis, which should
theoretically appear as intense as the tagged protein.
Biotin elutions of the sample are clear (data not included) and the protein can only be
observed when 20 µL resin samples are loaded onto an SDS-PAGE gel. There may be
a band present that corresponds to the C-terminal of Eaf5 (a common degradation
product from other TINTIN purifications), but this coincides with denatured
Strep-Tactin from the resin.
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Figure 5.8: Small scale purifications (from 50 mL expressions) of an Eaf5/Eaf3 pET-
28a construct. Containing a C-terminal Twin-Strep tag on the Eaf3 subunit. Two ex-
pression conditions are represented in two lanes. Each expression involved growing
Rosetta 2 cells (transformed with the construct) at 37 °C , until OD reached ~0.6, be-
fore either being transferred to 18 °C for 20 hours, or further incubation at 37 °C for 4
hours. Samples are the result of loading 20 µL 1X SDS-PAGE loading buffer onto 50
µL Strep resin and boiling for 1 min. The potential position of subunit bands has been
annotated, as well as the position of Strep-Tactin band from the resin.
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5.4 Small-Angle X-ray Scattering
Small-angle X-ray scattering (SAXS) was carried out on two of the most prominent
TINTIN constructs used throughout this project. This included the EA88A construct
(Eaf7, 1-221) and EA88B (Eaf7, 1-260). Both constructs were purified as described in
methods and results chapter 3.
EA88A was concentrated to 3.38 mg/mL and diluted in buffer A with two consecutive
twofold dilutions to 1.51 mg/mL and 0.72 mg/mL. The EA88B construct was similarly
diluted (3.59, 1.67 and 0.82 mg/mL), in order to generate a concentration series for
SAXS analysis.
Data was collected at the BM29 BioSAXS beamline at ESRF Grenoble (under the
supervision of Dr Nikos Pinotsis) and the following results were interpreted with the
ATSAS software suite (as described in Methods).
5.4.1 Raw Data and Initial Analysis
Raw signal from each of the protein samples was averaged over 10 x 1 second frames
with the buffer signal subtracted (Figure 5.9). The six resulting scattering data sets (2
constructs at 3 concentrations), were subjected to Guinier analysis with the Primus
software package, to evaluate the quality of the data, as well as find an approximation
for both the radius of gyration (Rg) and forward scattering intensity (I(0)) (Figure
5.10).
Guinier analysis shows no obvious signs of aggregation, with straight lines observed
within the theoretical limits of the Guinier approximation. However, analysis of the
Guinier plots (for both constructs EA88A and EA88B) showed increased estimations
of Rg and I(0), as the concentration of the the sample increased.
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Figure 5.9: Representative raw data from SAXS analysis and subsequent buffer sub-
traction. Plot represents the log of intensity vs. scattering vector. Raw data, background
buffer signal and buffer-subtracted signal, have been colour coded.
Raw data was further interpreted using PRIMUS/GNOM and subjected to indirect
Fourier transform, to produce the paired distance distribution (P(r)) function (Figure
5.11A and B). P(r) distributions for both constructs produce asymmetric curves,
suggesting that the protein contributing to the signal is in an extended conformation.
Dmax (the maximum dimension of the particle) was determined from these plots, as
well as Rg, which was in agreement with Guinier estimations.
As with Guinier calculated values, the I(0), Rg and Dmax were found to increase with
the concentration of the sample. For 88A, the Dmax ranged from 20.5-26.6 nm (lowest
to highest concentration), while 88B ranged from 19.6-26.51 nm. Kratky plots of the
raw data (Figure 5.11C and D) suggests that both complexes contain some flexible
regions. This extended/partially folded conformation was observed at all
concentrations.
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Figure 5.10: PRIMUS/GNOM autorg generated Guinier plots from SAXS raw data,
acquired for both EA88A and EA88B truncated TINTIN constructs. Plotting the natu-
ral log of intensity vs the reciprocal of the scattering vector squared. Red lines indicate
lines of best fit within the theoretical limits of the Guinier approximation and green
lines display the residuals. A–>C displays Guinier plots of the EA88A construct of
descending concentration (3.38–>0.72 mg/mL) and D–>F represents the EA88B con-
struct (3.59–>0.82 mg/mL). For both constructs, extrapolation from the Guinier plot to
determine Rg and I(0), varies with the concentration of the sample.
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Figure 5.11: Representative P(r) function and Kratky analysis of both truncated
TINTIN constructs. A) P(r) distribution of the EA88A complex. B) P(r) distribution
of EA88B. Both P(r) functions show tails in their distribution (as opposed to a normal
distribution) which suggests the complex is extended. C and D) Kratky plots of EA88A
and EA88B respectively, suggesting that both complexes are in a folded state, though
the tail at higher s values, suggests some flexibility within the complex.
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EA88A EA88B
Concentration (mg/mL) 3.38 1.51 0.72 3.59 1.67 0.82
I(0) 124 111 97.45 112.8 109 96
Rg (nm) 6.22 5.46 5.15 6.05 5.61 5.08
Dmax (nm) 26.61 23.76 20.5 26.51 24.5 19.58
Porod Volume (nm3) 262.6 230.9 221.4 249.9 228.0 214.0
Calculated MW(kDa) 115 99 89 104 101 88
Predicted MW (KDa) 106 111
Table 5.1: Initial analysis from P(r) function of both the EA88A and EA88B constructs,
comparing the calculated parameters at each concentration tested. Both sets of results
were dependent on the concentration of the protein. MW was calculated using the I(0)
of BSA standard (as described in methods).
BSA standards of known concentration, were used to calculate the MW of the species
producing the scattering signal. Considering the variation in Rg and Dmax with
concentration, MW was calculated for each concentration independently (Table 5.1.).
For EA88A (predicted MW: 106 kDa), the MW calculated ranged from 115 kDa (at
highest concentration) to 89 kDa. Interestingly, the larger EA88B (predicted MW: 111
kDa), produced a smaller set of calculated molecular weight (104–>88 kDa).
Calculating MW by Porod volume, resulted in higher estimations of MW compared to




GNOM .out files from the highest and lowest concentration datasets, were processed
by dammin to produce initial models (Figures 5.12 and 5.13). The P(r) analysis was
used to inform model building parameters, determining the use of a box shape
appropriate for an elongated protein complex (cylindrical), with dimensions that would
accommodate a structure with the calculated Dmax. χ2 values for the generated initial
models (generated in a output .log file by dammin), were checked and found to be
close to the ideal of ~1 and we were satisfied to continue processing.
Figure 5.12: Representative dammin generated initial model of EA88A (Eaf7, 1-221)
from the highest concentration dataset (3.38 mg/mL). The model is rotated 90° along
the x-axis.
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Figure 5.13: Representative of an initial model of EA88B (Eaf7, 1-260) produced by
dammin. The model represents the highest concentration dataset (3.59 mg/mL). The
model is rotated 90° along the x-axis.
Both complexes were purified separately and have a relatively small differences in
predicted molecular weight (~5 kDa). Analysis of the raw data and initial models,
suggest that both complexes are of similar MW (close to predicted MW of monomeric
TINTIN, at higher concentrations) and dimensions.
5.4.3 Refining SAXS Models
Models were further processed using the damaver software suite (as described in
methods). Damsel first aligned the low-resolution initial models using SUPCOMB and
then generated a list of models, based on their normal spatial discrepancy values
(NSD). Any model that deviated from the mean beyond the statistical constraints
(NSD > 2 standard deviations + Mean NSD), were discarded, with the remaining
models aligned by damsup (Table 5.2).
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Table 5.2: Representative summary of a damsel output file, listing all initial models
produced by dammin and ordering them based on their normal spatial discrepancy.
This particular dataset represents a TINTIN construct (EA88A, Eaf7 residues 1-221)
at the highest concentration (3.38 mg/mL), with a mean NSD of 0.788 and an SD =
0.038. None of the models listed have an NSD > (2xNSD+ µ), therefore all models
were accepted and aligned with damsup.
Damsup aligned models were then averaged with damaver and filtered with damfilt
(Figures 5.14 and 5.15). Comparison of high and low-concentration damfilt models,
highlights the concentration dependence of the data, though the two TINTIN
constructs share similar dimensions (Figure 5.16 and 5.17).
SAXS models of both constructs appear to be elongated, as the initial analysis of the
raw data suggested. In both instances, the complex appears to be divided into a large
lobe that extends into a narrower "tail" region. Higher concentration models appear
larger than those produced from the lower concentration datasets, with the larger
models ~5/6 nm longer than the lower concentration models.
However, both constructs produce low-resolution structures of similar shape and
dimensions, with an approximate molecular weight close to theoretical MW of
TINTIN (at the highest concentration values).
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Figure 5.14: Damaver probability map and damfilt model of the TINTIN EA88A con-
struct (Eaf7 residues 1-221, MW = 106 kDa). The structure was generated from the
dataset, that corresponds to the highest concentration of the sample (3.38 mg/mL). The
model is rotated 90° with respect to the x-axis, for a better representation of the entire
structure. The filtered (damfilt output) model is represented in light blue, the surround-
ing mesh represents the damaver probability map.
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Figure 5.15: Damaver probability map and damfilt model of the TINTIN EA88B com-
plex (Eaf7 residues 1-260, MW = 111 kDa). The structure was generated from the
dataset that corresponds to the highest concentration of the sample (3.59 mg/mL). The
model is rotated 90° with respect to the x-axis, for a better representation of the entire
structure. The filtered (damfilt output) model is represented in dark blue, the surround-
ing mesh represents the damaver probability map.
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Figure 5.16: Comparison of EA88A TINTIN construct SAXS models, generated
from highest and lowest concentration datasets(3.38 mg/mL and 0.72 mg/mL respec-
tively). The damaver probability map is displayed as a mesh, with the damfilt average
model displayed as light blue. The higher concentration model is approximately 5 nm
longer than the lower concentration model, possibly the result of some oligomerization/
aggregation event. Both models show an extended conformation, containing a dense
lobe that leads into a narrower tail region.
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Figure 5.17: Comparison of EA88B TINTIN construct SAXS models, generated
from highest and lowest concentration datasets (3.59 mg/mL and 0.82 mg/mL respec-
tively). The damaver probability map is displayed as a mesh, with the damfilt average
model displayed as dark blue. The higher concentration model is approximately 6 nm
longer than the lower concentration model, possibly the result of some oligomerization/
aggregation event. Both models show an extended conformation, containing a dense
lobe that leads into a narrower tail region.
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Chapter 6
Architecture of the TINTIN Complex:
Discussion
162
6.1 TINTIN Oligomeric State
SEC-MALS, IM-MS and SAXS analysis suggests that all purified TINTIN samples
are dominated by the "monomeric" species (a single copy of Eaf7, Eaf3 and Eaf5).
SEC-MALS chromatograms suggest that the most abundant species present in
solution, is this monomeric species, but higher order aggregates are present in trace
amounts for protein purified to <1 mg/mL. Ion mobility mass spectrometry analysis
supports this finding, possibly revealing the presence of a dimeric TINTIN species, as
well as Eaf5 and Eaf7 monomers. Other species that may correspond to TINTIN
subunits, in complex with contaminants/degradation products, may also be present.
The high levels of noise and overlapping peaks in the native MS spectra, make it
difficult to approximate relative abundance of each species accurately. Furthermore,
we cannot rule out the possibility that the buffer exchange into ammonium acetate,
followed by the vaporisation of sample by ESI, has altered the oligomeric composition
of the purified mixture. Eaf7 and Eaf5 peaks for example, are not observed in
SEC-MALS (or gel filtration purifications), neither is the suspected dimer of
Eaf5/Eaf3, which raises questions as to whether these species are artefacts of the
experimental procedure.
The Eaf5/Eaf3 dimer was an enticing prospect, as deletion of the Eaf5 subunit
appeared to reduce the affinity between Eaf7 and Eaf3 (Chapter 3 and 4), which might
hint at direct interactions between Eaf3 and Eaf5 that stabilise the complex. However,
a bacterially expressed dimer has yet to be purified in preliminary trials and the
feasibility of this dimer cannot be verified at present.
A current EM structure of the "core" TINTIN complex, proposes that Eaf5 forms a
weak/transient interaction with the rest of the TINTIN complex (Wang et al. 2018), as
Eaf3/Eaf7 were not present in the reconstruction.
163
CID of the TINTIN complex confirms the weaker/transient interaction between Eaf5
and the rest of the complex, as the subunit is shown to be ejected, while the subsequent
Eaf3/Eaf7 dimer remains stable.
6.1.1 Unexpected Species
The 11 kDa species identified by IM-MS, may correspond to an Eaf5 degradation
product, such as the contaminant species found to run close to the 15 kDa mark in
SDS-PAGE gels. This contaminant is produced in all TINTIN purifications containing
Eaf5 and was verified to be the C-terminal half of the protein, by the St. Andrews mass
spectrometry service. This region has already been proposed to bridge TINTIN to the
rest of NuA4 (Setiaputra et al. 2018).
Faint bands at the 10 kDa mark (SDS-PAGE analysis) were also noted to consistently
appear in the final TINTIN purification product (Chapter 3), though these have yet to
be identified.
If the 11 kDA species is an Eaf5 degradation product, it is potentially binding the
Eaf3/Eaf7 dimer to form a truncated TINTIN complex, similar to the artificially
generated constructs (EA125 and EA147). The 91 kDa species identified in the native
spectra, approximates well to theoretical MW of the complex of truncated Eaf7, Eaf3
and the 11 kDa species. This may explain why the Eaf3/Eaf7 dimer was not identified
in native spectra, despite the presence of Eaf5 monomer.
Weak interactions between Eaf5 and Eaf3/Eaf7 may result in an equilibrium between
the complete complex and these component subunits. The 11 kDa species is
potentially occupying the same interface as the full-length Eaf5 subunit, to form the 91
kDa species.
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SAXS data may also support this hypothesis, as P(r) function analysis of lower
concentration datasets of the same TINTIN construct (EA88B), provides a calculated
MW of ~88 kDa. However, the higher concentration dataset yields a calculated MW of
104 kDa. When the standard experimental error in MW calculations from SAXS data
is considered (±10%), then the lower concentration dataset matches close to the 91
kDa species, whereas the higher concentration MW matches more closely to the
TINTIN species containing full-length Eaf5.
Regardless as to whether this smaller TINTIN complex is represented by the 91 kDa
species observed, it is clear that other species are present in the purified sample,
though in trace amounts. These contaminants will certainly contribute to
polydispersity in the sample and therefore offer a possible explanation, as to why
TINTIN samples could not be crystallised.
6.1.2 TINTIN Structure
In the absence of protein crystals, high-resolution structures by X-ray crystallography
of the purified complex, could not be produced. However, a combination of native
IM-MS and SAXS data, provide insights into the overall dimensions of the EA88B
TINTIN complex (Eaf7, 1-260).
Ion mobility data suggest that while individual TINTIN subunits (Eaf5 and truncated
Eaf7), are extended/disordered to varying degrees, these species collapse into a more
stable/compact conformation upon complex formation.
The CCS values produced from IM-MS experiments, weakly correlate to the square of
Rg, that may be determined by other techniques such as SAXS (Chirot et al. 2010,
Beveridge et al. 2014). The square root of calculated CCS values for the TINTIN
complex is ~76 Å, which is significantly larger than the Rg calculations from SAXS
data (~51 Å).
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This could be a consequence of the weak relationship between CCS and Rg, or due to
the fact that TINTIN has been exchanged into a different buffer and phase for IM-MS
experiments, compared to SAXS experiments. CCS data also suggests that the TINTIN
complex has CCS:mass and charge:mass ratios comparable to folded/ordered protein.
SAXS models from the highest and lowest concentration data points were developed
for the EA88B complex (Eaf7, 1-260) and the smaller EA88A complex (Eaf7, 1-221).
The fact that both complexes, with a ~5 kDa difference in MW, produce structures of
similar shape and dimensions is encouraging. Truncated TINTIN is an extended
complex of ~200-260 Å in length and ~60 Å diameter, which may explain the early
elution profile in SEC purification steps (Chapter 3).
IM-MS data does not give indication of flexibility in the complex (though monomers
and dimeric species indeed show signs of disorder). Conversely, Kratky plots from
SAXS data, suggest that while the structure is folded, there may be regions of
disorder/partial flexibility throughout the complex. Flexibility would also disrupt the
process of crystal formation and when we also consider the presence of the
contaminants previously discussed, it is not surprising that current crystallisation trials
have failed.
The instability of the complex and the suspected flexibility observed, may potentially
be overcome with the inclusion of additional subunits from the NuA4, Rpd3S and Pol
II complexes. Interaction with other factors yet to be identified, may also contribute to
increased stability. Further investigation is necessary to better evaluate TINTIN’s
biological function.
We attempted assigning the Eaf3 chromodomain and the partial Eaf5 structure (from
the TEEAA cryo-EM structure) to a specific region within the SAXS models (data not
included). Unfortunately, these higher resolution structures are significantly smaller
than the overall SAXS model, which prevents accurate results from manual fitting, or
more systematic assignment methods (using software such as CRYSOL).
166
Damfilt models were also manually fit into an existing negative stain structure of
NuA4, which is proposed to contain the TINTIN complex, (Setiaputra et al. 2018).
However, our SAXS structures do not fit particularly well within the negative-stain
reconstruction (data not included). There could be several explanations for this
discrepancy between SAXS models and existing models in the literature.
Firstly, the low-resolution negative stain structure of Setiaputra et al. (2018) may
contain a partial TINTIN complex in their reconstruction (e.g Eaf5 but missing Eaf3
and/or Eaf7). This would not be unexpected, when we consider another
(higher-resolution) structure of NuA4 (Wang et al. 2018) contains Eaf5 in the
reconstruction, but not Eaf3 and Eaf7. Wang et al. speculate that Eaf5 creates a
transient interaction with the rest of TINTIN, which is supported by our CID data.
Alternatively, given the extended conformation and the potential flexibility identified
in Kratky analysis, it is possible that TINTIN undergoes a conformational change upon
interaction with the rest of NuA4. There is precedent for this, as Wang et al. (2018)
show that Eaf5 forms a highly ordered (α-helical) arrangement upon interaction with
Tra1, while the native MS data reported within this investigation, shows that the free
protein is highly disordered and folds upon incorporation into TINTIN. It is possible
that, while TINTIN assembly results in correct folding of its component subunits,
additional folding occurs, upon association with the rest of NuA4.
It is difficult to say at present, which of these two explanations is accurate, but
high-resolution reconstructions of TINTIN, in complex with NuA4 and free of the
coactivator complex, would provide a more definitive answer.
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Chapter 7
Discussion and Future Directions
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Summary
The following chapter takes into consideration all of the data presented herein and
aims to frame it within the context of what is currently known about TINTIN and the
parent NuA4 complex.
Firstly, the assembly of TINTIN subunits and the overall architecture of the
subcomplex is discussed, drawing from truncation analysis. A summary figure is
included, highlighting regions within the three subunits that are likely interacting,
based on said truncation/test-purification analysis. The overall 3D structure of the
complex is then discussed, using purification, native mass spectrometry and SAXS
data, where we conclude TINTIN is likely extended, with some flexibility within the
complex, though high-resolution structural data is not available at present. The
oligomeric state of the complex is also discussed and while all biophysical/biochemical
analysis indicates the presence of a single heterotrimer, higher order aggregates may
be present in trace amounts, which in turn may be impeding the crystallisation process.
A discussion of TINTIN’s interactions with Pol II CTD and chromatin, compares the
pull-down data to what existing literature says about the overall role of the complex.
TINTIN may indeed be interacting with both H3K36me3 and Pol II CTD, though the
data cannot confirm the specificity or strength of these interactions. This data may be
in agreement with the findings of Rossetto et al. (2014), who initially proposed a dual
interaction between TINTIN and both H3K36me3 and phosphorylated CTD. However,
the apparent weakness of binding observed in pull-down assays, may imply the need
for additional factors in the TINTIN recruitment process. Moreover, due to the low
sensitivity of these experiments, we cannot confirm an interaction with Pol II CTD,
though increasing the length of the Eaf7 C-terminal (from residue 1-221 to 1-260),
seems to facilitate low levels of binding.
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7.1 TINTIN Assembly and Architecture
Considering its continued degradation throughout purifications, much of the Eaf7
C-terminal is likely disordered, in agreement with disorder prediction software.
C-terminal truncations from residue 221, do not prevent association between the three
subunits. However, C-terminal truncation from residue 142 does not clearly co-purify
Eaf5 and may be weakening interactions between Eaf7 and Eaf3, despite the presence
of the complete MBD (in Eaf7) and MRG domain (in Eaf3). This suggests an
interaction between Eaf5 and residues 142-221 in Eaf7 and also implies points of
contact between Eaf5 and Eaf3, that stabilise the complex. The latter interaction was
not predicted in cross-linking mass spectrometry studies (Setiaputra et al. 2018), or
pull-down experiments (Rossetto et al. 2014).
When Eaf7 N-terminal truncations (up to residue 86) are combined with C-terminal
truncations (reducing Eaf7 to residues, 86-221 or 86-260), association with Eaf3 was
disrupted. It should be noted that N-terminal truncations of Eaf7, remove half of the
MBD, a domain that likely facilitates association with Eaf3’s MRG domain, as
observed in the orthologous MRG15/MRGBP complex (Xie et al. 2015).
However, this N-terminal truncation alone does not prevent Eaf3/Eaf7 association, as a
complex is restored when Eaf7 C-terminal is present (up to residue 354). This may
reveal additional points of contact made with Eaf3 with this region, that are sufficient
to overcome the loss of a complete MBD in Eaf7.
Yeast Eaf7 MBD, may therefore be less critical for interactions with its partner Eaf3,
compared to human MRG15/MRGBP complex. In addition to a lack of conservation
of key residues, that were shown to make hydrophobic interactions between the two
human domains (Xie et al. 2015), the 31-residue insertion in Eaf7’s MBD, may
contribute to weakening the interaction with Eaf3.
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The yeast complex may utilise additional points of contact, beyond the boundaries of
the MBD and MRG domain, perhaps relying on Eaf5 to stabilise the assembly.
Interaction between Eaf5 and Eaf7, is also prevented upon the truncation of the Eaf7
N-terminal, up to residue 86. Setiaputra et al. (2018), note the presence of a cross-link
between Eaf7 residue 77 and Eaf5 residue 216. Both this data and the truncations
reported herein, support interactions between Eaf7 N-terminal (between residues 1-86)
and the Eaf5 C-terminal (residues 141-279), as essential for association between the
two subunits. This is supported by our native mass spectrometry and purification data,
which suggests that Eaf5 degradation products that have lost their N-terminal region,
can still associate with the rest of the TINTIN complex.
Eaf5 N-terminal truncations, in combination with Eaf7 truncations (that did not disrupt
complex assembly when full-length Eaf5 was expressed), also provide information on
interacting regions. When Eaf5 is truncated from its N-terminal (Eaf5, 141-279), the
truncated Eaf7 (Eaf7, 1-221) can no longer co-purify the rest of TINTIN. When Eaf7’s
C-terminal is extended to residue 260, the trimer is purified, though Eaf5 association
may be reduced.
When we consider the purification results of Eaf5/Eaf7 truncations, compared to Eaf7
truncated constructs, we can identify boundaries for additional sites of interaction. The
C-terminal of Eaf5 (141-279) may make contacts with Eaf7 between 221-260, as Eaf7
requires this region for interaction with the Eaf5 C-terminal. The N-terminal of Eaf5
(1-140) on the other hand, likely interacts with Eaf7 at residues 142-221, explaining
why full-length Eaf5 can associate with Eaf7 (1-221), but not as strongly with the
shorter Eaf7 (1-142).
Removal of Eaf5 entirely, prevents clear association between Eaf7 N-terminal and
full-length Eaf3. Eaf7 (1-260), is capable of association with Eaf3 in the presence of
full-length Eaf5 and the Eaf5 (141-279) construct, but complete removal of Eaf5
prevents this interaction.
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The fact that this interaction is lost in the absence of Eaf5, further supports the notion
that Eaf5 plays a stabilising role in TINTIN and may directly interact with Eaf3. This
has yet to be predicted in other studies (Rossetto et al. 2014, Setiaputra et al. 2018,
Wang et al. 2018).
The result of these purification attempts is contradictory to the CID results, which
show that Eaf3/Eaf7 can dimerize (with the same C-terminal truncation in Eaf7, from
residue 260). However, CID analysis is more sensitive to detecting labile complexes
than by purification and SDS-PAGE. Considering the result of these mass
spectrometry experiments, we cannot rule out the possibility that Eaf3 is indeed
present in test purifications of truncated Eaf3/Eaf7 (Eaf7 1-260), though in lower
abundance, due to the loss of Eaf5.
It is important to point out that an Eaf3/Eaf5 dimer could not be expressed/purified.
While this does not rule out the proposed interactions between the two subunits, it is
clear that any interaction is relatively weak and/or transient, which is why
cross-linking experiments by Setiaputra et al. (2018) did not detect this interaction.
Earlier literature proposes that Eaf5 acts as an interface between TINTIN and the rest
of NuA4, positioned on the periphery of the subcomplex, with a relatively weak
affinity for Eaf3/Eaf7. This includes deletion/pull-down studies by Rossetto et al.
(2014) and the cryo-EM structure of the TEEAA complex (Wang et al. 2018). The
CID mass spectrometry data reported in this investigation, is indeed evidence that Eaf5
sits on the periphery of the TINTIN complex.
However, purifications, native MS, SAXS, SEC-MALS and truncation experiments,
suggest that a stable/complete trimer is not only possible, but more abundant than any
aggregates and dissociated subunits (at the concentrations tested).
172
This is in agreement with ChIP data from Rossetto et al. (2014), which shows Eaf5
localises with the rest of TINTIN, outside of the NuA4 complex. Eaf5 may therefore
compensate for differences between Eaf3/Eaf7 and human MRG15/MRGBP subunits,
that result in the weaker interactions we observe in the yeast subunits.
This stabilising role may prove to be one explanation for the presence of Eaf5 in yeast,
with no known orthologs in higher Eukarya. Figure 7.1 represents a schematic of
proposed TINTIN interaction interfaces, based on truncation studies and in agreement
with existing literature. The figure highlights that points of contact, likely occur over
relatively extensive boundaries.
Figure 7.1: A schematic summary of inter-subunit interacting regions in the TINTIN
subcomplex, deduced by truncation studies and in agreement with existing literature.
Each schematic has been annotated to show the length of the primary sequence, as well
as to identify the boundaries for conserved domains. Dashed lines connect surfaces pro-
posed to interact, which are labelled with black bands and annotated with their residue
boundaries. Eaf3 has been highlighted in red, to emphasise that this subunit has not
been subjected to truncation analysis and exact boundaries for its interacting surfaces,
cannot be deduced within the scope of this investigation.
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SAXS data collected, particularly P(r) functions, indicate that TINTIN is in an
extended conformation. The large interaction boundaries deduced by truncation
analysis, supports the concept of an extended conformation. "Higher resolution"
mutational analysis, coupled with structural data, may identify specific points of
contact, but current data does suggest the potential for many points of contact along all
three extended subunits.
In summary, Eaf7 association with Eaf5, is dependent on contact between the Eaf5
C-terminal (141-279) and two regions in Eaf7 (1-86 and 222-260). Additional points
of contact may be made between Eaf5 N-terminal and residues 142-221 of Eaf7.
Eaf3/Eaf7 association is facilitated by a series of interactions between Eaf3 and
residues 1-354 (in Eaf7). Loss of over 50% of the MBD in Eaf7 does not prevent
association with Eaf3, provided full-length Eaf5 is present and the Eaf7 C-terminal
includes residues up to position 354. The components essential for these interactions,
distinguishes TINTIN from the human MRG15/MRGBP complex.
Future work would evaluate the essential regions within the Eaf3 subunit for TINTIN
assembly and determine a minimal complex that may also allow for crystallisation.
Interaction with additional factors (such as Pol II CTD, Eaf1 etc.) likely require a
full-length complex (Rossetto et al. 2014) and efforts should be made to distinguish
minimally stable truncated constructs, from fully functioning TINTIN. This will prove
difficult in vitro, in the absence of catalytic activity, but may be measured with binding
experiments such as pull-down assays or BLI.
7.2 Structure and Oligomeric State
Trace amounts of disordered monomeric species and higher order aggregates in the
purified protein mixture, are likely the greatest detriment to the crystallisation of the
TINTIN complex. While in low-abundance (based on purification and SEC-MALS
data), future work would look to remove the source of this heterogeneity.
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CID data from mass spectrometry analysis, suggests that the Eaf5 subunit forms a
transient interaction with the rest of TINTIN, in agreement with Wang et al. (2018).
However, complete removal of Eaf5 has so far prevented the co-purification of Eaf3
via the Eaf7(1-260) subunit. Considering this data, questions regarding TINTIN
stability in vivo must be raised, and whether Eaf3/Eaf7 form a dimer (as their human
orthologs do) should be investigated further.
Native MS spectra obtained from the EA88B complex (Eaf7, 1-260), produced two
species that have not been identified with confidence, at present. The 11 kDa and 91
kDa species in question, may correspond to the Eaf5 C-terminal (a degradation
product in all TINTIN purifications) and a complex of this Eaf5 degradation product
with the Eaf3/Eaf7 dimer, respectively. This could explain why Eaf3/Eaf7 dimer
species were never observed in the native spectra, despite the presence of the
corresponding Eaf5 monomer.
Moreover, truncation analysis confirms that the C-terminal of Eaf5, is capable of
interacting with the rest of TINTIN (though contacts in the N-terminal also influences
the strength of interaction). This is in agreement with cross-linking data from
Setiaputra et al. (2018) and also supports the proposed identity of the two species
detected in native MS.
Generating an Eaf3/Eaf7 dimer construct, could remove these contaminant species,
assuming that they are indeed a consequence of Eaf5 degradation. However, constructs
containing C-terminal truncated Eaf7, failed to co-purify Eaf3 (in the absence of
Eaf5). Therefore, constructs containing a more complete Eaf7 must be produced and
tested, for example, spanning residues 1-354.
Parallel to this, the 91 kDa species could be subjected to CID in repeat experiments. If
the species does indeed correspond to a complex of Eaf7(1-260), Eaf3 and the Eaf5
C-terminal, then CID may yield an Eaf3/Eaf7 dimer and the 11 kDa species, similar to
the ejection of Eaf5 that has already been observed.
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The calculated dimensions of TINTIN constructs from SAXS analysis, was
proportional to the concentration of the protein under investigation. The source of the
concentration dependent effect on SAXS data is not clear, but diminishes the reliability
of the final models produced. Removal of Eaf5 may simplify resulting datasets and
comparison to trimeric datasets, may help determine the relative position of subunits
within models.
Native MS and SEC-MALS analysis reveal trace amounts of high-MW contaminants,
possibly aggregates of the TINTIN complex. These high-MW species and the
presence of monomeric species (identified in native MS spectra), will certainly hinder
SAXS investigations and the overall dimensions of the molecule cannot be quoted with
certainty.
However, both truncated constructs EA88A (Eaf7, 1-221) and EA88B (Eaf7, 1-260),
produce highly extended structures of similar dimensions, with molecular weights that
approximate to that of a single TINTIN trimer (at the concentrations tested). The
oligomeric state of the purified TINTIN species is further verified by native MS
spectra.
These SAXS models do not fit well into the electron density assigned to TINTIN,
within a NuA4 negative stain structure (Setiaputra et al. 2018). This may be due to the
absence of Eaf3 and/or Eaf7 in the negative stain structure. Alternatively, this could be
a consequence of additional folding/conformational changes, upon TINTIN interaction
with the rest of NuA4.
For example, while our IM-MS data suggests Eaf5 is highly disordered, the protein
adopts an ordered conformation in the presence of the rest of TINTIN. Eaf5 also
adopts a more ordered, helical conformation when interacting with the Tra1 NuA4
subunit (Wang et al. 2018) and the TINTIN complex may adopt a more compact
structure, upon interaction with the rest of NuA4.
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While the exact dimensions calculated by SAXS analysis need further verification,
initial analysis of P(r) functions and Kratky plots of both constructs at each
concentration, agree on some key features of the complex. P(r) functions indicate the
protein is extended, which may explain why the complex elutes from size-exclusion
columns, at a volume that we might expect to find larger macromolecular assemblies.
We note that Rossetto et al. (2014) observed a similar early elution, in their own
size-exclusion purification protocol.
Kratky analysis indicates that while the complex contains regions of high
order/stability, there may be regions of flexibility. This is again in agreement with our
native ion mobility experiments, which confirm that the trimer has a CCS profile and
charge state distribution indicative of an ordered complex. The partial structure of
Eaf5 in the TEEAA complex, which depicts a subunit comprised of helices connected
by loops/disordered regions, also support the results from this Kratky plot analysis.
Advances in electron microscopy, may lead to a high-resolution structural analysis of
TINTIN, in the absence of successful crystallisation. While the full-length complex is
relatively small, compared to complexes usually investigated with EM, mass
spectrometry and SEC-MALS data, alludes to the presence of "dimeric" TINTIN at
higher concentrations. This dimer may be suitable for the production of
high-resolution EM structures. Whether higher order oligomers of TINTIN are
biologically relevant, should be further explored, perhaps by native MS analysis of the
endogenously expressed and purified complex.
7.3 TINTIN Interactions and Function
Due to weak interactions between TINTIN subunits and the modified H3 tail peptides,
it is hard to discern differences in affinity, for post-translational modifications in
pull-down experiments.
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This also extends to potential interactions between TINTIN and Pol II CTD. The
smaller of the TINTIN constructs (Eaf7, 1-221) has no apparent affinity for any of the
CTD peptides, irrespective of the phosphorylation pattern, though the more complete
of the two complexes (Eaf7, 1-260), may show a slightly increased affinity for the
CTD.
On the other hand, based on current data, increasingly "complete" TINTIN constructs,
do not appear to improve the affinity of Eaf3 for methylated histones, contrary to what
was predicted at the beginning of this investigation. It may be that the complex offers
no additional stabilisation for the chromodomain and is simply a molecular courier for
the delivery of the Eaf3 subunit to the Rpd3S complex, after remodelling events
carried out by the FACT chaperone complex (which Rossetto et al. (2014) showed
directly interacts with TINTIN). The HDAC Rpd3S may in turn accommodate Eaf3, in
a position that presents the chromodomain in a more favourable orientation, for
interaction with methylated sites.
Work by Sun et al. (2008), also determined that the Eaf3 chromodomain had relatively
weak affinity for H3K36me3, in agreement with our own pull-down data. The work of
Rossetto et al. (2014), suggests that both interactions with methylated H3 and Pol II
CTD, facilitate recruitment of TINTIN over coding regions. We could speculate that
the weak affinity for both PTMs, necessitates this dual interaction for in vivo
recruitment of TINTIN, at the correct position and time.
The fact that Eaf3 deletion does not completely abolish recruitment of Eaf7 to coding
regions, implies that the strength of interaction between TINTIN and Pol II CTD, is
sufficient for recruitment. Given the weak interaction observed in our in vitro
pull-down assays, this seems unlikely. It is therefore more likely that additional factors
facilitate TINTIN-Pol II interaction, which would explain why Rossetto et al. (2014)
were able to isolate Pol II from cell-extracts using TINTIN, while our pull-down
assays using purified products, did not show as strong an interaction.
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The possibility of additional factors being necessary for recruitment, may be supported
by a feature observed in the purification of the full-length TINTIN complex. The Eaf7
C-terminal rapidly degrades in all our preparations of full-length TINTIN, to the point
where less than 50% of the subunit remains. This would be energetically wasteful in
the in vivo context and may suggest the protein relies on additional factors, that not
only stabilise, but assist in the recruitment process.
The low affinity for methylated H3 and Pol II CTD, may also enable a rapid turnover
of TINTIN recruitment/release. If recruitment of TINTIN is dependent on the weak
affinity for methylated H3 and phosphorylated CTD, this might ensure that Rpd3S
recruitment of Eaf3 and subsequent demethylation activity, can only occur in the wake
of Pol II (which is phosphorylated at Ser2 during the late elongation stage). In this
way, TINTIN may be responsible for coordinating the activity of complexes such as
FACT, Pol II and Rpd3S in the correct sequence, ensuring high rates of transcription
(via FACT recruitment) and also the correct stabilisation of chromatin in the wake of
Pol II (via Rpd3S recruitment).
A more sensitive, quantitative technique such as bio-layer interferometry (BLI) or
isothermal titration calorimetry, would be better suited for determining subtle
differences in affinity between protein and peptide. Such an investigation would also
be able to determine whether or not there is a preference for specific histone (and Pol
II CTD) PTMs. Increasingly "complete" TINTIN constructs, should also be evaluated
for their peptide affinity, as we cannot dismiss the potential of a biological role for the
Eaf7 C-terminal.
Considering Eaf5 may interact with Pol II CTD via phosphorylated Ser5 (Rossetto et
al. 2014), future experiments would compare TINTIN containing full-length Eaf5 and
the truncated variant, in their ability to pull-down Pol II. This would allow for the
identification of Eaf5 components, that contribute to TINTIN localisation and activity.
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The question as to whether TINTIN directly interacts with RNA polymerase II cannot
be answered with certainty, due to the weak signal from pull-down assays. However,
detection by SDS-PAGE is relatively insensitive, when compared to western blotting,
from which the original interaction was proposed (Rossetto et al. 2014). Pull-down
data may suggest that the EA88B construct (Eaf7, 1-260) is interacting weakly with
Pol II CTD mimicking peptides, though considering the weak bands and no apparent
difference between peptide affinity, we cannot dismiss a non-specific interaction.
However, this binding is not observed in the slightly smaller EA88A construct (Eaf7,
1-221), while sharing similar levels of binding for histone peptides. It may be that the
C-terminal region of Eaf7, is essential for interaction between TINTIN and Pol II
(Figure 7.1). Such a requirement would be unusual, as the C-terminal region is highly
negatively charged, according to ProtParam predictions and evaluation of the primary
sequence of the protein, which we would not expect to bind a highly phosphorylated
sequence. Moreover, the C-terminal region of Eaf7 is not conserved with orthologs,
such as MRGBP and we might expect some form sequence conservation, if this was
the site of a specific interaction.
Ultimately, comparing the full-length TINTIN complex with these truncated constructs
for their RNA Pol II affinity, would be highly informative, especially if the full-length
Eaf7 shows higher affinity for Pol II CTD. If an interaction is indeed confirmed, then
CTD peptides could be applied to purified TINTIN samples, in preparation for further
crystallography trials, or even analysis by electron microscopy.
Future experiments would attempt to replicate the ChIP assays, carried out by Rossetto
et al. (2014), using truncated TINTIN constructs generated in this investigation, that
we observe to form a stable trimer. By doing this, we can attribute truncated regions to
specific phenotypes, for instance the Eaf7 C-terminal truncations, may result in
reduced recruitment over coding regions, if we are to assume this component interacts
with Pol II CTD.
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7.4 Final Remarks
While low-resolution models of the TINTIN complex have been produced, weak
interactions between subunits, flexibility and trace quantities of higher order
aggregates, have impeded the production of high-resolution structures. Comparison of
SAXS models to partial structures and a negative stain structure of NuA4 in the
existing literature, suggests that in vitro TINTIN is more extended, compared to when
it associates with NuA4 (data not included). This may may reflect conformational
changes upon association/dissociation with NuA4, or possibly be an artefact of the
concentration dependence, observed in the initial SAXS data.
However, SAXS and native MS data does allude to an extended complex with regions
of flexibility, which may explain the gel-filtration elution profile of the complex.
Truncation analysis, suggests that points of contact are found across wide boundaries
in the three subunits, which may prove problematic for efforts to remove these flexible
regions, for the purposes of crystallisation.
TINTIN interacts with a number of complexes during transcription initiation through
to elongation, which may include; Pol II, FACT, Rpd3S, NuA4, and SWR1. The
proposed extended conformation of free TINTIN, may facilitate interactions with
multiple complexes, by providing distinct binding interfaces.
CID data concurs with literature, that describes Eaf5 at the periphery of the complex,
with relatively weak affinity for Eaf3/Eaf7. However, Eaf5 likely plays some
additional stabilising role in TINTIN, compensating for the weak MBD-MRG
interaction between Eaf7 and Eaf3, which is not as essential for maintaining subunit
interaction (as observed in the human MRG15/MRGBP complex). The relatively weak
association between Eaf3/Eaf7 (compared to the the human orthologous complex),
could be the basis for Rpd3S recruitment and may enable the HDAC to outcompete
TINTIN/NuA4, for the chromodomain containing Eaf3.
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The delivery of Eaf3 by TINTIN to Rpd3S, may be a critical checkpoint after
chromatin remodelling events, carried out by the FACT complex and in the wake of
Pol II during the elongation process. This would place TINTIN as a conductor within
the overall process, coupling the remodelling events necessary for high elongation
rates, with the subsequent demethylation event, that stabilises chromatin after RNA
polymerase II activity.
While pull-down assays potentially identify an interaction between Pol II CTD and a
truncated TINTIN construct (Eaf7, 1-260), these results are inconclusive and will only
be confirmed with more sensitive techniques.
The TINTIN complex resides at the interface between several key coactivator
complexes and understanding its role within this sophisticated network of histone
modification and transcription, requires further investigation. The features essential for
complex assembly described herein, may inform further investigation, to identify
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Figure 9.1: MobiDB disorder prediction results for the full-length TINTIN subunits.
The predicted percentage of disorder in each subunit is listed for each corresponding
prediction software result. Schematics represent the mobiDB-lite averaged disorder
predictions, and highlights regions of disorder in yellow or orange. Eaf7 is predicted
to be highly disordered between residue 142 and the C-terminal. Eaf5 is predicted to
be primarily ordered, with the exception of a small region of disorder (146-179). Eaf3




Figure 9.2: Example of thermofluor dataset of the full-length TINTIN construct, in
HEPES buffer (pH 7.5) in increasing concentrations of NaCl. Plot is the change in flu-
orescence over time vs temperature. The Tm is defined as the temperature at which half
of the protein species in solution is denatured. Comparison on the x values of minima
of each trace (which represents TINTIN in a different buffer condition) compares their
Tm. More stabilising buffers will produce higher Tm values.
Tm values (°C)
100 mM SPG 100 mM Hepes 100 mM Tris.HCl
50 mM 56.5 56.0 56.0
125 mM 55.5 55.0 55.0
250 mM 55.5 54.7 54.5
500 mM 55.0 54.5 54.0
Table 9.1: Summary of thermofluor experimental results, where 2.7 mg/mL of full-
length TINTIN is incubated in varying concentrations of salt/buffer from the RUBIC
commercial screen. All buffers listed here were used at the same concentration and
pH (100 mM, pH 7.5). Tm values listed above are the average from duplicate experi-




Figure 9.3: Calibration curve of the HiLoad Superdex 200 PG 16/600 column, courtesy
of Dr Alan Cheung. 5 protein standards of molecular weight ranging from 29-669 kDa
were eluted through the column. Elution volumes (Ve) are divided by the void volume
(Vo) which is determined by the elution of a large molecule such as blue-dextran. Plot-
ting the log of the MW of these species against Ve/Vo provides a line of best fit that can
be used to approximate the MW of experimental molecules during purification.
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